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The adjuvants, non-specific substances
stimulating the development of immunity, have
been developed, mainly empirically, in response
to a need for methods which would simplify and
extend the possibilities of vaccine therapy.
Jenner's and Pasteur's convincing demonstrations
of the effectiveness of artificially created
immunity opened up a vast and exciting field;
but in practice the low antigenicity of some
materials, the short persistence of detectable
antibodies and the need for repeated injections,
often hindered its full application in the field
of prophylaxis.
The rapid development of techniques for the
study of humoral immunity which followed Von
Behring and Kitasato's discovery of antitoxin in
1890, led many workers to investigate the factors
which governed the development of serum immunity.
To obtain something for nothing is always
attractive, and the adjuvant effect received a
fair share of attention. Not, however, until
Ramon's and Glenny's publications of 1925 and
1926 did any of the discoveries made lead to
their immediate practical exploitation as an
adjunct to immunization procedures.
2.
The term 'immunologic* or 'antigen adjuvant'
is probably best reserved for substances which
can be given mixed with the antigen and which
have no other gross physiological properties at
their effective dose level. The first sub¬
stances shown to have an adjuvant action were,
however, already known to have a general
stimulant action on the metabolism of the body.
In 1904 Priedberger injected rabbits with
alcohol and at the same time gave them a heat
killed cholera vaccine (Vibrio metschnikovii?)
intravenously. After a single dose of alcohol
they produced up to four times as much antibody
as did controls. Others, given repeated
injections of alcohol, showed a twenty-five fold
increase. Priedberger also appears to have been
the first to notice that an adjuvant effect is
obtained when Gram-negative bacteria are
included in a mixed vaccine. The addition of
heat killed typhoid bacilli to his cholera
vaccine, gave up to 37 times more antibody
against the latter.
Nothing seems to have come of these observa¬
tions at the time, and the next reports are
those stemming from the work of Agazzi in 1909•
He showed that very small doses of arsenic com¬
pounds enhanced the agglutinin production of
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rabbits against Bacterium typhi-giessen. This
effect was confirmed by Friedberger and Masuda
in 1911 who showed up to 32 fold increases in
antibody production by rabbits against
V. metschnikovii, typhoid bacteria and sheep red
cells when single doses of Salvarsan were given
at the same time.
Also in 1911, Hektoen was the first of a
number of workers to report on the adjuvant
action of sodium iodoxybenzoate and similar com¬
pounds whose oxygen content was thought to be
physiologically active. He found that a single
dose of this compound stimulated a tenfold
increase in peak antibody titres in the dog
against goat red blood cells.
In 1916 (a), le Molgnic and Pinoy produced
the first 'lipovaccines* and showed that mineral
oil might be useful not only as an excipient for
vaccines but also as an adjuvant. The subse¬
quent development of oil adjuvants will be
discussed in detail below; the immediate effect
of Le Moignic and Pinoy's work was the widespread
use of oils as convenient vehicles for various
antigens, rather than the exploitation of their
adjuvant effect.
Strong incentives for a search of the
laboratory shelves for substances stimulating
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antibody production were Ramon's first report on
the use of tapioca in 1925 and Glenny et al.'s
exciting discovery of the effect of alum in 1926.
Ramon reported on 7th May 1925 that horses
developing abscesses at the injection site during
routine hyperimrounization with diphtheria toxoid,
developed much higher antitoxin titres than those
without. He found that the deliberate infection
of the inoculation site with streptococci and
staphylococci produced the same effect, but that
there was no increase when an abscess was
provoked away from the site. Ramon experimented
with various materials with the object of pro¬
ducing a sterile inflammatory lesion and even¬
tually found that tapioca was simple to use and
very effective.
Glenny, Pope, Waddington and Wallace (1926)
were attempting to purify diphtheria toxoid by
precipitation with potassium alum and other sub¬
stances. They found that toxoid precipitated
by acetic acid was still an effective antigen,
and was in fact a slightly better one than the
fluid toxoid. This discovery led them to test
the antigenicity of the alum precipitate itself
rather than the purified eluate from it. This
precipitate turned out to be strikingly more
antigenic than the fluid toxoid from which it was
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prepared. In this way the foundation was laid
for the present extensive use of vaccines con¬
taining alum, and aluminium hydroxide precipita¬
ted antigens of all kinds.
Since 1925 an enormous number of
miscellaneous substances have been added to anti¬
gens in the hope of producing an adjuvant effect,
mostly with little rationale except to follow
Ramon and his tapioca in trying to absorb the
antigen or cause some inflammation at the site
of injection. The two pioneers were at the
forefront of this work. In 1926 Ramon reported
that gelatin was effective and turpentine or
toluol, causing tissue damage, were found by
Glenny and Waddington (1928) to produce an
increase in antigenic efficiency similar to that
produced by tapioca. Glenny et al. (1931)
tested cerium nitrate, zinc sulphate, calcium
chloride, tungstic acid and dialysed iron as
precipitants for diphtheria toxoid. They all
had an adjuvant effect. Calcium chloride was
added to diphtheria toxoid and tested in children
by Ramon and Nelis (1932); the calcium chloride
became converted to calcium phosphate so that the
procedure was not as heroic as it sounds, though
repeated injections caused some violent general
reactions. Ramon, Lemetayer and Richou (1937)
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found that saponin caused tissue damage and
scarring but fair adjuvance for diphtheria
toxoid, and again Ramon et al. (1949) showed
that even pectine and glycerine had some stimula¬
ting effect on antibody production against
tetanus toxoid.
Many substances which were tried did not
produce any adjuvant effect; those which do are
a strange miscellany. Lewis and Loomis (1926)
found trypan blue effective in increasing the
production of haemolysin against sheep erythro¬
cytes. Nemchiloff (1937) reported on the
adjuvant action of charcoal, cholesterol, and
codliver oil. Boquet and Sandor (1937) found
bread crumbs, infusorial earth and egg yolk
effective adjuvants and Ungar (1952) mentions the
use of yeast cells. Dresser (1961) showed that
sorbital raon-oleate (Crill 16), sorbital mono-
laurate (Span 20) and oleic acid possessed some
stimulating effect in antigen elimination tests,
and Sakanyan et al. (i960) used caffeine to
increase antibody production to live Brucella
abortus vaccine. Pernis and Paronetto (1962),
after suggestions that some immunologic mechanism
might be involved in the pathogenesis of sili¬
cosis, showed that silica could be used as an
adjuvant.
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Attempts to adsorb the antigen to some
substance so that a depot is formed at the
injection site have become more sophisticated in
recent years. Adsorption on to the latex of
Hevea brasiliensis (cultivated rubber) (Jacotot,
1947) or collodion particles (Ungar, 1952) are
effective methods. Holl and Youngner(l959)
found that influenza virus was strongly and
irreversibly adsorbed to bexdecylamine and lost
its infectivity. Guinea-pigs given the adsorbed
virus produced about ten times more haemaggluti-
nating antibody than controls. hven plastics
have been used, anthrax antigen adsorbed on to
styrene crosslinked by antibody was shown by
Kent and Slade (i960) to be more antigenic than
alum precipitated antigen in sheep, rabbits and
guinea-pigs. A clever method of fixing the
antigen in one place is that of Amies (1959) who
mixed sodium alginate with it. This becomes
converted to insoluble calcium alginate after
subcutaneous injection and the adjuvant effect
is similar to that of aluminium phosphate. More
at
subtle still is the action of phosplwlated
hesperidin. This substance, which inhibits the
action of hyaluronidase (Preston et al. 1953) is
used as an adjuvant for drugs (Cohen et al. 1953).
Martin, Moss and Beiler (1953) found that it also
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acted as an antigen adjuvant in rabbits given
typhoid vaccine and they later showed that it
had an adjuvant action, possibly comparable with
that of water-in-oil emulsions, when used with
influenza virus vaccine, tetanus and diphtheria
toxoids, and pertussis vaccine (Moss, Beiler and
Martin, 1956).
An adjuvant action is shown by some drugs
and physiological effects that,whilst not holding
out much hope of practical application, may be
of value in helping to elucidate the mechanism
of adjuvance. For instance, sensitivity to
horse serum was shown by Swift and Schultz (1936b)
to potentiate antibody formation against lens
extracts in the rabbit. Good et al. (1957)
confirmed this by showing that rabbits, already
sensitised to tuberculin, produced more antibody
against an antigen injected at the same time as a
test dose of tuberculin than did unsensitised
controls. Winter et al. (1962) found that if a
course of treatment with cortisone or prednisolone
was finished a few days prior to sensitization
with antigen there is stimulation of antibody
formation. This is probably due to a 'rebound
effect', i.e. the rapid build up of a depleted
cell population. An intriguing report along the
sane lines is that of Hadnagy (1963) who found
9.
that a cytotoxic serum prepared in the dog and
directed against rabbit spleen, had a stimulating
effect on antibody production by the rabbit.
Once again this is probably due to a rebound of
regenerating cell population. Of the drugs and
vitamins, Katitch et al. (1962) found that B-, ?
had an enhancing effect on tetanus antitoxin
production. Long and Shewell (1955) found that
thyroxine treatment increased the level of
diphtheria antitoxin in the guinea-pig and TJngar
in the same year reported that adrenalin, benze¬
drine and ephedrine stimulated antibody formation
to diphtheria toxoid. Other amines without a
vaso-constrictor action had no effect.
In practical vaccination procedures,
vaccines adsorbed on to alum or similar materials,
for long held the field. Pew of all the long
list of substances cited above have had any
practical application, a strange exception being
saponin which has for long been added to anthrax
spore vaccine for cattle (E.P. lindley, personal
communication, I960). The alarming finding
(Hill and Knowelden, 1950) that inoculation with
alum based vaccines might potentiate paralytic
poliomyelitis; an impression amply confirmed by
Bodian's experiments on monkeys reported in 1954,
led to the near abandonment of this type of
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adjuvant for use in man, though it is still
extensively used in vaccines prepared for
veterinary purposes.
The known stimulating effect of certain
bacterial preparations on toxoidal immunity was
exploited to take its place. Although Fried-
berger in 1904 had shown adjuvance in mixed
vaccines, Ramon and Zoeller (1926) were the
first to mix a toxoid (diphtheria) with a
bacterial vaccine (T.A.B.) and show that the
combination worked well. In 1927 they showed
that T.A.B. had an adjuvant effect in man on
responses to tetanus toxoid given at the sane
time, and in 1936 Bordet first used diphtheria
toxoid mixed with pertussis vaccine to produce
the adjuvant effect amply confirmed by later
workers (Fleming et al.t 1948).
This use of bacteria themselves or their
products as adjuvants had already been
investigated by various workers. Lewis and
Loomis had found Brucella abortus and a strepto¬
coccal infection to be adjuvant (1926). Ramon,
Richou, and Staub (1937) tested Preiss-Nocard
bacilli and Ramon et al. (1949) killed Brucella
abortus. The finding of Swift and Schultz
(1936a) that staphylococcal toxin itself was an
adjuvant is of significance in explaining the
effectiveness of abscesses at the injection site
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as first noticed by Ramon in 1925. She stimu¬
lating effect of Gram-negative bacilli appears to
be due to their endotoxin content, the adjuvant
effect of which was first noticed by Stuart and
Windel in 1951 and then investigated in detail
by Johnson, Gaines and Landy (1954 & 1956).
One of the most important observations was
that of Lewis and Loomis (1924) who noted that
living virulent tuberc^'le bacilli given intra-
peritoneally at the same time as various anti¬
gens, caused enhanced antibody formation to them.
Shis was exploited by Freund and McDermott (1942)
in their outstanding work involving the combina¬
tion of mycobacteria and oil to make the most
widely used and useful adjuvant for experimental
work at the present time. Subsequently it was
found that Freundfs adjuvant was still effective
for many purposes even if the mycobacteria were
left out. The stage v/as thus set for the
development of oils as safe and effective
adjuvants for the immunization of man.
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B. THE OIL ADJUVANTS
Le Moignic and Pinoy (1916a) appear to be
the first workers to have used a vaccine in which
the antigen was enclosed in mineral oil.
Rabinovitsch in 1897 had incorporated myco¬
bacteria into butter and injected the material
into animals, but he was interested in the histo-
pathological response as was Grassberger (1899)
who found that paraffin oil v/as a more effective
vehicle.
Le Moignic and Pinoy found that it was
necessary to use lanolin as an intermediary for
incorporation of salmonellae into the oil. They
therefore produced a true v/ater-in-oil emulsion,
remarking that the bacteria are 'embalmed' in the
oil. Vaccines made in this manner protected
mice against challenge with S. paratyphi B. and
S. typhimurium. In the latter case they
reported that it was markedly more effective than
a saline vaccine, but were mainly interested in
the safety of the materials and the reduction of
reactions. Olive oil was also tried but in
their hands this caused abscesses, though Achard
and Poix in the same year reported on agglutinin
production by guinea-pigs against S. paratyphoid
B incorporated in this oil. Achard and Poix did
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not use lanolin as an eraulsifier and their
results show no adjuvant effect. Later, Le
Moignic and Pinoy (1916b) reported a test in man
of a triple vaccine of S. paratyphi A & B and
Eberths bacillus (Salmonella typhi?), all incor¬
porated in mineral oil. There were no local or
general reactions and excellent titres were
raised against all three antigens.
Whitmore, Fennel and Petersen (1918) incor¬
porated various vaccines into lanolin and
vegetable oils. They showed that a typhoid
vaccine so prepared gave as high an agglutinin
titre after one dose as did three doses of a
saline vaccine. Cecil and Vaughan (1919) used
a pneunococcus vaccine in vegetable oil
extensively in American Army camps and apparently
achieved some degree of protection. They
reported that Whitmore, finding that olive oil
caused some degree of subcutaneous irritation,
now prepared the vaccines with cotton seed oil.
By 1934, these lipovaccines had fallen into
some disrepute and Fleming was of the opinion
that, although they did confer some immunity they
were less effective than saline vaccines.
Perhaps this was partly due to their use as
vehicles for typhoid vaccine. Until very
recently the protective value of all such
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vaccines, however prepared, has been doubted.
It was also due to the unfortunate circumstance
that vegetable rather than mineral oils were
used for preparing the vaccines. It is,
perhaps, understandable that a bland natural oil
should have been chosen rather than mineral oil
with its irritant, inflammable, and carcinogenic
relatives, but Saenz (1937), Friedwald (1944),
Freund et al. (1948), and Berlin (1957) have all
shown that there is very little adjuvant effect
to be obtained from the vegetable oils.
The modern use of oil, linked closely with
the name of Jules Freund as his 'complete' and
•incomplete' adjuvants (i.e. with or without
mycobacteria), began with a chance observation by
Preund et al. in 1937. They noticed that the
complement obtained from guinea-pigs which had
been given a single dose of killed tubercle
bacilli in paraffin oil a year before, gave
false positive reactions when used in complement
fixation tests with tubercle bacilli. This
turned out to be due to residual high antibody
levels in the guinea-pigs, an unexpected finding
as it is usually difficult to raise complement
fixing antibodies against tubercle bacilli even
by repeated injections.
It was known that the suspension of
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Mycobacterium tuberculosis in solid paraffin or
paraffin oil greatly favoured the development of
tuberculin hypersensitivity (Coulaud, 1934;
Saenz, 1939). The new observation of ?reund et
al. suggested that it might influence antibody
formation as well.
M. tuberculosis itself has this effect on
other antigens. In 1924 Lewis and Loomis had
noticed that guinea-pigs infected with tuber¬
culosis produced higher titres of antibody to
unrelated antigens than did non-tuberculous pigs.
They were able to show that living, virulent
tubercle bacilli injected intra-peritoneally at
the same time as an antigen (sheep red cells)
caused enhanced antibody formation against it.
Dienes (1927; 1928) followed this up
by showing that if the antigen was injected
directly into a tuberculous lesion a similar
effect was produced, together with a much more
marked skin sensitization to the antigen, in this
case egg-white. Dienes (1929) also showed that
killed tubercle bacilli given at the same time as
the antigen worked just as well. Later, Land-
steiner and Chase (1940) suspended the dead
tubercle bacilli in paraffin oil before injecting
them intra-peritoneally with the antigen.
The critical contribution of Freund and
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McDermott in 1942 was to incorporate the antigen
into this mixture as well, by the use of an
eraulsifier promoting the formation of a water-in-
oil emulsion.
Preund and ^cDermott's method was to mix the
antigen (horse serum) with Aquaphor, a lanolin¬
like substance used as an ointment base. This
was then blended with paraffin oil in which
killed tubercle bacilli had already been suspen¬
ded, Aquaphor or other emulsifiers were found
to be essential for the formation of a stable
mixture, as had been noticed earlier by Le
Moignic and Pinoy. The mixture was found to
sensitize guinea-pigs to horse serum without
difficulty, and these animals also showed higher
precipitin titres than did controls.
Freund's original mixture, his 'complete
adjuvant' is widely used in experimental work
with laboratory animals. It stimulates the
production of high antibody titres and hyper¬
sensitivity against many antigens. It was soon
found to be very useful for the production of
allergic encephalomyelitis in guinea-pigs by a
single injection of brain or spinal cord (Preund,
Stern and Pisani, 1947) and in other studies of
autoimmunity. It is also particularly useful
in the examination of antigens for impurities by
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raising detectable levels of antibody to minor
components (Kabat, 1958).
Freund himself and other workers carried out
experiments on immunization, with the help of
complete adjuvant, against various diseases of
man such as: Malaria (Freund et al. 1945),
Influenza virus (Friedwald, 1944), and Shigella
paradysenteriae (Halbert et al. 1946).
Unfortunately, disastrous results followed the
only recorded therapeutic use of a vaccine so
prepared. Thousands of cattle in East Africa
which were immunised with a formalinized rinder¬
pest vaccine made up in complete adjuvant,
developed an excellent immunity but also frank or
hidden abscesses at the injection site. These
led to condemnation of the carcases by meat
inspectors at slaughter, or worse, their
discovery in the butcher's shop (Scott and
Ginsberg, 1959).
Killed Mycobacterium tuberculosis itself
was not a component of the complete adjuvant for
the above experiments, Freund and Walter (1944)
and Friedwald (1944) having shown that non¬
pathogenic saprophytic mycobacteria such as M.
phlei were just as effective for most purposes.
The use of light, low viscosity mineral oils like
Bayol F and the simple emulsifier Arlacel A
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(mannide mono-oleate) simplified the preparation
of the water-in-oil emulsions (Freund et al.
1948).
Long before the adjuvant rinderpest vaccine
debacle, the marked local reaction to complete
adjuvant had been noticed. Freund et al. (1940)
even being of the opinion that the greater the
reaction the greater the antibody production.
Quite apart from other objections to the use of
mycobacteria such as sensitization to tuberculin,
these reactions made the adjuvant quite
unsuitable for use in man and for most veterinary
purposes.
The omission of mycobacteria (to form
'incomplete adjuvant') was shown by Freund and
Walter as early as 1944 to cause little change
in the ability of the oil to stimulate antibody
production, though the potentiation of hyper¬
sensitivity was very much reduced (Freund, 1951).
This incomplete form of the adjuvant was an
obvious candidate for development as an adjunct
to the immunization of man and domestic animals.
Tests were soon carried out by Henle and
Henle (1945) who immunized human beings against
A and B strains of influenza virus contained in
a water-in-oil emulsion ('incomplete adjuvant').
Excellent titres of haemagglutination inhibiting
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antibody were obtained, six times higher than
those of controls given saline vaccine. There
was also a persistence of the high titres in the
adjuvant group for at least six months, but
unfortunately nearly every subject developed a
nodule at the injection site and some of these
developed into abscesses.
Undaunted, Henle et al. (1946) continued
with their investigations in man, showing that
with an adjuvant influenza virus vaccine good
'protective' antibody titres lasted for over a
year from vaccination. Mudd et al. (1948a & b)
tested, in nan, Shigella paradysenteriae vaccine
and Hemophilia pertussis vaccines prepared in
the same way. In this case the adjuvant effect
was disappointingly small and the local reactions
severe. Most subjects retained, for 6 to 12
months, subcutaneous nodules which became tender
and increased in size periodically. In 60 per
cent, abscesses either ruptured spontaneously or
had to be opened. Volunteers given a second
dose of the pertussis vaccine developed a rapid
focal inflammation at the site of the nodule and
Mudd et al. interpreted this as a hypersensiti¬
vity reaction of the Arthus type. $he only
hopeful aspect of their report was that systemic
toxic reactions to the shigella vaccine were
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very mild in the adjuvant group.
Doubtless the incomplete adjuvant caused
similar nodules, tissue destruction and abscess
formation in laboratory animals, but this was
easily overlooked under their hair, as such
lesions are much milder than those produced by
the complete adjuvant.
Despite these discouraging effects Salk and
Laurent began to experiment with an adjuvant
influenza virus vaccine in 1952. They used a
more highly purified oil and an emulsifier of a
batch selected as causing no tissue reactions.
They gave the completed vaccine intramuscularly
instead of subcutaneously. The first tests were
done in monkeys which showed maximum antibody
titres 300 times higher than those of controls
given the saline vaccine alone, and these high
titres declined only slightly over a period of
4-12 months. The intramuscular route seemed to
eliminate local reactions, there was no inflamma¬
tion at the injection site and small doses could
not be traced on histological examination.
These results were so encouraging that the
vaccine was tested in man on a large scale.
Salk, Bailey and Laurent (1952) reported that no
local reactions occurred following the intra¬
muscular injection of 2000 doses. There was
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marked enhancement of antibody formation, and a
good persistence of antibody for two years after
vaccination (Salk, 1953)»
Salic1 s results were the turning point for
water-in-oil emulsion vaccines. Once he had
shown that they could be safely and effectively
administered to human beings the way was open
for more extensive testing and the improvement
of methods and materials.
A few cases of cyst formation still occurred
after their use (Bell et al. 1961). This was
traced to a particular lot of the Arlacel A
emulsifier, so tests were worked out to screen
batches for safety (Berlin, 1962). A more
refined and tested oil (Drakeol 6 VR) was substi¬
tuted for Bayol P, and by 1961 over 100,000 doses
of adjuvant influenza virus vaccine had been
given at Americal Naval and Air Force bases
without mishap (Davenport, 1961).
That these vaccines were protective as well
as raising high antibody titres was shown by
Meiklejohn (1962) who obtained a 17:1 protection
ratio against influenza strain A2 in men at an
American Air Force base, though his tests were
controlled by placebo rather than by the saline
form of the vaccine.
Early tests in the United Kingdom were
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unsatisfactory as nodule formation and late
abscesses followed the injection of influenza
virus vaccine in oil adjuvant (M.R.C. Report,
1957). In later trials, however, Hiramelweit
(I960) used toxicity tested oil and emuleifier
and inoculated the vaccine Intramuscularly. Ho
local or general reactions were encountered and
excellent levels of antibody were raised.
Hiramelweit also described a power enulslfier
suitable for the large scale production of water-
in-oil emulsions, which was a great advance on
the laborious 'squirting through syringes' method
previously used.
All these reports laid tbe basis upon which
the world's first commercial, water-in-oil
adjuvant vaccine for human use, was marketed in
this country in 1963. This was 'Admune', an
influenza virus vaccine prepared by Bvans Medical
Ltd. After forty-seven years of effort the
mineral oil adjuvants- had really arrived.
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C. THB MODE OP ACTION OP THE ADJUVANTS
Investigations into the mode of action of
adjuvants divide broadly into two streams? the
first dealing with adjuvants for which some
physiological action on the antibody forming
tissues can be postulated, i.e. the endotoxins,
cortisone, etc.; and the second, those adjuvants
forming an antigen depot at the site of
injection, for instance the alums, and the oil
emulsions. This thesis is mainly concerned with
the last of these adjuvants.
The principal theory of the action of depot-
forming adjuvants was formulated by Ramon in his
first paper in 1925. Ramon suggested that the
oedema, inflammation and collection of leucocytes
at the injection site of tapioca absorbed vaccine,
fixed the antigen in place, protected it from
rapid destruction and allowed its gradual release
into the circulation. Glenny et al. (1926) sub¬
scribed to this theory but also considered that
the purity of their alum precipitated product and
hence the absence of competing antigens might be
of importance. later, Glenny and Barr (1931)
formulated the depot theory in a more precise
form, suggesting that the slow release of antigen
from a depot supplied repeated secondary
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stimulations to the antibody forming apparatus
and that these explained the high titres reached.
Blow release of antigen from the depot was
held to apply also to the water-in-oil emulsions
(Preund, 1947) and this theory is widely accepted
as explaining the action of all adjuvants which
form a depot at the injection site.
Direct support for the theory has come from
a number of workers. Farago (1935) found that
the longer a depot is left in situ, the longer is
a high titre sustained, and. the earlier a depot
is removed the earlier the fall in titre starts.
He also found that the peak titre is lower if the
depot is removed before a maximum is reached.
Ramon (1938) noted that the toxicity of highly
poisonous substances such as tetanus toxin and
strychnine could be greatly reduced by absorption
into tapioca or incorporation into an oil
emulsion. Halbert et al. (1946) found that
active antigen was present in water-in-oil
emulsion for up to 22 weeks after injection, and
Herdegan et al. (1947) found that deterioration
Shigella paradysenteriae antigen in the depot
at the site of injection was associated with a
fall in agglutination titres though the oil
emulsion itself was stable throughout.
The effectiveness of phosphorylated
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hesperidin (a hyaluronidase inhibitor which
prevents the rapid spread of an antigen away
from the injection site) as an adjuvant lends
considerable support to this theory (Moss et al.
1956). Finally, the findings of Parks et al.
(1961) that the injection of antigen into the
cornea or vitreous humour was as effective as
intramuscular injection of the antigen after its
incorporation into water-in-oil emulsion, seems
good evidence that a slow release mechanism can
be effective.
Although it is obvious that a depot of
antigen is produced when these adjuvants are
used and that for some tine at least some leakage
of antigen must occur, several workers have
challenged the view that this is the only
mechanism of their action.
Holt (1950) in a classic monograph on alum-
precipitated diphtheria toxoid reported experi¬
ments showing that:
a) The repeated daily injection of plain antigen
to mimic the slow release from a depot, did not
produce an antibody level comparable to that seen
after the alum-precipitated antigen had been used.
b) The removal of the nodule of antigen and
adjuvant later than seven days after injection
made no appreciable difference to the height of
26.
the antibody response.
c) Pour weeks after the initial injection, encap¬
sulated depots were surgically removed. The re-
injection of the material contained in these into
the animals from which each depot had been
removed, produced a strong secondary response.
This suggested that by four weeks the depot had
been completely walled off and was inactive.
d) Encapsulated depots, carefully dissected out
unruptured from the subcutaneous tissue and then
transferred to fresh guinea-pigs already
sensitized to the antigen by a primary injection,
produced only a tiny secondary response in them
suggesting that any leakage of antigen was very
small indeed and not enough to produce sustained
high tltres.
Holt considered that these results showed that
the depot theory was inadequate.
Other experiments tending to show that the
depot at the actual injection site was
unimportant were reported by Popovici and Gogoa^a
(1955) and Freund and Lipton (1955)• Each of
these reports described the removal of the depot
between 1 hour and 48 hours after injection but
this failed to affect the final antibody titres.
Preund and Lipton were further able to show that
there was a rapid dispersal of particles of
27.
adjuvant (in their case a water-in-oil emulsion)
from the injection site and that these reached
the local lymph nodes within an hour of
injection. This would vitiate the results of
depot excision experiments.
Steiner et al. (I960) showed dissemination
of Preund's complete adjuvant all over the
rabbit's body following subcutaneous injection.
Granulomata were found in the lungs, liver,
kidneys and lymph nodes, a confirmation of the
earlier findings of Rist (1937, 1938) who found
that metastatic lesions in the lungs and lymph
nodes appeared very soon after the subcutaneous
injection of dead tubercle bacilli in paraffin
wax or oil. Holt (1950) reported that very
small doses of precipitated diphtheria toxoid
formed no nodules and that the material was un¬
traceable at nost-morten. He held this to imply
that depots were not necessary for adjuvance but
presumably small depots could have been formed in
lymph nodes and other sites.
Another theory of the action of depot-forming
adjuvants is that an antibody producing
•organelle' is formed round the adjuvant depot.
Preund et al. (1952), when hyperimmunising horses,
found high titres of antibody in the fluid from
areas of inflammation at the site of repeated
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subcutaneous injections of diphtheria toxoid and
oil adjuvant. The antibody concentration in
this fluid was higher than that in the blood so
they suggested that it was actually being formed
at the injection site. Westwater (1940) had
already noted that for the first three weeks
following the injection of dead tubercle bacilli
in oil, complement fixing antibody was more
abundant at the injection site than in the serum.
Salk e"t « (1952) and Salk (1955) strongly
siipported the idea and suggested that the oil and
the emulsifier were as important in attracting
cells to the antigen site as in retaining the
antigen there.
Quite a lot of evidence for the theory has
been accumulated. Oakley et al. (1949) found
that there was as much antibody in extracts from
the site of injection of alum-precipitated
diphtheria toxoid in the rabbit, as there was in
extracts from the local lymph nodes. Askonas
and Humphrey (1955) showed that the granuloma
tissue at the site of injection of Freund's
complete adjuvant in the rabbit was actively
producing antibody and they calculated that it
could account for 80/> of the total antibody in
the serum. White, Coons and Connolly (1955a &
b) using fluorescent antibody techniques, showed
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that there were many antibody-containing cells in
the alum granuloma, but in contrast to Askonas
and Humphrey's findings they were not seen when
oil and tubercle bacillary wax was used as the
adjuvant.
White, Coons and Connolly's (1955b) findings
of "a remarkable systematized stimulation of the
reticuloendothelial system" with the oil
adjuvant rather than local activity is difficult
to reconcile with Askonas and Humphrey's showing
that there was great antibody forming activity at
the depot. The antibody and antibody containing
cells found there may perhaps be considered as
having been chemotactically attracted because of
the presence of antigen. On the other hand, it
may be that the actual placing of the depot, in
panniculus muscle, loose connective tissue, fat
layer, semi-intraderraally, etc., may have some
bearing on these differences.
Many other suggestions to account for the
action of the depot-forming adjuvants have been
made, either to stand alone, or as additions to
the classical slow release theory. Landsteiner
(1946) suggested that the particulate state of an
alum precipitated antigen was probably important
as it facilitated phagocytosis from the depot.
Burnet (1959) suggested that a sensitive cell
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able to react with the antigen at once and form
a clone of antibody producing cells might not be
present in the body at the time of vaccination.
The slow release of antigen from the depot would
then ensure that it was available for an extended
period during which such a cell might arise by
random mutation. However, there seems to be no
evidence for the widely different response time
between individuals of the same species which
would be implied by this idea. The first
appearance of detectable antibodies may show
considerable variation in time, but the slow
starters usually only show low peak titres
implying a variation in quantity rather than in
the time of initial stimulation.
Dale (I960, 1961) found that marked
lymphatic proliferation occurred in the neigh¬
bourhood of Freund's adjuvant depots. This she
considered might lead to a more efficient
direction of the antigen to the local lymph nodes
rather than its rapid dispersion into the blood.
Some support v/as given to this suggestion by the
work of Bishop (1961) who injected the antigen
uncorabined with, and at a different site from,
oil adjuvant. He found that the latter was only
effective if the lymphatic drainage from the two
injection sites was the same.
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The inflammatory response was found to be
important by Wilner et al. (1963) who showed that
there was a positive correlation between the
effectiveness of various hydrocarbon oils as
adjuvants and their irritant properties. Wilner
et al. and Berlin (I960) also showed that the
more viscous the emulsion, the less the adjuvant
effect. This suggests that release of particles
of emulsion from the main depot is important.
Oil alone has no adjuvant action according
to Preund et al. (1948) and simple lipids such as
ethyl palmitate, cholesterol oleate and glycerol
trioleate seem either to have no effect at all
when given v/ith a particulate antigen or only to
depress the antibody response. They are,
however, very active in modifying the phagocytic
activity of the reticulo-endothelial system
(Stuart and Davidson, 1964).
On the other hand, Stanley (1950) showed
that the lipoids of Aspergillus fumigatus, and
Listeria monocytogenes, and also lecithin,
augmented antibody production against Salmonella
typhi-murium. Preund et al. (1948) found that
lipids extracted from M. tuberculosis had an
adjuvant effect, though not all of the tubercle
wax D fractions tested by White et al. (1958)
were active. Pound (1958) carried out experi-
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ments which showed that these lipids acted only
by stimulating the lymphoid and reticulo-endo-
thelial tissues. They neither bound the antigen
at the site of inoculation to make a depot, nor
formed a more potent antigen by combining with it.
Dresser (1961) thought that lipid and
lipiaophilic substances showing adjuvant activity
might in some way stimulate cells to take up
antigen, possibly by damaging their cell mem-
brances. The lipid A portion of the endotoxins
of gram-negative bacteria is thought to be
responsible for their adjuvant activity
(Farthing, 1961). Thus it is possible that the
oils do in fact have some subtle action on the
antibody forming, or antigen recognizing tissues.
The most recent, detailed investigations,
are those of McKinney and Davenport (1961) who
used water-in-oil emulsion vaccines, and a model
system of cotton wool pellets implanted sub-
cutaneously. They concluded that an initial
large loss of antigen from the injection site was
important, that a continual leak of antigen from
the depot was essential for the maintenance of
titres at a high level, and that the early
inflammatory response round the depot occurred
during a critical period so that antigen was
being released whilst cells were available
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locally to react with it. By transferring the
granuloma enclosed antigen depots to fresh mice
they demonstrated that these were not antibody
forming organelles of any importance.
All this evidence is difficult to sum up,
isolated investigations have been carried out on
such a variety of substances and mixtures of
substances under different conditions that it is
not surprising that many results are contra¬
dictory. With Freund's adjuvant in particular,
it may be that it is acting both as a depot type
adjuvant and also as one having more far-reaching
effects when mycobacteria are added to make the
'complete' form. Prom the glimpses of their
mechanism that we have gained so far, it appears
that: the slow release of antigen over an
extended period is important, that small dis¬
persed depots may be as important as the large
one at the injection site, that the concept of
gross antibody formation round the main depot
only applies in special cases, and that the
inflammation and reaction set up by the adjuvant
around the depots may lead to a better utiliza¬
tion of the antigen than occurs without adjuvant.
That these depot-forming type of adjuvants have
any more direct physiological action on the anti¬
body forming cells is problematical.
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D. THE PRESENT INVESTIGATION
The objects of the present investigation
were, first, to fill in some of the gaps in our
knowledge of the basic pattern of antibody-
response to an antigen given in water-in-mineral
oil emulsion, and second, to carry out experi¬
ments to help clarify the unresolved problems of
their mode of action. Aspects of the basic
response were chosen for study with reference to
the practical use of adjuvant vaccines in man and
animals; particularly with regard to the effect
of subsequent injections of the same or other
antigens and the formulation of adjuvants more
easily handled than the usual viscous emulsions.
To simplify these investigations, the
response of mice to a single subcutaneous dose of
a pure protein antigen in water-in-oil emulsion
was taken as the standard with which the other
results could be compared.
A pure protein antigen was chosen to avoid
the possible presence of a toxic or adjuvant
moiety as might occur in an antigen derived from
a micro-organism. This antigen was ovalbumin.
It was prepared by chromatography because
commercial, crystallized samples were found to
contain conalburain, an impurity reported to
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interfere with the tanned cell agglutination
test. Some further investigations on this point
were carried out.
The antigen was given subcutaneously as this
is the usual route for vaccination. Multiple
doses were not used, for though they nay raise
very high titres, the presence of a secondary or
even hyperimmune response is confusing. The
prime requirement of an adjuvant should also be
that an excellent response follows a single dose.
Mice were used as the experimental animals.
Individuals are easily bled repeatedly and they
could be obtained in the numbers necessary to
carry out a wide range of experiments.
Mineral oils and emulsifiers are poorly
defined materials. Toxicity tested batches
supplied for the preparation of human vaccines
were used to prepare the emulsions, in order to
reduce this variable as much as possible.
Serum antibodies were titrated by the tanned
cell agglutination test, a technique which is
very sensitive, yet easy to carry out. After
some investigation of variables in the method of
preparing the cells, formalinized cells were
coated in large batches and preserved by
freezing. These cells could be used at any time
and batches checked against each other for
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variations in sensitivity.
In addition to studies of the mode of
action of adjuvants in experimental animals, the
author participated in trials with human
volunteers. This was undertaken to study the
antibody response and reactions to an adjuvant
type influenza virus vaccine which was to be made
available commercially in this country. The
water-in-oil type of adjuvant was thus seen in




A. EXPLANATION OP SPECIAL TERMS AND





This term indicates the standard
mixture of nine parts of Drakeol
6-VR with one part of Arlacel A,
sterilized by Seitz filtration.
Ovalbumin purified by ion exchange
chromatography is meant when the
term 'ovalbumin' without any
qualification is used in descrip¬
tions of experiments carried out
by the author.
Weights of ovalbumin given refer
to the freeze dried material.
This is a 0.85 per cent W/V
solution of sodium chloride in
distilled water.
Titres are recorded as the







C.P.S. ® cycles per second.
G = relative centrifugal force
x gravity.
g = gramme.
G.M. titre = geometric mean titre.
H.A. unit = haemagglutinating unit.
IgG type antibody = 7Sif, f °r V ss antibodies.
IgM type antibody = J^M, or 19S JT antibodies.
m/a = milliamperes.
mgm or mg = milligramme.
ml = millilitre.
mm = millimetre.
M.S.E. = Measuring and Scientific
Equipment ltd., London S.W.I.
mji = millimicron.




P.B.S. = phosphate buffered saline.
U.V. = ultra violet.
V = volts.
W/V = weight in volume.




Details of the materials used and their
suppliers have usually been given with the first
mention of each in the Methods or Results
sections. Other materials and equipment are
listed below.
Acetate buffer for ion-exchange chromatography
Solution A. 0.1 M ammonium acetate
(7.7 g CH3COONH3 in 1000 ml
distilled water).
Solution B. 0.1 M acetic acid
(5.7 ml glacial acetic acid
in 1000 ml distilled water).
Some of the combinations needed to obtain a
desired pH are:
£H Solution A Solution B
4.2 14 ml 34 ml
4.4 19 ml 31 ml
4.7 27 ml 23 ml
5.0 35 ml 15 ml
5.3 43 ml 7 ml
Higher pH values were obtained by adding a 0.1 M
solution of sodium carbonate as required.
Adjuvants
Preund's Incomplete Adjuvant (a mixture of
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the mineral oil Bayol P, 8.5 parts, with Arlacel
A, 1.5 parts) and Preund's Complete Adjuvant (as
above but with the addition of 5 mg of dried,
heat killed Mycobacterium butyricum to each 10 ml)
were obtained from: Baird and Tatlock (London)
Ltd., Chadwell Heath, Essex, the British agents
of the Difco Laboratories Inc., Detroit, U.S.A.
Agglutination plates
World Health Organization plastic agglutina¬
tion plates (8 x 10 wells) were obtained from:
Prest?/are Ltd., Raynes Park, London S.W.20.
Aluminium hydroxide gel
A sample of 'Alhydrogel* brand of aluminium
hydroxide gel was kindly supplied free by the
manufacturers: Dansk Svovsyre-OG Superphosphat-
Pabrik, Copenhagen.
Animals
The mice used in the experiments were either
The Laboratory Animals Centre Grey strain, bred
in the Bacteriology Department animal house; or
Swiss white mice obtained from the M.R.C.
Clinical Endocrinology Research Unit in
Edinburgh. Both strains were random bred.
Rabbits, of various breeds, were obtained




A sample of the ointment base •Aquaphor'
was presented to the laboratory by Professor S.
Raffel of Stanford University.
'Arlacel'
A supply of Arlacel A was most kindly given
by Dr. D. Hobson of Evans Medical Ltd. Arlacel
A (mannide mono-oleate) is a product of the
Atlas Powder Company, ¥/ilmington, Delaware.
Carboxymethyl-cellulose
Whatman CM 70 carboxymethyl-cellulose powder
was used for ion-exchange chromatography.
'Courlose' commercial CM-cellulose purchased
from J.M. Steel and Co., Glasgow, was used for
removing excess water from proteins held in
dialysis tubing.
Conalbumin
A specimen of electrophoretically pure
conalbumin was most kindly supplied by Dr. I.E.
Lush of the Agricultural Research Council Poultry
Research Centre, Edinburgh.
Corks
Small natural corks (3/8th x 1/4PI x 3/16th
inch) suitable for stoppering Durham tubes were
obtained from Symington and Dumbreck, 32 South
Portland Street, Glasgow C.5.
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Crystalline ovalbumin
Twice re-crystallized ovalbumin was
obtained from L. light and Co. Ltd., Colnbrook,
England.
Dialysis tubing
Visking cellulose tubing, size 18/32 or
32/32 was used. This is manufactured by the
Union Carbide Corpn., U.S.A.
Distilled water
De-ionized, or occasionally glass distilled,
water was used.
Durham tubes
Very small glass test tubes were used for
collecting mouse blood, storing sera and for
many other purposes. These were the Durham
tubes normally employed to test for gas production
by bacteria in sugar solutions. The most useful
type were those supplied by G.W.S., sized 20/21
x 6/7 mm. Natural corks of a standard size to
fit these tubes were obtained from Symington and
Dumbreck, Glasgow. The tubes were supported
during use in wooden blocks drilled with
9/32 inch holes.
After use, the Durham tubes were cleaned by
putting them into a conical flask partly filled
with a solution of detergent. The flask and
43.
contents were gently agitated, as in a 'Bendix'
washing machine, by being placed in a wire test
tube basket attached to a 'Matburn* blood cell
suspension mixer. When clean, the tubes were
rinsed many times with tap water and distilled
water before being dried in the hot air oven.
On occasion it was also necessary to steep the
tubes overnight in dilute caustic soda to remove
traces of blood clot, etc.
'Matburn* blood cell suspension mixer
This most useful piece of equipment consists
of a metal gramophone turntable inclined at an
angle of about 45°, which can be made to revolve
at a slow speed. The edge of the turntable has
spring clips of various sises to hold bottles
and it was also found possible to attach a
6x6x6 inch wire test-tube basket to the
centre. larger bottles and flasks could be
placed in this. Depending on the position in
which a bottle was placed, it received very
gentle or more vigorous agitation, but without
the more violent type of shaking produced by
machines of the reciprocating type. The mixer
is supplied by Baird and Tatlock (London) Ltd.
Mineral oil
A bottle of Drakeol 6-VR was most kindly
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supplied as a gift by the Pennsylvania Refining
Company, Butler, Pennsylvania.
Miniature pipettes
Small Pasteur pipettes only 7 cm long were
used extensively for the work reported in this
thesis. They were prepared from soda glass
tubing having an outside diameter of about 5 mm
and an internal diameter of about 3 mm. Rods
11 cm long were cut from this material and drawn
out in a small Bunsen flame to make two pipettes.
These were cut to a length of exactly 7 cm each
and then sorted into classes according to the
diameter of their tips. The sorting was done
with the assistance of a special gauge. This
was a small sheet of copper with a V-shaped slot
cut into it and marked off in four sections.
After manufacture or washing the pipette tip
sizes could rapidly be checked with this.
Those suitable for removing sera from
blood samples, etc. These were the
smallest and had a tip diameter of less
than 0.5 mm.
Those used for bleeding mice from the
eye. External tip diameter of about
0.7 mm.
Those used for preparing 1:10 dilutions





agglutination test. Tip diameter
about 1.5 mm.
Size D. Those used for making doubling dilutions
with the aid of an automatic syringe.
They were slipped into a hole bored
through a cork attached to the tip of
the syringe. These pipettes were the
widest with a tip diameter of over
1.75 mm.
Immediately after use all pipettes were
dropped point first into a 250 ml plastic beaker
filled with a detergent solution. After
soaking in this for some time they were washed
well with many changes of tap-water followed by
changes of distilled water before being dried in
the oven. Being all of the same length they
were very easy to handle in the beakers.
Occasionally the pipettes were allowed to
soak in dilute caustic soda for a few hours or
overnight. This was particularly necessary to
clean those which had been used with whole blood.
Tween
Tween 80 (T.B. Culture Grade) was obtained
from Honeywill and Stein Ltd., London. Tween 80
is polyethylene sorbitan mono-oleate.
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Ultrasonic disintegrator
An M.S.E. (Measuring and Scientific
Equipment Ltd., London S.W.l)/Mullard,ultrasonic
disintegrator was used to form emulsions. The
titanium probe with a diameter of 1 cm was found
to be the most suitable. The frequency of the
ultrasound produced could be varied from 18,000
to 20,000 c.p.s. The machine was tuned within
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1. The separation of egg-white proteins by ion-
exchange chromatography on carboxymethyl-
cellulose
Ion exchange, the reversible exchange of
ions in a solution with those of an insoluble
material, is well known in its classical form in
the domestic water softener. The development
of synthetic resins led to its much wider
application particularly with organic materials.
Peterson and Sober (1956) first employed carboxy-
methyl-eellulose for the separation of proteins
by this technique and Rhodes, Azari and Peeney
(1958) used the same material to separate the
proteins found in egg-white.
Rhodes et al. applied the whole egg-white
at a low pH to a column packed with carboxy-
methyi-cellulose. By passing a series of
buffers of increasing pH through the column the
component proteins of the egg-white were
separately eluted. Their method was followed
in the present work.
a) Pre-treatment of the carboxymethyl-cellulose
(CM-oellulose)
Twenty-five grams of CM-cellulose were
steeped overnight in distilled water. The
swollen material was then placed in a large
conical flask with side arm and de-aerated under
the vacuum from a filter pump. This took
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several hours with magnetic stirring and
frequent shaking.
The supernatant fines were next removed
from the slurry. The mixture was allowed to
settle for some minutes until a clear cut
surface could be seen above the deposit. The
supernate and small particles still suspended
were then removed by sucking them off with a
pipette attached to the filter pump. This was
repeated several times until the heavier material
would settle out in about five minutes leaving a
substantially clear supernate.
Unless the removal of fines was done
adequately it was found that the columns gave a
very poor flow rate.
b) Column packing
A column of the form shown in figure 1 was
used. This was the receiver of the Parnas-
Wagner automatic discharge arrangement of a
micro Kjeldahl apparatus (part number NR 653;
Gallenkamp and Co. Ltd.). It was 20 cm long and
5 cm in diameter.
The narrow portion at the bottom was filled
with glass beads and these were covered with a
thin layer of glass wool to obtain a flat base
for the packing.
D I.
Fig.l. Separation of egg-white proteins by-
ion exchange chromatography on CM-cellulose.
Details of the column packing and arrangement of
the apparatus for elution by stepwise pH changes.
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About one fifth of the carboxymethyl-cellu-
lose,which had been soaked and de-aerated a3
detailed above, was fed into the column as a
slurry in distilled water. The column had
already been filled with water to the level of
the glass wool and as the CM-cellulose settled,
water was allowed to escape slowly by opening
the screw clamp at the bottom. When the surface
of the CM-cellulose was still just wet, a wide
glass rod was used to tamp down the packing as
tightly as possible. More water was allowed to
escape as this was done, care being taken to
avoid any entrapment of air. More aliquots of
the slurry were added and tamped down as hard as
possible until the column had been filled as
shown.
The packing occupied a volume of about
150 ml and it was found that when really well
packed the column held water by capillary action.
Even if allowed to run dry, air was not drawn
into it.
A disc of filter paper was placed over the
surface of the CM-cellulose to prevent its
disturbance by the eluting and washing buffers
dropped on to it. Air was passed into the glass
bead packing at the bottom to increase the crisp-
ness of the changes in the components eluted.
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The columns were kept at 4° when not in use^
without any preservative.
c) Cleaning the column before use
Several litres of N/10 hydrochloric acid and
N/10 sodium hydroxide were alternately and
quickly passed through the column. Finally one
litre of 0.1M (7.7 g/litre) ammonium acetate was
passed through it. The column was then ready to
he equilibrated with the starting buffer.
This equilibration was done at a very slow
flow rate and samples were taken at Intervals to
be checked for pH. When several hundred milli-
litres of buffer at the wanted pH had passed
tfo- cdwmn
through,A" was considered to be ready for use.
All buffers, etc., were de-aerated and
filtered before being passed through the column.
d) Preparation of the materials to be
fractionated
Fresh eggs were broken into a large Petri
dish and the thin portion of the white carefully
transferred to another container with a Pasteur
pipette. This egg-white was then homogenised
for 5-10 minutes in an M.S.E. (Measuring and
Scientific Equipment Ltd.) homogeniser at a speed
just below that at which marked frothing occurred.
It was then put into Visking dialysis tubing and
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dialysed against several changes of 0.1M acetate
buffer, pH 4.2, for two days at 4°. During this
time a precipitate of ovomucin developed. This
precipitate was removed from the egg-white by
centrifugation at 3000 G for 30 minutes in the
cold.
Partly purified egg-white proteins in
solution in distilled water were dialysed over¬
night against the starting buffer to bring them
into equilibrium with it. If any precipitate or
denatured ovalbumin was present the solution was
filtered before being applied to the column.
e) Application of egg-white proteins to the
column
To avoid contamination of the upper flask
(fig. 1), the stopper at the top of the column
itself was removed and the dialysed material
poured directly on to the CM-cellulose. This
was done with care and in small volumes at a time
to avoid frothing. The screw clamp at the
bottom of the column was opened to allow the
displaced liquid to run out and it was closed
again when all the liquid had been absorbed into
the packing.
f) Elution of proteins from the column
(i) Using stepwise pH changes
After the egg-white protein had been
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applied, a small qiaantity of the starting buffer
was allowed to run in to form a shallow pool on
top of the CM-cellulose. The eluting buffers
were then run through, in order, from the
reservoir above as shown in figure 1. The rate
of flow was controlled with a screw clamp. It
was found convenient to draw off to a point, the
glass tube leading into the column. It was then
cut, as one would cut a dropping pipette, to
Morse gauge 36. A dropping rate of 76 per
minute then gave a flow of about 4 ml per minute.
This was the usual elution rate used with this
column.
All of the previous buffer, including that
forming the shallow pool above the packing, was
allowed to enter the column material before the
next buffer was applied.
(ii) Using a gradient buffer
This is a method by which a buffer of
continuously varying pH can be passed through the
column.
The apparatus was arranged as shown in
figure 2. The starting buffer (300 ml) was
placed in the container B and stirred magneti¬
cally. Buffers of increasing pH were added from
the reservoir A, the flow being controlled by the
screw clamp. The mixed buffer siphoned out of
Fig.2. Chromatography of egg-vhite
proteins on CM-cellulose. The apparatus used
for elution of the proteins by a gradient pH
change. Details of the column packing are
shown in fig.l.
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container B and passed through the column.
The buffer was allowed to fall into a
shallow pool above the packed surface of the CM-
cellulose. This pool was introduced at the
start by opening the side arm for a short while.
As the whole system was airtight the flow rate
could be accurately controlled by the screw
clamp below reservoir A. A flow rate of 76
drops per minute was used.
g) Fraction collection
With both methods, fractions of approxi¬
mately 20 ml each were collected by hand in 1 oz
screw capped vials.
h) Treatment of the column after use
After use the columns were purged of
remaining proteins and prepared for the next
fractionation by passing through them the
following solutions:
500 ml N/10 NaOH
500 ml N/10 HC1
500 ml N/10 NaOH
750 ml 0.1M ammonium acetate
and then about 1000 ml of the starting buffer
until the eluate was of the same pH.
If bands of colour were seen passing down
the column whilst the second wash of NaOH was
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being passed, the washing with acid and alkali
was repeated.
i) Measurenent of pH
An Electronic Instruments Ltd. Model 23A
Direct Reading pH meter with ordinary glass and
calomel electrodes was used to measure the pH of
the buffers used and of the fractions collected.
When great accuracy was required the special
'extended range facility*, which doubles the
scale over a smaller range, was used.
The calibration of the instrument was
checked at frequent intervals (before each buffer
and between every five or six fractions) with a
standard buffer prepared from tablets (Burroughs
?/ellcome and Co.).
.1) Measurement of protein concentration
(i) The biuret method
This was used when fractions contained a
large quantity of protein such as those from the
initial fractionation of egg-white. The method
used was adapted from that of Pleury and
Eberhard (1951).
Reagent. The following solution was made up:






When the solids had dissolved 350 ml
of 0.1 N NaOH was added. The reagent
was used on the da;/ of preparation.
Method. One ml of each fraction was added to
4 ml of the reagent and the mixture
allowed to sta/id for half an hour.
The light absorption of the liquid was
then measured with an EEL portable
colorimeter Model A (Evans Electro-
selenium Ltd.). Buffer and biuret
reagent were used as a blank. The
green filter OGR 1 was found to be the
most suitable.
The readings of the colorimeter were used
as they stood. No attempt was made to obtain
absolute values by comparison with protein
solutions of known strength.
(ii) Spectrophotometry method
When there was little protein present it was
determined by measuring the optical density of
the solution in ultra-violet light at 280 mji, A
Unicam spectrophotometer type SP 500 was used.
The light source was a hydrogen arc and fused
silica cells were used for the samples. If
necessary the samples were suitably diluted to
obtain a reliable reading.
Protein concentration was recorded as
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optical density at 280 nyti and not converted to
protein.
A great advantage of the method was that no
portion of each fraction was lost in making the
estimation.
k) Preservation of the purified proteins
Fractions containing the wanted materials
were pooled and filled into dialysis tubing. A
layer of commercial grade carboxymethyl-cellulose
powder ('Courlose', J.M. Steel and Co., Glasgow)
was placed in an aluminium bread tin, the filled
dialysis tubes placed on top and more of the CM-
cellulose added to cover them. The tin was
stored at 4° until the desired reduction in the
volume of protein solution had taken place.
The now jelly-like CM-cellulose adherent to
the tubes was washed off with cold tap water and
the tubes tied off short to confine the protein
to a small volume. To remove the remaining
buffer salts the tubes were dialysed for several
days at 4° against changes of distilled water.
Finally, the materials were freeze dried in
an Edwards High Vacuum Ltd. Speedivic Model 10?
freeze dryer. This type of machine can deal
readily with large quantities of liquid in flasks.
Primary drying only was carried out, without the
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use of phosphorus pentoxide.
The resultant powder was stored in glass
vials closed with screw caps and rubber washers.
2. Short method for preparing recrystallized
ovalbumin from egg-white by salting out with
ammonium sulphate
This was adapted from the methods of
S^rensen (1915) and Cole (1933, as described by
Koch and Hanke, 1953)* Fresh egg-white is
acidified with acetic acid which causes some
precipitation of ovomucoid. It is then brought
to 44 per cent saturation with ammonium sulphate
which completes the precipitation of the ovo¬
mucoid and of some of the globulin. After
removal of the precipitate, the solution is
brought to 52 per cent saturation with ammonium
sulphate and the ovalbumin crystallizes out.
This ovalbumin is removed, dissolved in distilled
water and recrystallized by once again bringing
the saturation of the solution with ammonium
sulphate to 52 per cent.
All the processes were carried out at room
temperature, centrifugations being carried out in




a) A stock saturated solution of ammonium
sulphate was prepared by dissolving:
550 g ammonium sulphate
6.8 g sodium acetate 3 H^O
and 3 ml glacial acetic acid
in 750 ml of warm distilled water. The solution
was then filtered and checked to see that
crystals separated on cooling. If necessary a
little more ammonium sulphate was added.
b) The whites of six medium-sized fresh eggs
were collected, care being taken to avoid
contamination with yolk. This egg-white was
gently homogenised in a M.S.E. homogeniser,
frothing being avoided as far as possible.
c) To 100 ml of the homogenised material 11 ml
of N acetic acid was added (5.7 ml glacial acetic
acid in 100 ml distilled water).
After stirring for one minute, 22 g of solid
ammonium sulphate was added to the mixture.
Stirring was continued for 10 minutes until it
had completely dissolved.
d) To the resultant solution, 22 ml of the
stock saturated solution of ammonium sulphate
was added over a period of 5 minutes whilst
stirring was continued.
e) The resultant precipitate was spun down by
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centrifugation at 3000 G for 30 minutes. The
supernate was removed and filtered.
f) Whilst the filtration was being carried out,
the precipitate remaining in the centrifuge
bottles was washed with 44 per cent saturated
ammonium sulphate solution. It was then re-
centrifuged at 3000 G for 15 minutes and the
supernate added to that being filtered in step e)
above. The precipitate was then discarded.
g) Whilst gently swirling the filtrate from
step e) in a conical flask, the following
additions of ammonium sulphate solution were
made:
26 ml of 55 per cent saturated solution
in one lot
and 52 ml of 55 per cent saturated solution
in small amounts over 30 minutes.
A precipitate appeared which, after being allowed
to stand for several hours or overnight, showed
the typical 'shot silk' swirls of ovalbumin
crystals when disturbed. These were checked
under the microscope.
h) The precipitate was resuspended and the
following additions of ammonium sulphate made:
20 ml of 55 per cent saturated solution
over 20 minutes
and 48 ml of 70 per cent saturated solution
over 20 minutes.
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The mixture was then allowed to stand for a few
hours or overnight.
i) The precipitate which had formed (ovalbumin)
was then spun down by centrifugation at 1500 6
for 30 minutes, the supernate discarded and the
pellet washed once with 51 per cent saturated
ammonium sulphate.
The ovalbumin was further purified by re-
crystallization,
j) The pellet was carefully dissolved in 30 ml
of distilled water, and 40 ml of 70 per cent
saturated ammonium sulphate solution added
slowly. The mixture was continually stirred
during this addition so that any precipitate
produced dissolved up again.
k) The solution was filtered, and the paper
washed through with 20 ml of 40 per cent
saturated ammonium sulphate. To the filtrate
was added 120 ml of 55 per cent saturated
ammonium sulphate solution over a period of
30 minutes. A precipitate appeared.
1) After standing for one hour, 40 ml of 70 per
cent saturated ammonium sulphate solution was
added and the mixture allowed to stand for a few
hours or overnight.
m) The recrystallized ovalbumin was removed by
centrifugation at 1500 G for 30 minutes, the
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supernate discarded and the pellet washed with
51 per cent saturated ammonium sulphate solution,
n) The ammonium sulphate was removed from the
recrystallized ovalbumin by dissolving it in tap
water and then dialysing it against running tap
water overnight.
Note. It was occasionally found that precipi¬
tates did not appear as expected in steps g) and
k). This appeared to be due to the great day-
to-day variations in the room temperature of the
Edinburgh laboratory affecting the saturation
point of the solutions. Small quantities of the
stock saturated solution of ammonium sulphate
were therefore added to the preparation until a
precipitate was seen.
3. Routine method for the further purification
of recrystallizedovalbumin by chromatography
on carboxymethyl-cellulose
Ovalbumin, partially purified by crystalli¬
zation, was applied to a carboxymethyl-cellulose
column. A very pure ovalbumin preparation was
eluted by a single pH change leaving any other
unwanted materials on the column. Elution could
be followed visually and checked by measuring the
pH of the eluate. Details of the method used
are as follows:
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A column was packed with CM-cellulose and
cleaned and equilibrated to pH 4.2 as detailed
earlier. The apparatus was arranged as shown
in figure 1.
After dialysis against pH 4.2 acetate buffer
overnight, once recrystallized ovalbumin v/as
applied to the column by the method previously
described. The solution was passed through a
filter paper to remove any insoluble particles.
After application, a white band could be
seen in the upper third of the column. This
represented the ovalbumin. It was more opaque
than the rest of the packing and changes in its
position during elution could best be seen by
transmitted light from an Anglepoise lamp
suitably masked with cardboard.
The column was washed with 250 ml of buffer
at pH 4.4 to remove any ovomucoid, etc.; this
did not affect the position of the white oval¬
bumin band.
Ovalbumins A1 and A2 were eluted by passing
300 ml of buffer at pH 4.65-4.70 through the
column. The movement of the white band was
watched and collection of the eluate started as
soon as it neared the bottom of the packing.
Collection was continued until all of this buffer
had passed through, making a total of about
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150 ml. Alternatively, the eluate was collected
in 50 ml fractions, and all those showing a pH of
4.45 or above were assumed to contain ovalbumin.
A sample was set up in double diffusion against
an anti-egg-white serum to confirm its purity.
The eluate containing ovalbumin was reduced
in volume with commercial grade CM-cellulose.
Any remaining buffer was removed by dialysis
against changes of distilled water and the
material was then freeze dried.
4. Characterization of the egg-white proteins
The proteins in egg-white and purified
preparations of them were characterized by the
three techniques of electrophoresis, imiauno-
electrophoresis, and immunodiffusion.
Proteins will move in an electric field
(electrophoresis), the extent of their travel
being determined by the charge on them and the
nature of the material in which they are
supported. This effects a separation of the
individual proteins.
If the electrophoresis is carried out in a
solid support such as paper or agar, the
positions of the proteins can be revealed by
specific staining. Another method is to apply
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an antiserum which will reveal its corresponding
protein antigens by precipitating with them.
This latter method, called Immunoelectrophoresis,
is usually more sensitive as it combines the
advantages of electrophoresis with those of
immunodiffusion.
In immunodiffusion an antigen and antibody
are allowed to diffuse towards each other in a
support such as agar. Precipitation occurs
along a line where they meet and are present in
equivalent proportions. When several antibody-
antigen systems are present at the same time, the
precipitation lines for each are often separated.
This is because the relative concentrations of
the materials, their abilities to diffuse
through the support, and thus the position at
which equivalence will occur, will differ for
each system.
a) Electrophoresis in cellulose acetate paper
This was carried out in a Shandon electro¬
phoresis box in conjunction with a Vokara constant
current, constant voltage, power supply (Shandon
Scientific Co. Ltd., London). Strips of 'Oxoid'
cellulose acetate electrophoresis paper,
10 x 5 cm, were soaked in veronal buffer pH 8.6
and ionic strength 0.1, and mounted in the box.
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Connection to the two buffer compartments was
made with filter paper strips. The compartments
had been filled with the same buffer, prepared
from ready mixed salts supplied by L.K.B.
Produkter A.B., Sweden.
The samples were applied to a marked
position at the cathode end of the strips with a
capillary tube. Current at 4 m/a per strip and
a starting voltage of 200 Y was allowed to run
for a period of 2-4 hours with the power pack at
the constant current setting. Any variations
in this procedure are noted in the text.
After electrophoresis, the strips were dried
in an oven at 100° for 10 minutes and then
stained with either Ponceau S or with Higrosine
as follows:
Ponceau S (G.T. Gurr Ltd., London) was used
as a 0.15 per cent solution in 3 per cent tri¬
chloracetic acid. The strips were soaked in
this for five minutes, cleared in 5 per cent
acetic acid, washed well in distilled water and
dried under pressure between sheets of blotting
paper.
Nigrosine (G.T. Gurr Ltd., London) was used
as a 0.0025 per cent solution in 2 per cent
glacial acetic acid in distilled water. The
electrophoresis strips were stained with this
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for 1-4 hours or overnight and the excess stain
washed out with many changes of tap water.




of Scheidegger (1955, as described by Crowle,
1961) was generally followed.
Clean standard microscope slides were coated
with a layer of agar about 3 mm thick. This
agar was made up as one per cent Hew Zealand or
Ionagar Ho. 2 (Oxoid) in 0.02 M phosphate buffer
at pH 7.2 (Cruickshank, I960). Two holes with a
slot between them were cut in the agar on the
slide using 2 mm diameter cut-off needles and the
two halves of a razor blade, all mounted in a
cork. The centres of the holes were removed by
suction with a Pasteur pipette but the centre
trench was not opened until after electro¬
phoresis.
The slides were supported on plastic pins
in the same Shandon electrophoresis box as that
used for electrophoresis on cellulose acetate
paper. Connections were made to the buffer
wells (containing 0.02 M phosphate buffer) by
strips of blotting paper. It was found
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necessary to use many layers of blotting paper
to reduce the resistance as much as possible and
therefore increase the effective voltage drop
across the agar itself.
The specimens (usually 1 per cent solutions
in phosphate buffer) were put into the wells and
the current allowed to flow at 2.5 ra/a per slide
and at an initial voltage of 50 V. The
constant current setting was used.
After two hours the slides were removed from
the box, the agar removed from the centre trench
and this then filled with serum. The slides
were incubated in moist chambers at 37° overnight
and sometimes for some days subsequently at 4°
until the lines were sufficiently developed.
The slides were then washed, dried, and
stained in the same manner as the immunodiffusion
plates (see below). The figures in this thesis
are direct enlargements made from them.
o) Immunodiffusion
The Ouchterlony method of double diffusion,
as described by Kabat and Mayer (1961), was used.
Petri dishes were filled with a layer of
agar about 3-4 mm deep. Wells were cut in it
with a 7 mm diameter cork-borer or with a
Peinberg cutter (Shandon Scientific Co., London).
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The centres of these wells were sucked out with
a wide-mouthed pipette attached to a filter pump.
The Petri dishes were clean but not other¬
wise specially prepared, and the bottoms of the
wells were not sealed with agar. The agar was
prepared as one per cent New Zealand agar or
Ionagar No. 2 (Oxoid) in saline, phosphate
buffered saline or tris buffer at pH 7.2
(Cruickshank, I960).
The wells were filled with the reagents
a
(antigens were made up as^l per cent solution in
distilled water or saline and the sera were un¬
diluted, unless otherwise stated) and the results
were read after overnight incubation at 37° or
after a further 24-48 hours in the refrigerator
at 4°. The wells were never refilled or topped
up whilst the reaction was taking place.
The plates were preserved by soaking for
one day in normal saline and for two days in
changes of distilled water. The agar was then
removed from the Petri dish and dried on to a
clean lantern plate cover glass. It was then
stained with naphthaline black made up as a one
per cent solution in a mixture of methylated
spirit 50 parts, glacial acetic acid 10 parts,
and distilled water 40 parts. After staining
for 5-10 minutes the plates were cleared with
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changes of the same solvent. They were dried
at room temperature and in some cases varnished
later with Griffin picture varnish (Windsor and
Newton ltd.).
The figures in the text are direct enlarge¬
ments made from the stained plates.
5. Preparation of precipitating sera
Anti-sera against the antigens: whole egg-
white, commercial twice recrystallized ovalbumin,
and chromatographically purified ovalbumin were
prepared in rabbits. Schedules of the
inoculations given and of the designations of
the sera obtained during the courses of
immunization are given in tables 1, 2 and 3.
6. Capillary tube precipitation test
Doubling dilutions of antigen (usually a
one per cent solution) were made with normal
saline in the wells along one edge of a. W.H.O.
plastic agglutination plate.
Standard capillary tubes of 1.5 mm external
diameter were marked with a grease pencil at
points 4 and 8 cm from one end. Neat antiserum
was allowed to fill a tube to the first mark and
the tip was wiped clean with paper tissue.
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Table 1. Schedule of inoculations given to a rabbit for the
preparation of antisera against whole egg-white.










1 ml 1 Ell - 0.5 ml - 10 mg -
Vehicle Complete
adjuvant
Saline - Saline - Saline -





- - R50 - R5E - R5F
EW = whole egg-white.
•Globulin' = Globulin peak from chromatography of whole
egg-white (see figure 22).
Complete adjuvant = Ereund's complete adjuvant (Difco).
S/C = subcutaneously.

















































2xCrystOA=commercialtwiceecrystallizedovalbumin. Chromat.OA=chromatographicallypurifiedovalbuminbatch18(fig r16) S/C=subcutaneously.
Incompleteadjuvant=Preund'sinco pleteadjuvant(Difco). EW=egg-white.
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Table 3. Schedule of inoculations given to a rabbit for the
preparation of antisera against ovalbumin purified
by chromatography.
Day 0 16 44 56 83 94
Antigen OA (1) - OA (1) - OA (2) -
Amount
injected
10 rag - 5 mg - 5 rag -
Vehicle Complete
adjuvant
- Saline - Saline -




- R4B - R4C - H4E
OA (1) = chronatographically purified ovalbumin
batch CIS (figure 16).
OA (2) = chromatographically purified ovalbumin
batch C21 (figure 16).
Complete adjuvant = Freund's complete adjuvant (Difco).
S/C = subcutaneously.
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Antigen solution from one of the wells in the
plastic plate was then allowed to fill the tube
until the top edge of the liquid in it reached
the upper mark. The tube was next tilted to
bring the contents to the centre and, whilst
holding a finger over one end, the other was
thrust vertically into a piece of Plasticine
mounted along a strip of wood. Tubes were
prepared in this way with each antigen dilution
and placed in order along the Plasticine.
When the set was complete, it was incubated
at 37° for two hours and then left on the bench
overnight. Next morning the length of precipi¬
tate in each tube was measured with the help of a
strip of millimeter graph paper and a magnifying
glass. Where all of the precipitate had not
fallen to the bottom of the tube, the length of
each portion was measured and added together.
7. Absorption of sera with ovalbumin or conal-
bumin prior to their titration with tanned
cells coated with ovalbumin or with conal-
bumin or with a mixture of the two antigens
(Part 4, Experiment 2)
Experiments were designed to determine
whether conalhumin was the dominant partner when
used with ovalbumin in the tanned red cell
agglutination test. For these experiments sera
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were required which had been absorbed to remove
anti-ovalbumin or anti-conalbumin antibodies.
Precipitin curves with respect to ovalbumin
and conalbumin for the sera R4B and R4C (anti-
ovalbumin), BWE and R5C (anti-egg-white), and BWC
(anti-commercial crystalline ovalbumin), were
constructed. Tables and graphs for some of
these are presented in tables 9 and 10 and
figures 34 and 38. Tables 5 and 6 show the
results for the remaining combinations of serum
and antigen.
The absorptions were carried out by mixing
neat serum with an equal volume of antigen
diluted to a point just on the antigen excess
side of equivalence, or a point taken to
represent it.
The dilutions of one per cent antigen
solution used are shown in table 4. After being
mixed with the antigen the sera were incubated at
37° for 2 hours and then at 4° overnight. Any
precipitates formed were then removed by centri-
fugation at 3000 6 for 30 minutes at 4°.
Table 4. Dilutions of one per cent antigen
solution used to absorb sera to be
tested with cells coated with oval¬
bumin, or conalbumin, or with a
mixture of them
Antigen Serum
R4B R4C BWC BWE R5C
Conalbumin: Neat Neat 1:8 1:16 1:2
Ovalbumin: 1:16 1:4 1:32 1:16 1:8


















































Table6.Heightsofprecipi ateformedinca illarytubbyhe ct on neatserumandneq alvolumefo eperc ttion conalbumin(«»>.dilutedasshown SerumDilutionofan ige-1parti : 24816326428565120 4 R4B (anti-OA) BWC (anti-crystOA)1.00.25Trmm 0.751.02mm Tr=trace.OA=ovalbumin. crystOA=ommercial,twicere ryst lized0=noprecipitate.
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8. Antibody nitrogen determinations
Where sufficient serum waa available, anti¬
body nitrogen estimations were carried out on the
sera used in the experiments to investigate the
influence of conalbumin in the tanned cell
agglutination test (Part 4, Experiment 2).
The equivalence points of the sera were
determined by capillary tube precipitation tests.
For the preparation of precipitates, 0.1 or 0.2
ml volumes of neat serum and a dilution of
antigen just on the antigen excess side of
equivalence, were mixed in Durham tubes. These
were then corked and inverted several times to
mix the contents. After incubation at 37° for
one hour they were left overnight in the
refrigerator at 4°.
In the morning the tubes were centrifuged at
3000 G for 30 minutes at 4°. The supernates
were removed and some of them preserved for cross
precipitation. The supernates which were not
kept were checked by capillary tube precipitation
to ensure that they did not contain unprecipita-
ted antibody.
The precipitates were then washed twice with
cold saline (4°). Their nitrogen content was
measured by the Markham micro-Kjeldahl technique
as described by Kabat and Mayer (1961). An
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ordinary 2 ml burette was used for the titra¬
tions. ^t was found that 0.01 ml volumes could
be added to the distillate if the burette was
used with the tip touching the surface of the
liquid instead of allowing drops to fall from it.
The titration was done with R/1G0 H^SO^ and the
indicator used was methylene blue/methyl red
(Kabat and Mayer, 1961).
The first step in these estimations was to
determine how much nitrogen the antigens them¬
selves contained.
a) Ritrogen content of the antigens
The nitrogen content of chroraatographieally
prepared ovalbumin (batch M) and a conalbumin
containing material D10 were measured by the
micro-Kjeldahl method. The results for 1 per
cent solutions of both antigens are shown in
table 7.
b) Antibody nitrogen in the sera
The specific precipitates produced by the
interaction of various sera and the antigens
were analysed by the micro-Kjeldahl technique as
described above. In some cases, where the
serum contained antibodies to more than one of
the antigens, the supernate remaining after pre¬
cipitation with the first antigen was
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re-extracted with the second antigen. The
results of the determinations are given in
table 8.
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9. Sterilisation of materials and equipment
Antigen solutions and the oil/Arlacel
mixture were sterilized by Seitz filtration
through Ford's grade SB filter pads. This was
either carried out with a conventional filter and







Antigen dilution (of1$ solution)
Volume of antigen used
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0.1 0.1 0.2 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.2
OA OA OA OA
CA CA CA CA OA CA CA
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filter (A. Gallenkaiap and Co. ltd.) in a centri¬
fuge.
Other materials and equipment were
sterilized by boiling, autoclaving, or with dry
heat as appropriate. Chemical sterilisers and
preservatives were not used.
10. Preparation of water-in-oil emulsions
A number of different methods and materials
were used to form water-in-oil emulsions for the
earlier experiments. Some of these were
inefficient or difficult to carry out and they
are described with the experiments in which each
was used.
In all other experiments the following
technique was adopted:
The mineral oil Drakeol 6-VR and the
emulsifier Arlacel A were mixed together in the
ratio of nine parts by volume of oil to one part
of emulsifier and then sterilized by Seitz
filtration.
The antigen was dissolved in saline and
likewise Seitz filtered.
One volume of the oil/Arlacel mixture was
placed in a suitable vessel such as a 25 ml
•Universal' screw cap container. An equal
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volume of the antigen solution was available in
another container.
A small portion of the antigen solution,
say one fifth of its volume, was taken up in a
disposable hypodermic syringe and violently
squirted into the oil through a 0.5 mm needle,
the point of which was held below the surface of
the oil. The container was then capped and
shaken vigorously before another portion of
antigen solution was added in the same way.
After the second or third addition of antigen,
the mixed emulsion was taken up into the syringe
through a wide bore (1 mm) needle and squirted
out again through the fine bore (0.5 mm) needle
used initially. More portions of the antigen
solution were added and the process repeated
until all of the antigen had been incorporated
into the oil.
The dispersion of the water phase within the
oil could be increased by repeatedly squirting
the emulsion through 0.5 mm or 0.6 mm needles.
This became very hard work as the viscosity of
the emulsion increased with the increasing
dispersion of the water phase. Some makes of
syringe broke up under the pressure that it was
necessary to exert.
Dispersion of the water phase could also be
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increased by ultrasonication with a M.S.E. probe,
but the emulsions produced were so viscous that
they did not flow at all. They were, however,
useful for further treatment to form multiple
emulsions.
A more useful method was to make the
emulsion with a syringe as described above and
then pass it through a modified 'Bel' cream maker
(Royston (Bel) Sales Ltd., Riversite Buildings,
Erith, Kent). This is a kitchen implement used
for making •cream* from melted butter and milk.
To adapt it for smaller quantities, three of the
four intake holes were blanked off and a funnel
attached to the fourth. This funnel embraced
the top of the barrel so that emulsion which
leaked past the piston was not lost but returned
to the emulsifying valve (figure 3). The metal
parts of the machine (after modification the
emulsion only came into contact with these) could
be sterilized by boiling. When assembled, the
machine was held in a laboratory clamp and the
output from below passed directly into a sterile
container.
For most of the experiments syringes alone
were used to prepare the emulsions. If ultra¬
sonication or the 'Bel* cream maker were used,
this is specially noted.
Fig.3. Diagrammatic cross-section through
the modified 'Bel' cream maker used to prepare
water-in-oil and multiple emulsions.
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Before use, all water-in-oil emulsions were
tested by allowing a portion to drop into iced
water. If they were true water-in-oil emulsions
they remained as discrete drops in this and did
not disperse.
Emulsions were used within a day of prepara¬
tion, unless otherwise stated.
11. The adsorption of ovalbumin on to aluminium
hydroxide
An aluminium hydroxide precipitated oval¬
bumin preparation was made so that this type of
depot forming adjuvant could be compared with the
water-in-oil emulsion adjuvant.
Optimum conditions for the adsorption of
protein on to aluminium hydroxide gel were
determined by the method of Dr. Albert Hansen of
the Danish State Serum Institute, Copenhagen, as
described in a letter from Dansk Svovlsyre-0(J,
Superphosphat-Babrik, the manufacturers of
•Alhydrogel' (1964). The method was altered
slightly so that small quantities of material
could be used.
Ovalbumin was dissolved in distilled water
at a concentration of 1.25 mgm per ml. One ml
of this solution was put into each of 12 plastic
Wassermann tubes. Distilled water in amounts
85.
decreasing in 0.1 ml steps from 1.1 to 0 ml was
then added to each tube in the row.
The aluminium hydroxide gel was diluted
1:10 with distilled water and added to the tubes
in volumes increasing in 0.1 ml steps from 0.1
to 1.2 ml. Each tube now contained a total of
2.2 ml.
After inversion to mix the contents^ the
tubes were allowed to stand undisturbed on the
bench. Flocculation rapidly occurred in two of
the tubes leaving a completely clear supernate
within 30 minutes. Slight flocculation was
observed in the tubes on either side of them.
To obtain this good end-point it had been
necessary to repeat the titration twice,
decreasing the concentration of ovalbumin each
time. In the earlier attempts flocculation
occurred first in the tube containing most
aluminium hydroxide. It took rather longer to
appear and most of the other tubes flocculated
at about the same time.
Using the proportions of protein and
aluminium hydroxide shown to be optimum, a batch
of material for inoculation was prepared.
To 25 mgm of ovalbumin dissolved in 26 ml
of distilled water, 18 ml of aluminium hydi'oxide
gel (stock solution diluted 1:10 with distilled
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water) was added. The mixture was allowed to
flocculate overnight. It was then centrifuged
at 500 G for 30 minutes and the supernate
removed.
The pellet was made up to 2.5 ml with saline
and well resuspended. A dose of 0.2 ml of this
suspension was equivalent to 2 mgra of ovalbumin,
12. Inoculations, Collection of blood samples,
Separation and preservation of sera
a) Inoculations
(i) Rabbits
Subcutaneous inoculations in rabbits were




All subcutaneous inoculations in mice were
made in the dorsal/lateral area of the back in
the loose subcutaneous tissue.
Inoculations of oil emulsions were made with
disposable 2 ml plastic syringes through a 0.5 mm
x 16 mm needle. Other solutions in saline
solution were injected with a 'Plim' type 1 ml
tuberculin syringe with an adjustable stop
(Arnold and Sons, 54 Wigmore Street, London W.l)




Intravenous injections were made into the
tail veins of mice with an all-glass 1 nl tuber¬
culin syringe and a number 20 x § inch needle.
The mice were held in a small perforated zinc
cage with the tail protruding. The veins were
dilated by the application of warm water on a
pledget of cotton wool before the injection was
made.
Mice were not anaesthetized for either the
subcutaneous or intravenous injections.
The injection of very small volumes of
water-in-oil emulsion into lymph nodes
Very fine pipettes were made by drawing out
1.5 mm diameter capillary tubing in a microburner
flame and separating the two pipettes thus formed
by melting the connection.
For use, a pipette was thrust through a
hole made with a needle in the top of an ordinary
red rubber pipette teat. After being opened by
breaking off the seal to leave a square cut tip,
a very small amount of emulsion was drawn up into
the narrow part of the pipette by manipulating the
bulb whilst the normal opening was closed by one
finger.
After initial anaesthesia in a jar, the
mouse to be operated on was placed on the bench
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and anaesthesia continued by allowing its muzzle
to rest in a vial containing an ether-soaked pad.
With the animal lying on its right side the
inguinal lymph node (Dunn, 1953) was located by
palpation. The hair over a small area of the
flank skin fold anterior to it was clipped away
with wetted scissors. A fold of skin was then
picked up and an incision made with the scissors.
It was found to be best to make this incision
run in an anterior-posterior direction and not
across the body.
By manipulation with the fingers of the left
hand, the lymph node was brought up to the
incision and partly extruded through it. The
tip of the pipette was then pushed into the node
and a portion of its contents injected. It was
sometimes possible to see the emulsion form a
deposit within the node.
The lymph node was then allowed to slip ba.ck
in place and a small quantity of a sulphonamide-
urea-gentian violet powder (Cooper's Wound
Dressing Powder) dusted on to the incision.
By weighing full and empty pipettes it was
estimated that between 0.5 and 1 mgm of water-
in-oil emulsion was injected into each node.
89.
b) Collection of blood samples, separation and
preservation of sera
(i) Human
Human blood samples were collected with a
10 ml syringe and allowed to clot overnight at
room temperature. The sera were then removed
and stored at -30°.
(ii) Rabbit
Rabbits were bled from the marginal ear
vein. They were made to sit in a box of
internal dimensions 5 x 5 x 16 inches with a
moveable partition. In a quiet room no other
restraint was found to be necessary. The hair
over the vein was shaved, a thin smear of
petroleum jelly applied, and a diagonal incision
made across the vein.• The base of the ear was
then compressed with the left hand. An ample
flow of blood was usually obtained if the rabbit
was allowed to settle down quietly for a few
minutes. Only rarely was it necessary to apply
any benzole to the ear to encourage vasodilation.
Up to 50 ml of blood was collected at one time.
Pressure over the cut with a small cotton¬
wool swab stopped the blood flow very readily if
benzole had not been used.
The blood was collected into very clean
25 ml Universal containers and clotting had
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usually occurred by the tine of return to the
laboratory. The containers were then placed in
the 37° water bath for 30-60 ninutes to cause
rapid clot contraction. A check was made after
15 minutes or so to ensure that separation of
the clot from the container walls was taking
place. If this was not adequate, the clot was
ringed by shaking.
When contraction was judged to be complete
the clot was removed by hooking it out with a
swab stick. The remaining red corpuscles were
spun down by centrifugation at 1000 G for 10
minutes and the supernatant serum removed. It
was storedfrosen at -20°.
If the interior surface of the Universal
container was coated with a thin layer of agar,
clot retraction was cleaner and fewer suspended
cells were left. A 1 per cent solution of agar
in saline was made by boiling. A portion of
this was poured into a cold Universal container
and out again quickly so that only a very thin
layer remained. The containers were then capped
and stored on the shelf until required,
(iii) Mouse
Mice were bled from the retro-orbital
venous plexus by the method of Halpern and
Pacaud (1951). They were not anaesthetized for
91.
this procedure.
Miniature glass pipettes were used (as
described elsewhere) and about 0.2 - 0.3 ml of
blood was collected from each mouse. After
collection the blood was gently expelled from
the pipette into a Durham tube and this was
stoppered with a natural cork on which the
identity of the specimen had been noted. The
pipettes were immediately dropped into a plastic
beaker of cold water to lyse the blood remaining
adherent to them. No anti-coagulants were used
as serum samples were wanted. Only very rarely
was any trouble experienced with clotting in the
pipette during collection. If this did happen
a fresh pipette was used to make another
collection from the other eye.
Individual mice were bled up to 24 times
over a period of 18 months without hurt. In
the course of the present work about nine
thousand blood samples were collected by this
method without death or apparent injury to a
single mouse.
The blood samples were allowed to clot and
retract overnight at room temperature. In the
morning the clots were removed by hooking them
out with a bacteriological wire which had a small
right angle bend at the tip. This wire was
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flamed between each specimen. In some cases,
when the clot was still adherent to the walls of
the tube, it was found best to break up the clot
rather than attempt to remove any of it and lose
much of the serum as well.
After clot removal or break-up, the Durham
tubes were packed into small plastic cups and
centrifuged at about 1000 G- to bring down the
remaining red cells. These plastic cups were
made from the bottom of a polythene bottle which
would just fit into a large metal centrifuge
bucket. A string was attached to the cup to
enable it to be easily drawn out of the bucket.
After centrifugation, the serum supernate
in each Durham tube was removed with a fresh
miniature pipette and put into a clean tube.
The cork bearing the identification number of
the blood sample was transferred to the new tube.
A clean pipette was used to transfer each sample.
The serum samples were stored at -20° in
old cardboard slide boxes subdivided into small
compartments. Identification of the individual
samples was easy as the tubes were stored
upright so that the numbers and a colour coding
on the corks could be seen.
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13. The preparation of tanned and coated sheep
red cells
Most titrations of serum antibodies were
carried out by the passive haemagglutination
test of Boyden (1951). Fresh or formalin!zed
3heep red cells were used. They were washed
and then treated with a very dilute solution of
tannic acid. After washing again, the cells
were mixed with a solution of antigen some of
which became adsorbed on to the cells. They
thus became agglutinable by antibody against the
antigen.
Due to the pre-treatment with tannic acid,
these cells would give an agglutination pattern
when allowed to settle out in a test tube even
if no antibody was present. The addition of
normal rabbit serum as a stabilizer prevented
this non-specific agglutination.
Washing after coating was therefore carried
out with dilute normal rabbit serum and the
cells were finally suspended in this for use.
When formalinized cells were used, the normal
rabbit serum could be omitted until the last
stage without harm. A test was then made to
choose the best concentration for stabilization.
It was found that fresh cells became irreversibly
agglutinated unless normal rabbit serum was used
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in all the washes done after coating.
Details of the methods used to prepare
small and large volumes of cells and to
formalinize the cells are given below.
a) Materials
(i) fresh sheep cells
Fresh sheep cells from defibrinated blood
were washed three times in 0.85 per cent sodium
chloride (saline). They were packed at 750 G
for 15 minutes before the volume required was
measured out with a pipette.
(ii) Pormallnized sheep red cells
Fresh 3heep blood was collected from the
abattoir and defibrinated by shaking in a bottle
containing a wire spiral. The cells were then
washed five times with phosphate buffered saline
(P.B.S.) before being formalinised by the method
of Csizmas (i960). During the formalinization
process it was found convenient to have the cell
suspension in a flask placed in a wire basket
attached to a 'Matburn' mixer. The rotary
movement imparted by this machine kept the
contents of the flask well mixed without
producing too much foam.
After formalinization the cells were washed
seven times with saline. Sometimes several of
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the washes were carried out with tap or distilled
water without any deleterious effects. After
washing, the cells were made up as an approxi¬
mately 25 per cent suspension in saline. The
exact strength of the suspension was checked by
spinning down a portion in a haematocrit tube at
2000 G for 30 minutes. The suspension was
stored in the refrigerator at 4°. For use,the
volume of suspension calculated to give the
wanted packed cell volume was measured out. The
cells were spun down from this and washed once
with saline.
(iii) Phosphate buffered saline (P.B.S.)
The following salts were dissolved in




The solution was stored in the refrigerator at
4°. For use, it was diluted 1:5 with distilled
water. The pH was between 7.2 and 7.4.
(iv) Tannic acid
The tannic acid solution was freshly
prepared for each batch of cells. It was a
1:10,000 solution of tannic acid (Mallinkrodt
Chem. Corp.) in P.B.S. (2.5 mga in 25 ml).
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(v) Antigen
Protein antigen for coating the cells was
prepared as a 0.2 per cent solution in P.B.S.
(20 ragm in 10 ml).
(vi) Normal rabbit serum (N.R.S.)
Normal rabbit serum was inactivated at 56°
for 50 minutes and then absorbed with cells of
the batch to be coated. Packed cells equivalent
to one fifth or one tenth of the volume of serum
to be treated were added to it and absorption
carried out at room temperature for at least 30
minutes. It was found advantageous to do this
with gentle agitation on a 'Matburn* mixer. The
cells were removed by centrifugation.
A single absorption was usually sufficient,
but when time was available, the cells were
absorbed a second time. This made quite sure
that no agglutinins remained to spoil the
settling patterns of the cells.
b) Tanning and coating small (50 ml) quantities
of fresh or formalinized cells
All manipulations were carried out in 1 oz
screw cap vials (McCartney bottles) which are
convenient for use in a bench centrifuge.
(i) In each of two vials 0.6 ml of packed
cells were suspended in 10 ml of P.B.S.
(ii) 10 ml of tannic acid solution was rapidJy
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added to each and they were shaken up
immediately. Both vials were then allowed to
stand in the water bath at 37° for 15 minutes.
(iii) The cells, now tanned, were spun down
at 750 G for 5 minutes, the supernate discarded
and thr cells washed once with P.B.S. When re-
suspending fresh cells for washing it was found
best to add only 1-2 ml of P.B.S. at first and
suspend them in this. If more P.B.S. was added
the cell pellet tended to come off the bottom of
the vial in a lump which was difficult to break
up.
(iv) One vial was put aside to be used for
the control cells which are tanned only. The
cells in the other vial were resuspended in 10 ml
of P.B.S. and 10 ml of the antigen solution
added. The whole was then quickly shaken up and
placed in the 37° water-bath for 30 minutes.
During this time it was gently shaken once or
twice.
(v) After coating, the cells were spun down
at 750 G for 5 minutes and the supernate dis¬
carded. The cells in both vials were then
washed three time3 with 1 per cent normal rabbit
serum in P.B.S. After the third wash they were
resuspended to 50 ml each.
The suspension was stored in flat sided
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screw cap medicine bottles at 4°, and in the case
of fresh cells was used within three days of
preparation. The final suspensions contained
approximately 1 per cent of cells, it being
assumed that about 0.1 ml of the 0.6 ml of
packed cells taken to start with would have been
lost during the various washes.
c) Tanning and coating large (500 ml) quantities
of formalinized cells
The same methods and materials were used as
are given above for the preparation of small
volumes of cells.
The process was carried out in a 1 oz vial
(McCartney bottle) but the packed cell volume of
formalinized cells used was 6 ml. This quantity
of cells made a deep and thick pellet after
centrifugation so that resuspension had to be
done by gentle stirring with a thin glass rod.
Creat care was taken to ensure that the cells
were properly resuspended at each stage.
Por tanning, the cells were suspended in
sufficient P.B.3. to half fill the vial and 12 ml
of P.B.S. containing 40 mg of tannic acid added.
This addition was done very quickly and the whole
vial was shaken vigorously immediately afterwards,
stoppered only with a finger. Very rapid mixing
of the cells and tannic acid was essential to the
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successful preparation of tanned cells in bulk
by this method. The cells were tanned at room
temperature for 20 minutes, the vial being
clipped to the 'Matburn' mixer so that they were
continually agitated during this period.
After tanning, the cells were washed once
with P.B.S. and resuspended to half fill the vial.
Twenty milligrams of ovalbumin in 12 ml of P.B.S.
were added and the whole mixed quickly. The
vial was then placed for 45 minutes on the
'Matburn* mixer at room temperature.
After coating, the cells were washed three
times with P.B.S. and then made up to 500 ml in
P.B.S. Portions of the suspension were tested
in a doubling dilution series of normal rabbit
serum in saline and the highest dilution giving
a good negative button was noted. Sufficient
normal rabbit serum to bring the whole suspension
to this dilution was then added to it.
Whilst the above test was being carried out,
10 ml of suspension stabilized with normal rabbit
serum at a dilution of 1:100 was tested with an
anti-ovalbumin serum. This was to ensure that
the cells were working properly before they were
frozen.
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d) The preservation of tanned and coated
formalinized cells, by freezing
The completed suspension was distributed,
in 10-20 ml quantities, to 1 oz vials (McCartney
bottles) or Universal containers and the caps
screwed on tight. Some material was also put
in Wassermann tubes so that small quantities of
frozen cells were available for test and
standardization purposes. These were stoppered
with rubber corks.
The bottles were shaken to ensure complete
suspension of the cells and quick freezing was
carried out by immersing the bottles in a mixture
of dry ice and acetone until the contents were
solid. The bottles were then placed in the
deep-freeze cabinet at -20° for long term
storage.
e) Standardization of each batch of fresh or
formalinized cells
Each batch of cells tended to vary in its
sensitivity to antibody. Each batch was there¬
fore compared with standard material so that if
necessary a correction could be made to all serum
antibody titres measured with it.
Doubling dilutions of a mouse anti-ovalbumin
serum were made in 1 ml volumes in saline.
Portions of each dilution in this series were
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then distributed in 0.1 ml volumes to the wells
in a plastic agglutination plate. Thus the
1:1280 dilution in each row of wells would be
comparable even though they might not really be
dilutions of exactly 1:1280. To the wells in
each row were added 0.1 ml portions of batches
of cells of known and unknown sensitivity. The
plate was shaken well and left on the bench over¬
night before the end-points were read. It was
then possible to compare accurately the relative
sensitivities of the cells and these were noted
for reference.
14. The titration of sera by the tanned cell
technique
a) General method
Firstly it was necessary to absorb out any
agglutinins against the sheep cells themselves
which would have given erroneous non-specific
titres. Sera were diluted 1:10 with a 1 per
cent suspension of tanned but uncoated cells.
They were then allowed to stand on the bench for
1-2 hours, with occasional shaking, before the
cells were removed by centrifugation. The sera
were not inactivated before titration. »
Doubling dilutions of the supernate were
made in 0.1 ml volumes in a W.H.O. plastic plate
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using an automatic 1 ml syringe (R.B. Turner and
Co., London N.2) and miniature Pasteur pipettes.
An extra well was prepared with 0.1 ml of the
1:10 dilution. In the test, uncoated cells were
added to this well as a control to check that all
non-specific agglutinins had been removed.
Coated cells in 0.1 ml volumes were added to
each of the wells containing the doubling
dilution. The plate was shaken well and left
on the bench for 2 hours in the case of fresh
cells, or overnight when formalinised cells had
been used, before the titres were read. If
evaporation was prevented, there was very little
change in end-point position if these times were
extended. If necessary, the cells could be re-
suspended and allowed to form fresh settling
patterns without any change occurring in the
position of the end-point.
The settling patterns were read by taking a
complete coating of the bottom of the well as
+++, a neat round button as - and the inter¬
mediate points as ++, + and + . The end-point
was then the + point. In the experiments
reported in the present work, numerous titrations
were carried out at the same time. It was
therefore quite easy to choose a suitable pattern
to be taken as the end-point by examining a whole
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plate of titrations before starting to record
the results.
Sera were always set out in a random order
on the plates to minimize any subjective
influence on end-point reading due to knowledge
of the experiment being conducted.
b) Modifications of the general method; used
when mouse sera were being titrated
(i) To ensure the complete removal of non¬
specific agglutinins, it was found preferable to
absorb all sera with a 2 per cent suspension of
untanned cells when formalinized cells were to
be used for the test.
When very low titres were expected, fresh
cells were used to titrate the sera as these
cells were usually more sensitive. it was then
found convenient to make sure that any non¬
specific agglutinins were eliminated by making
the initial 1:10 dilution with one drop of un¬
treated packed cells, eight drops of 1 per cent
tanned but uncoated cells and one drop of serum.
(ii) Initial dilution and absorption was
carried out in Durham tubes (22 mm x 6 mm).
Dropping dilutions were made using the miniature
pipettes described elsewhere. The cell suspen¬
sion was measured out first, the tip of the
pipette wiped and then one drop of serum added
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from it. The pipette was then discarded to he
washed. The tubes were corked (the reference
number being marked on the cork) and left on the
bench for 1-2 hours for absorption to take place.
They were inverted to mix the contents several
times during this period. The cells were
brought down by centrifugation before the
supernate was titrated.
(iii) With some very low titred sera, initial
dilutions of 1:2, or 1:3, etc., were made by the
dropping method. The actual dilution prepared
depended on the amount of serum available and
the necessity of having at least 0.3 ml of
diluted material available to supply the initial
dilution, start of the doubling dilution, and
the control well.
15. Haemagglutination inhibition tests for
antibodies against influenza virus
a) Human sera
Haemagglutination inhibition tests for anti¬
bodies in human sera were carried out by the
standard plastic plate method (W.H.O., 1953)
using 4 minimum haemagglutinating doses (M.H.D.)
of the appropriate strain of virus. The last
well showing complete agglutination was taken as
the end-point in the virus titrations. The last
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well showing complete inhibition was taken as the
end-point in the serum titrations. Fowl cells
were used as the indicator.
Before titration, non-specific inhibitors
of viral haemagglutination were removed by over¬
night treatment with cholera filtrate (l.D.E.)
obtained from Burroughs Wellcome and Go. The
residual R.D.E. was inactivated by heating to
56° for one hour before titration.
b) Mouse sera
The standard method was followed but the
mouse sera were titrated in 0.1 ml, instead of
0.25 ml volumes. The diluted virus and the
fowl cells suspension were also added in 0.1 ml
volumes. The fowl cells were used as a 1 per
cent suspension instead of the 0.5 per cent
suspension used for the human sera. If the more
dilute suspension was used it was found that
there were insufficient cells to give adequate
settling patterns. The virus was titrated in
these same small volumes and with the 1 per cent
cells so that 4 M.H.D. were added to each well
in the test proper, in the usual way.
Heating to 56° or treatment with cholera
filtrate did not remove the non-specific
inhibitors in mouse sera. The sera were there-
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fore merely diluted with calcium saline (saline
containing 0.1 per cent of calcium chloride;
the diluant used in all of these tests) before
titration.
16. Analysis of sera for IgM type antibodies
The immunoglubulins in serum are of at least
two main types, IgG ( Y, ISY, X0, , etc.) and
c. SS
IgM 19Sif, etc.). The amount of each
of these present varies during the course of the
antibody response and they may thus be indicators
of the type of antibody forming mechanism which
is active at any one time.
As their immunological reactions are very
similar, separation has to be carried out by
physical methods. One way in which this can be
done is to destroy the IgM type. Treatment of
the serum with 2-mercaptoetbanol achieves this ty
splitting the molecule at S-S bonds to leave
inactive fragments. The unaffected IgG antibody
titre can then be measured and hence the IgM
titre by difference.
Another way of separating the two types of
immunoglobulins is by gel filtration on the cross-
linked dextran preparation Sephadex G200. This
is packed into a column and a buffer containing
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the serum to be separated allowed to flow it.
The smaller IgG molecules enter the gel structure
and are retarded. The larger IgM molecules
cannot enter, flow faster through the column and
appear first in the eluate.
Both methods of separation were used in the
present work.
a) Treatment of sera with 2-mercaptoethanol to
destroy IgM antibodies
The method of Deutsch and Morton (1957) was
followed; they treated a 1 per cent solution of
protein with 0.1 M 2-mercaptoethanol.
The serum to be treated was therefore
diluted 1:3 with phosphate buffered saline
(P.B.S. prepared as in Method 13) and an equal
quantity of 0.2 M 2-mercaptoethanol added. The
0.2 M solution was made by diluting 1.9 ml of
2-mercaptoethanol (light and Co. Ltd.) to 100 ml
with P.B.S.
A control for each serum treated was set up.
In these the raercaptoethanol was replaced by
saline.
All manipulations were carried out in a fume
cupboard. The tubes containing the treated
serum and the control tubes were then stoppered
and they were left at room temperature overnight.
In the morning each serum was put into dialysis
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tubing and placed in a beaker of P.B.S. to
dialyse away the excess mercaptoethanol. The
controls were put into a separate beaker to
ensure that they were not affected by mercapto¬
ethanol, but otherwise they were treated in
exactly the same way throughout.
Dialysis was carried out over a period of
10 days at 4° during which time the P.B.S. was
changed five times. The sera were then removed
from the dialysis tubes, put into Wassermann
tubes and frozen at -20° for storage prior to
titration. The volume of each serum recovered
was very much the same and no adjustments were
made.
Before titration with fresh tanned sheep
cells, samples of the treated sera and of the
controls were measured into Durham tubes and one
drop of packed sheep cells added to each. The
tubes were then stoppered, shaken up several
times and left at 4° overnight in order that any
agglutinins for sheep cells present might be
absorbed out.
b) Separation of IgM and IgG type antibodies on
a Sephadex G200 column
The method used followed in general that of
Plodin and Killander (1962).
A glass tube about 2 metres long by 4 cm
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wide was prepared to hold the Sephadex. It was
stoppered at one end with a rubber cork through
which ran a narrow glass outlet tube. Inset
into the upper side of the cork was a perforated
zinc disc supporting six layers of surgical gauze
to retain the Sephadex. A single layer of glass
beads prevented disturbance of the gauze during
filling procedures.
About 20 grams of Sephadex G200 (Lot TO
3017, Pharmacia, Upsala, Sweden) was allowed to
swell in 0.2 M tris-HCl buffer (pH 8.0) diluted
in 0.2 M NaCl (Cruickshank, I960) for three days.
It was then well de-aerated using a filter pump,
and poured into the glass tube which had already
been partly filled with buffer. The whole
contents of the column were well stirred up and
allowed to settle for a short while before any
buffer was allowed to run from the outlet at the
bottom.
Buffer was then allowed to flow very slowly
overnight whilst the Sephadex settled and
compacted. The Sephadex level was marked on the
outside of the tube at intervals until it
stabilized. The height of the column was then
67 cm, corresponding to a volume of 3370 ml.
The serum to be treated was layered on to
the Sephadex surface with the aid of a 1 ml
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tuberculin syringe attached to a length of narrow
polythene tubing (3 ram external, and 2 mm
internal diameter). The outlet end of this
tubing had been constricted a little in a Bunsen
flame.
Syringe and tubing were completely filled
with buffer, care being taken to eliminate any
bubbles. With the syringe clamped to a
convenient support and the 3erura container held
outside the tube at the level of the Sephadex
surface, about 1 ml of serum was drawn into the
tubing. The tube was then passed into the top
of the column and down through the overlying
buffer until it was three or four centimetres
above the Sephadex surface. The plunger of the
syringe was pushed in very gently whilst the tip
of the polythene tube was moved about a little,
so that a layer of serum was deposited over the
Sephadex surface without disturbing it. Buffer
was not allowed to run through the column whilst
this was being done.
When the layering had been completed the
column outlet was opened and more tris buffer
added to fill up the long column as soon as the
serum layer was seen to enter the packing.
The flow rate from this column with the
outlet unrestricted, and the upper part of the
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tube filled with buffer, was about 40 ml an hour.
Fractions were collected in an automatic fraction
collector (Locarte Company, London S.W.7) using
a drop counter.
The protein content of the fractions was
estimated in an ultra-violet spectrophotometer
and recorded as optical density at 280 mp. A
curve was drawn from these measux-enents and the
fractions constituting each peak were pooled.
These pools were put into Visking dialysis
tubing and reduced almost to dryness by
surrounding then with polyethylene glycol (raol.
wt. 6000, L. Light and Co. Ltd., Colnbrook) at 4°.
Each pool was then reconstituted to the
original serum volume by the addition of
distilled water and they were stored at -20°
until titration was carried out.
17. Statistical methods used
Student's t tests were carried out by the
methods described by Croxton (1959) and Simpson,
Hoe, and Lewontin (I960). This test measures
the extent to which it is probable that two
groups of results come from the same population
of possible results. It should be noted that
the method Involves the comparison of the
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arithmetic means of the results for each group.
In the tables of results and graphs presented,
geometric mean titres are used.
The geometric mean gives a lower figure
than the arithmetic mean but is less affected by
extreme values or the occasional apparently
aberrant reading which occurs in work of this
type. There is therefore no need to make an
arbitrary discard of such readings. Another
advantage is that the 'centre of gravity' of the
geometric mean is relatively difficult to move.
Curves drawn from geometric means are therefore
smoother than those drawn from arithmetic means
of the same results. In all the graphs
presented below, the plotted points have been
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A. INTRODUCTION
Crystalline ovalbumin was for long
considered to be one of the purest proteins
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available. Physical and chemical studies sub¬
stantiated this proposition but immunological
methods of analysis have shown that it is not
free from a number of other egg-white proteins
(Munoz and Becker, 1950).
Absolute purity of any substance, organic
or inorganic, is difficult to achieve, and in
many cases the presence of a minute quantity of
some other material is not important, unless this
impurity has some extremely potent biological
function. None of the proteins found in egg-
white, except perhaps lysozyme, can be considered
to be in this category and for most purposes
crystalline ovalbumin can be treated as a single
material.
However, Borduas and Grabar (1953) reported
anomalous results when crystalline ovalbumin was
used as the coating antigen in the very sensitive
tanned red cell agglutination test of Boyden
(1951). These were possibly due to the presence
of another egg-white protein conalbumin.
Borduas and Grabar believed that, not only was
the conalbumin a more potent antigen than oval¬
bumin but that it was preferentially adsorbed on
to the red cells. Thus the titre of an anti-
ovalburain serum measured by this method might in
fact be the titre of a trace of anti-^conalbumin
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in it.
Ovalbumin had been chosen as the chief
antigen to be used in the adjuvant experiments.
The antibodies raised against it could be
measured most conveniently by the tanned cell
technique. It was therefore necessary to re¬
investigate Borduas and Grabar's findings; con¬
firmation would mean, either that conalbumin-free
ovalbumin must be used in all the investigations,
or that another antigen must be sought. In any
case at least a small quantity of very pure oval¬
bumin would have to be prepared for the
Investigation.
Following the work of Sjirensen in 1934 it is
generally agreed that in egg-white there are five
major proteins from which the ovalbumin would
have to be separated. These are:
a) The simple proteins






The usual method of extracting ovalbumin
from egg-white is by salting out and crystalliza¬
tion using either ammonium sulphate (S^rensen,
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1915), or sodium sulphate (Kekwick and Cannan,
1936). Commercially available ovalbumin has
usually been recrystallized two or three times.
Consideration was given to the possibility of
preparing a much purer sample by repeated re-
crystallizations but Stavitsky (1954J>) has shown
that even after seven recrystallizations oval¬
bumin is still contaminated with conalbumin.
Other methods of preparation are: electro¬
phoresis in a starch block (Kunkel, 1954), and
ion exchange chromatography (Rhodes, Azari, and
Feeney, 1958; Mandeles, I960). The first would
only be suitable for the production of minute
quantities of material, but the second might be
used on a much larger scale.
Rhodes et al. separated the egg-white
proteins with carboxymethyl-cellulose (CM-cellu-
lose). The egg-white was adsorbed on to this
material at an acid pH and the proteins eluted
off in sequence by a series of buffers of
increasing alkalinity. Ovalbumin is not homo¬
geneous, and Rhodes et al. were able to obtain
separation of the ovalbumin itself into three
components by this method. Mandeles used di-
ethylaminoethyl cellulose (DEAE-cellulose) and
buffers of varying molarities and composition.
His results showed only two, poorly separated,
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ovalbumin elution peaks.
The method of Rhodes et al. seemed very
promising but a digression must be made here to
elaborate further on ovalbumin itself. Early
studies of the egg-white proteins by the moving
boundary method of electrophoresis showed two
peaks in the albumin region. These were called
Al and A2 (Tiselius and Ericksson-Quensel, 1939).
Later investigations showed that there is a third
peak A3 (MacPherson, Moore and Longsworth, 1944;
Cann, 1949), and the most recent work using
starch-gel electrophoresis suggests that there
may even be a fourth in some cases (Lush, 1961).
MacPherson et al. (l94/0 found that the
proportions of the different ovalbumins varied
with time. Presh albumen (egg-white) contained
Al in the greatest quantity but this changed
entirely to A2 during seven months storage in
salt-free solution. The change also occurred in
ovalbumin dried to a powder, though more slowly.
By enzymic degradation, Perlmann (1932) showed
that the three ovalbumins differed in the number
of phosphorus atoms per molecule. Al having
two atoms, A2 one atom, and A3 none.
In 1956 Durieux and Kaminski showed that the
three ovalbumins were immunologically identical.
After separation by electrophoresis in agar, they
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were eluted and examined by double diffusion
against an anti-ovalburain serum. The precipita¬
tion lines formed with each ovalbumin linked up
in a reaction of identity. The presence or
absence of phosphorus atoms does not, therefore,
appear to affect the antigenic determinants of
the molecule.
Rhodes et al. reported that these three
ovalbumins could easily.be separated by the
chromatographic method. Although no reference
to the immunologic purity of ovalbumin prepared
in this way could be found it commended itself
as one v/hich might produce, in quantity, a purer
material than those that had hitherto been used.
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B. RESULTS
1. Examination of whole egg-white
As a preliminary to any other investiga¬
tions, it was first necessary to make a pre¬
sumptive identification of the components of
whole egg-white revealed by electrophoresis,
immunodiffusion, and Immunoelectrophoresis.
Where possible this was done by comparison with
known materials.
a) Electrophoresis on cellulose-acetate paper
Diluted whole egg-white and a known sample
of conalbumin (kindly siipplied by Dr. I.E. Lush)
were electrophoresed at the same time on one
sheet of paper. Figure 4 shows that a strong
conalbumin component in the egg-white could be
identified and that the three ovalbumins were
resolved.
Figure 5 shows the electrophoretic pattern
of neat egg-white. The staining is irregular
due to the high concentration of protein, but
more components are shown. They are identified
on the figure from the data of Lush (1961).
b) Immunodiffusion
In double diffusion tests, whole egg-white




Fig.4. Electrophoresis on cellulose
acetate paper.
Above: Vhole egg-vhite diluted 1:5, shoving
the three ovalbumins (left) and a
single conalbumin band (right).
Belov: A knovn specimen of conalbumin (kindly-
supplied by Dr.I.E.Lush).
Electrophoresis carried out for 7 hours.
src.«*
4-
Fig.5. Electrophoresis of vhole egg-vhite
on cellulose acetate paper. The egg-vhite
proteins revealed are labelled from the data
of Lush (1961).
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anti-egg-white sera. The heavy line near the
antibody well in figure 6 can be identified with
the ovalbumin, anti-ovalbumin system. It shows
a reaction of identity with the line formed by a
chromatographically prepared material with the
electrophoretic characteristics of ovalbumin
(fig. 7).
The other heavy line, nearer to the antigen
well, shows a reaction of identity with the
conalbumin system (fig. 8).
c) Immunoelectrophoresis
Figure 9 shows Immunoelectrophoresis of
whole egg-white, developed with anti-egg-white
serum.
In the top slide the egg-white was accom¬
panied by commercial crystalline ovalbumin.
This enables identification of the ovalbumin line
to be made. At the bottom, a known sample of
conalburain was run at the same time, and the line
probably corresponding to the conalbumin system
can be picked out.
2. Examination of the purity of crystalline
ovalbumin
A commercial sample of twice recrystallized
ovalbumin (L. light and Go. Ltd., Colnbrook,
Fig.6. Immunodiffusion analysis of vhole
egg-vhite in P.B.S. agar.
B.V.E. = anti-egg-vhite serum.
E.V. = egg-vhite diluted 1:5.
C21 & Cl8 = chromatographicslly purified
ovalbumin.
The arrov points to the precipitation line of
the ovalbumin-anti-ovalbumin system.
l?ig.7. Electrophoresis on cellulose
acetate paper.
Above: Vhole egg-vhite diluted 1:5.
Belov: Chromatographically purified ovalbumin
batch Clo.
Electrophoresed for 2 hours in a discontinuous
buffer pH 8.65 as described by Poulik (1957).
Fig.8. Immunodiffusion analysis of whole
egg-white in P.B.S. agar.
B.V.E. = Anti-egg-white serum.
CA = Electrophoretically pure conalbumin
(Dr.I.E.Lush).
EW = Egg-white diluted 1:5«
Coml OA = Twice recrystallized ovalbumin from
a commercial source.
The arrow points to the precipitation line
representing the conalbumin-anti-conalbumin
system.
Fig.9. Immunoelectrophoresis of egg-white,
crystalline ovalbumin, and conalbumin.
EW = Whole egg-white diluted 1:5«
Coml OA = Tvd.ce recrystallized ov lbumin from
a commercial source.
CA = Electrophoretically Dure conalbumin
(Dr.I.E.Lush)
R5C = Anti-egg-white serum in the centre
trough.
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England) was examined to find out whether other
antigens were present in addition to ovalbumin.
a) Electrophoresis on cellulose-acetate paper
The electrophoretic pattern of the
crystalline ovalbumin is shown in figure 10. A
slower moving component is present in addition
to the ovalbumins. This component is in the
same position as is pure conalbumin run on the
sane sheet.
b) Immunodiffusion
When set up in double diffusion against
anti-egg-white sera (figs. 8 and 33), crystalline
ovalbumin showed a very similar pattern to that
given by whole egg-white. One of the lines in
figure 8 shows a reaction of identity with that
of a known conalbumin preparation.
c) Immunoelectrophoresis
Three components were resolved by Immuno¬
electrophoresis developed by an anti-egg-white
serum (fig. 9).
These tests showed that the recrystallized
ovalbumin was very impure. It contained many
of the antigens present in whole egg-white and
in particular was rich in conalbumin. If,
Fig.10. Electrophoresis on cellulose
acetate paper.
Above: Flectrophoretically pure conalbumin
(Dr.I.E.Lush).
Belov: Twice recrystallized ovalbumin from
commercial source. This shows a
marked conalbumin band in addition
the ovalbumins.
Electrophoresis carried out for 2 hours.
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therefore, conalburain did interfere with the
tanned cell test for anti-ovalbumin antibodies,
ovalbumin prepared in this way could not be used
to coat the cells.
3. The separation of egg-white proteins by
elution from a carboxymethyl-cellulose
column using stepwise pH changes
It has been noted in the introduction that
Rhodes, Azari and Feeney (1958) separated the
egg-white proteins by ion exchange chromatography
on carboxymethyl-cellulose. Althoiigh they did
not examine the immunological purity of the
materials obtained, their method appeared to be
one by which ovalbumin, free of conalbumin, might
be prepared.
A column packed with carboxymethyl-cellulose
was set up as shown in figure 1, and equilibrated
to pH 4.2 with ammonium acetate - acetic acid
buffer. Egg-white was prepared as detailed in
the Methods section and 75 ml applied to the
column.
Rhodes et al. (1958) found that peak
elution of the egg-white proteins from CM-cellu-
lose occurred at the following pHs:
Ovomucoid and Flavoprotein pK 4.3
Ovomucoid 4.4
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Other 'globulin' fractions and lysozyrae were
eluted at higher pHs.
This data was followed using slightly more
alkaline buffers to ensure a good change-over
between the steps.
The unwanted ovomucoid and flavoprotein were
first removed by passing 200 ml of pH 4.2 and
then 200 ml of pH 4.4 buffer through the column.
As these were flowing a white band with a yellow
flare below it was seen to pass down the column
but another white band remained at the top. The
eluates were discarded.
Elution of the wanted materials was carried
out as described in the Methods section using









and then sufficient 0.1 M ammonium acetate
solution to run out the last buffer.
The eluate was collected in 20 ml fractions.
The pH of each was measured, and its protein
content determined by the biuret reaction.
The results were plotted and are shown
graphically in figure 11. There was a very
crisp separation of the different protein peaks.
The A2 peak is higher than expected for ovalbumin
A1 is claimed to be the major component in fresh
material (MaePherson et al., 1944).
The fractions were pooled in groups as
indicated by square brackets on the graph (fig.
11). Each pool was identified by the number of
the first fraction in it. The pools were
examined by electrophoresis and iramunodifftision.
a) Electrophoresis on cellulose acetate paper
The electrophoretic patterns of all the
pools are shown in fig. 12a and b. That of one
of the pools and egg-white is shown in fig. 13.
These patterns show that only the first and last
of the peaks are electrophoretically homogeneous.
Despite the relative sharpness of the other
peaks, they contain mixtures of proteins known
to be antigenically different.
Fig.11. Separation of egg-vhite proteins
by chromatography on CM-cellulose. Elution
of the proteins by stepwise pH changes.
The protein content and pH of each fraction is
Indicated on the graph. The pH curve is marked
at the points given by Rhodes et al. (1958)
for the peak elution of each protein.
Fig. 12s. Electrophoresis on cellulose
acetate paper of egg-vhite proteins elut.ed from
CM-cellulose by e stepvise increase of pH. The
numbers refer to the fraction pools shovn in
fig.11. Pools 15 and 20 shov ovalbumin only.
The later pools contain increasing emoent. s of
conalbumin.
Fig.12b. Electrophoresis on cellulose
acetate paper of egg-white proteins eluted from
CM-celluiose by a stepwise increase of pH. The
numbers refer to the fraction pools shown in
fig.11. All the pools show conalbumin. Pools
41 and 47 show some ovalbumin. Pools 47 and 53
also show some 'globulin'.
Electrophoresis carried out for 2 hours.
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b) Immunodiffusion
The pooled fractions were allowed to react
with anti-egg-white serum by double diffusion
through agar (fig. 14). This showed that all of
the pools except No. 15 contained more than one
antigen. The relative abundance of the proteins
in each can be followed clockwise round the
plates, those present in the greatest quantity
giving lines nearest to the antibody well. The
earlier pools contain ovalbumin. This decreases
in quantity in each pool after No. 41 but conal-
bumin then appears in increasing amounts.
The electrophoretic patterns (fig. 12a and
b) show a band in the conalbumin region in all
except the first two pools (15 and 20). However,
in the double diffusion plates an antigen showing
a reaction of identity with the conalbumin line
in the egg-white control does not appear until
pool 47 (fig. 14). Therefore pools 15 to 41 do
not contain conalbumin itself but another un¬
identified antigen which moves in a similar way
to conalbumin on electrophoresis.
This degree of separation, though
incomplete, was encouraging. It seemed possible
that further treatment of the ovalbumin
containing peaks by chromatography might produce
a very pure antigen.
Fig. 13. Electrophoresis on cellulose
acetate paper of -whole egg-vhite and pool 26 of
egg-white protein eluted from CM-cellulose
(fig.11). The three ovalbumins and conalbumin
can be identified in the eluate pool.
Electrophoresis carried out for 5 hours.
Fig.14. Immunodiffusion analysis of egg-
white proteins eluted from carhoxymethvl-
cellulose by stepwise increases of pH.
The numbers indicate the fraction pools shown
in fig.11.
ev = egg-white diluted 1:5.
BVE = anti-egg-white serum.
The arrows point to the ovalbumin and conalbumin
precipitation lines.
126.
4. Further purification of the ovalbumin
containing portion of the eluate from a
primary separation of the egg-white proteins
by chromatography on carboxymethyl-cellulose
The fractions constituting the ovalbumin A2
peak from a stepwise elution of egg-v/hite
proteins from CM-cellulose were pooled. On
electrophoresis (fig. 15) this material was found
to contain an antigen running in the conalbumin
position, as well as ovalbumin. The pool was
dialysed against buffer at pH 4.0 and applied to
a CM-cellulose column already equilibrated with
the same buffer. The column was then washed
through with 200 ml of buffer at pH 4.2.
Slution of the ovalbumins was carried out
in a stepwise fashion as described in the Methods
section, using the following buffers:
200 ml pH 4.55
200 ml pH 4.70
200 ml pH 4.90
300 ml pH 6.20
The eluate was collected in 20 ml fractions.
Their protein content was measured as optical
density at 200 mju in the ultra-violet spectro¬
photometer, and their pH was checked. The
results when plotted (fig. 16) showed mainly a
single peak of ovalbumin A2.
Certain fractions were pooled in groups as
Fig.15. Electrophoresis on cellulose
acetate paper.
Above: Flectrophoretically pure sample of
conalbumin (Dr.I.E.Lush).
Be.lov: Pooled, ovalbumin containing peaks
from a primary separation of egg-
vhite proteins by chromatography
on CM-cellulose.
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Fig.16. Re-chrome tography of the ovalbumin
containing peaks from a primary separation of
egg-white proteins on CM-cellulose. Elution
by stepwise pH changes.
The protein content and pH of each fraction is
indicated on the graph. The pH curve is marked
at the points given by Rhodes et al. (1953) for
the peak elution of each egg-vhite protein.
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shown by the square brackets in figure 16.
These were examined to detect the presence of
antigens other than ovalbumin.
a) Electrophoresis
Ho conalbumin or 'globulin' appeared to be
present in any of the pools when they were
electrophoresed on cellulose acetate paper (fig.
17).
After concentration and freeze drying, one
of the pools, number 18, the first part of the
main peak, was made up as a 5 per cent solution.
The electrophoretic pattern of this alongside
that for whole egg-white is shown in figure 18.
This ovalbumin concentration is about 4 times
that of the ovalbumin in the diluted egg-white
(7 per cent in neat egg-white), but no protein
other than ovalbumin was detected.
b) Immunodiffusion
In double diffusion against an anti-egg-
white serum, the pools showed only ovalbumin.
The reactions of two of these (Nos. 18 and 21)
constituting the bulk of the peak are shown in
figure 6.
7/ith another anti-egg-white serum, one
which was particularly sensitive to conalbumin
and 'globulin'^ only one of the four main pools
Fig.17. Electrophoresis on cellulose
acetate paper of pooled fractions from the
elution of ovalbumin from CM-cellulose by
stepwise pH changes.
The four pools (numbered as on fig.l6) only
show protein bands in the ovalbumin position.
Electrophoresis carried out for 2 hours.
Fig.18. Electrophoresis on cellulose
acetate paper.
Above: Fraction pool number 18 (main peek
fig. 16) from the elution of ovalbumin
from CM-cellulose by stepwise pH
changes. This material was mac-e up
as a 5 per cent solution after freeze
drying. This concentration is about
four times that of the ovalbumin in
the diluted egg-vhite elect.rophoresed
belov.
Belov: Vhole egg-vhite diluted 1:5.
Electrophoresis carried out for 5 hours.
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(C25) showed signs of the presence of an antigen
other than ovalbumin (fig. 19).
When examined with a serum raised against
one of the pools (C18) only single lines were
produced (fig. 20).
c) Immunoelectrophoresis
In Immunoelectrophoresis, developed with an
anti-egg-white serum, no antigen other than oval¬
bumin could be detected in pools 18 and 21 (fig.
21).
These results were evidence that three of
the fraction pools contained only one antigen,
ovalbumin. No other materials could be detected
in them. The results also indicated that the
antigen so prepared could safely be used for
immunization purposes as only one antibody was
seen in sera raised against it.
Of particular importance was the failure to
detect any eonalbumin or conalbumin-like
materials in these preparations. They therefore
appeared to be suitable for use as reagents in
investigations of the influence of conalbumin on
the tanned red cell agglutination test.
Fig.19. Immunodiffusion analysis in P.B.S.
agar of the eluate pools from the re-fractionation
on CM-cellulose of partially purified ovalbumin.
C18-C25 = successive fraction pools from the
ovalbumin peak s'novn in fig.l6.
EW = vhole egg-white diluted 1:5.
R5C = anti-egg-white serum.
On the original plate pool C25 shows traces of





Fig.20. Immunodiffusion analysis in P.B.S.
agar.
Cl8 & C21 = fraction pools from the ovalbumin
peak of the re-fractionation of
partially purified ovalbumin.
EW = whole egg-white diluted 1:5.
CA = electrophoretically pure conalbumin
(Dr.Lush).
R4B = antiserum to fraction pool Cl8,
i.e. anti-ovalbumin.






Fig.21. Immunoelectrophoresis of two
eluate pools from the re-fractionation of
partially purified ovalbumin on CM-cellulose.
Developed vith an anti-egg-white serum.
C3B13 = pool Cl8 in fig.l6.
CJB21 = pool C21 in fig.l6.
R^C = anti-egg-vhite serum in the
centre trough.
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5. Further purification of the eonalbumin
containing portion of the eluate from a
primary fractionation of egg-white on
CM-cellulose
Considerable success in purifying ovalbumin
was obtained by first separating it from egg-
white by chromatography on CM-cellulose and then
removing residual contaminants by passing it
through the column again. It seemed probable
that very pure conalburain could be extracted from
egg-white by the same process.
Pooled fractions from the conalbumin
containing peaks of a stepwise fractionation of
whole egg-white were dialysed against buffer at
pH 5.0. They were then applied to a CM-
cellulose column which had previously been
prepared and equilibrated to pH 5.0 as detailed
in the Methods section.
Proteins were eluted from the column by the
stepwise sequence of buffers:
200 ml pH 5.6
100 ml pH 5.7
100 ml pH 5.8
200 ml pH 6.0
followed by 0.1 M ammonium acetate.
Fraction collection was begun after the
first 150 ml had passed through the column.
The protein content of the fractions was
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measured in an ultra-violet spectrophotometer and
recorded as optical density at 280 mp. (fig. 22).
The pH of each fraction is also shown in the same
figure.
This graph shows that there are two marked
peaks at points corresponding to the data given
by Rhodes et al. (1958) for the elution of
conalbumin from CM-cellulose. Certain of the
fractions, indicated by the square brackets at
the bottom of the graph, were pooled and then
examined for purity.
a) Slectrophoresis
Cellulose acetate paper electrophoresis
showed only a single component in each of the
pools examined (fig. 23). In each case this
ran in the conalbumin position. The first peak,
assumed to be 'globulin', was seen in the same
position as the two conalburains.
b) Immunodiffusion
Figure 24 shows individual (i.e. not pooled)
fractions set up in double diffusion against an
anti-egg-white serum. The lines are split in
some cases but they all appear to be continuous
with the line given by a known pure sample of
conalbumin on the right-hand plate. Fraction 3
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Fig. 22. Re-chromatography of the conalbumin
containing peaks from a primary separation of
egg-vhite proteins on CM-cellulose. Flution
by stepwise pH changes. The protein content
and pH of each fraction is indicated on the
graph. The pH curve is marked at the points
of maximum elution for each of the proteins






Fig.2J. Electrophoresis on cellulose
acetate paper of pooled fractions (as shown in
fig.22) from the re-chromstography of conalburain
on CM-cellulose. Pool 1 is from the 'globulin'
peak. The other pools ar° from the conalbumin
peaks. /.II the bands are in the conalbumin
00sition.
Electrophoresis carried out for 4 hours.
Fig.24. Immunodiffusion analysis of
individual fractions from the re-chromatography
of conalbumin on CM-rcellulose.
3 = fraction from the 'globulin' peak, fig.22.
12-30 = fractions from the conalbumin peaks,
fig.22.
ev - -whole egg-vhite diluted 1:5.
CA ~ electrophoretically pure sample of
conalbumin (Dr.I.E.Lush).
BVE = anti-egg-white serum.
Fig.25. Immunodiffusion analysis of two
fraction pools from the re-chromatography of
conalbumin on CM-cellulose.
D24 and D28 = pooled fractions from the
conalburoin peaks, fig.22.
EV/ = whole egg-white diluted 1:5.
R5C = anti-egg-white serum.
Lines corresponding to several antigen-antibody
systems can be seen with both pools.
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fron the others.
Two of the pooled groups of fractions were
also examined with another anti-egg-white serum
(fig. 25). In this case both were seen to
contain two well marked components and possibly
some ovalbumin as well.
c) Immunoelectrophoresis
Immunoelectrophoresis of pooled fractions
when developed with anti-egg-white serum did not
show up any antigens other than conalbumin except
perhaps in pool 1 from the 'globulin' peak. The
patterns for pools 1, 10, 15 and 19 are shown in
figure 26. The other two pools gave a similar
picture.
These results were disappointing. None of
the conalbumin preparations were as pure as had
been hoped. They were, however, judged to be
sufficiently free of ovalbumin to be useful for
investigation of the tanned cell test.
6. The separation of egg-white proteins by
elution from a CM-cellulose column using
a gradient buffer
_____
Crisper separation of the materials eluted
from an ion exchange chromatography column is
reported to occur if gradient rather than step-
V
V Di/9 11
Fig.26. Immunoelectrophoresis of fraction





= D1 'globulin' peak, fig.22.
D10, D15, and D19 fraction pools
from the conalbumin peaks, fig.22.
RSC = anti-egg-vhite serum in the centre
trough.
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wise changes in the eluting buffer are used
(Kabat and Mayer, 1961). This method of eluting
the egg-white proteins from CM-cellulose was
therefore tried in the hope that a single pass
of the column might be sufficient to produce
useful quantities of very pure ovalbumin.
Egg-white was homogenized, dialysed and
centrifuged as described in the Methods section,
and 191 ml applied to a CM-cellulose column
previously equilibrated to pH 4.4. Ovomucoid
and ovoflavine were then removed by passing
500 ml of buffer at pH 4.4 through the column.
The remaining proteins were then eluted with
a continuously rising pH gradient. The mixing
chamber (B in fig. 2) contained 300 ml of buffer
at pH 4.4 at the start. The following buffers
were then run in successively in 300 ml quantities
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Fig.27. Separation of egg-vhite proteins
by ion exchange chromatography on CM-cellulose.
Elution of the proteins by gradient pH change.
The protein content and pH of each fraction is
plotted on the graph. The pH curve is marked
at the points given by Rhodes et al. (1958) for
the peak elution of each protein. The fractions
examined by immunodiffusion (fig.28) are marked
vith arrovs.
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20 ml fraction collected and its protein content
as measured by the biuret reaction. The pH
curve is marked at the points found by Rhodes e_t
al. (1958) to correspond with the peak elution
of each protein.
Pour fractions: numbers 28 and 34 from the
ovalbumin peak, number 58 from the 'globulin'
peak and number 85 from the conalbumin region,
were examined by double diffusion against an
anti-egg-white serum. The results (fig. 28)
showed that the ovalbumin fractions were not
particularly pure and that each of the other
peaks contained a mixture of all the proteins.
A gradient buffer thus appeared to be less
useful than stepwise pH changes for eluting the
protein. The latter method was easier to
arrange and it also showed promise of being
modified to a simple technique useful for the
routine preparation of conalbumin-free ovalbumin.
7. Development of the routine method used to
prepare ovalbumin for use as an antigen
Considerable quantities of ovalbumin were
required for the experiments with adjuvants and
tanned red cells. The method eventually adopted
to separate it from the other egg-white proteins
was a combination of crystallization and
Fig.28. Immunodiffusion analysis in P.B.S.
agar of fractions from the elution of egg-vhite
proteins from CM-cellulose by means of a
gradient buffer.
20 - 85 = individual fractions from the
ovalbumin, 'globulin' and conalbumin
peaks as indicated in fig.27.
ew = egg-vhite diluted 1:5.
R5E = anti-egg-vhite serum.
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chromatography. Crystallization, if carefully
carried out, produced quite a pure material
though it still contained some conalbumin and
other antigens. These were removed by chromato¬
graphy on CM-cellulose using a simplified
technique.
The preliminary purification was carried out
by an adaptation of the crystallization methods
of S^rensen (1915) Cole (1933, as described
by Koch and Hanke, 1953) using ammonium sulphate.
This normally takes 13 days but it was found that
even if the time was shortened, as described in
the Methods section, a satisfactory product was
obtained. On electrophoresis only a faint trace
of conalbumin was found to be present in this
(fig. 29), much less than that in the commercial
product (fig. 10).
The once recrystallized material was further
refined by ion-exchange chromatography on
carboxymethyl-cellulose. After dialysis against
tap water to remove ammonium sulphate, followed
by equilibration with the starting buffer at pH
4.2, it was applied to the column. The oval¬
bumin then appeared as a white band in the upper
half. Washing with a pH 4.4 buffer did not
move this band.





Fig.29. Electrophoresis on cellulose
acetate paper.
.Above: Neat egg-vhite.
Belov: Once recrystallized ovalbumin prepared
by the short method described in this
thesis. Note that there is only a
v^ry faint trace of conalbumin
compared vith the large amount present
in the commercial sample of twice
recrystallized ovalbumin, fig.10.
Electrophoresis carried out for 3 hours.
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pH 4.70 the band was seen to move down the
column and could be collected as a single
fraction probably containing ovalbumins A1 and
A2.
A preliminary double diffusion test was set
up with this fraction against an anti-egg-white
serum. Whilst this was developing, the fraction
was reduced in volume with commercial grade CM-
eellulose and after that the remaining buffer
salts were dialysed away with distilled water.
After freeze drying, a further double
diffusion test was carried out to test the purity
of the ovalbumin. Figure 30 shows examples of
these for four separate batches of ovalbumin
prepared by this method. The yield from 100 ml
of egg-white was up to l.lgof ovalbumin.
Ovalbumin separated from egg-white by this
method was used for all the experiments reported
in the tanned cell and adjuvant sections of this
thesis. Complete details of the method of
preparation are given in the Methods section.
Fig.50. Immunodiffusion analysis of
crystallized and chroma tographically prepared
ovalbumins.
Cryst OA = once recrystaliized ovalbumin prepared
by the short method described in this
thesis.
= batches of ovalbumin further purified
by chromatography on CM-cellulose
after preliminary extraction from
egg-white by crystallization.
EW = egg-white diluted 1:20.
The centre well contained anti-egg-white serum
R5F.
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c- DISCUSSION aito conclusions
The object of this preliminary investigation
was to find out whether ovalbumin, which was free
of conalbumin by immunological criteria, could be
separated from the other egg-white proteins by
ion-exchange chromatography.
Experiments with the mineral oil adjuvants
and tanned cells would require large amounts of
antigen for immunisations and for coating the
cells. If ovalbumin prepared by chromatography
was as pure as hoped, it would then be necessary
to devise a simple, practical and easily repro¬
ducible method for carrying out the process. It
was essential that the method chosen should not
require such continuous and detailed supervision
as would interfere with the other investigations
being carried forward.
The results of Rhodes, Azari and Feeney
(1958) showed that ion-exchange chromatography
on CM-cellulose gave sharp peaks for the elution
of each of the main egg-white proteins. They
were able to remove the three different types of
ovalbumin (Al, A2, and A3) separately from the
column and they reported them to be conalbumin-
free. The ovalbumins were eluted in three well
defined peaks over the very small pH range of
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0.35 units. A much larger change than this, of
0.95 units, was then required before conalbumin
appeared in the eluate. This large pH gap
appeared to be a favourable indication that the
ovalbumin night really be conalbumin-free.
Rhodes et al. identified each peak by a
consideration of the known isoelectric points of
the proteins, by special analytic techniques
where this was possible, and by comparing them
with the same materials prepared by other means.
The comparisons were carried out by moving boun¬
dary and filter paper electrophoresis which would
also give some indication of the purity of the
substance eluted in each peak, Rhodes et al.
were quite satisfied on this point and of course
the very sharpness of the elution peaks was
indicative of a purity sufficient for many bio¬
chemical purposes.
The present work confirmed the findings of
Rhodes et al. and it was also possible to
identify some ox" the eluted proteins by immuno¬
logical means. Despite the sharp peaks given
by stepwise elution of the proteins of egg-white
(fig. 11), electrophoresis on cellulose acetate
paper showed that an impurity running in the
conalbumin position was present in all except the
first ovalbumin (Al) peak.
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However, this impurity was not conalbumin.
Hone of the precipitation lines produced in a
double diffusion test (of the ovalbumin
containing eluates against an anti-egg-white
serum) showed a reaction of identity with the
conalbumin system in egg-white (fig. 14). The
first traces of conalbumin were seen in the
'globulin' peak. This was eluted as the pH of
the buffer was raised after all the ovalbumin had
been removed from the column. The other antigen
eluted as a contaminant in the ovalbumin peaks is
presumably this 'globulin' material.
No attempt was made to identify 'globulin'
specifically but there is some evidence to
indicate that it is not a conalbumin. (i) In
immunodiffusion tests it gave no reaction of
identity with conalbumin. (ii) The line which
represented 'globulin' in immunodiffusion tests
on the column eluates was seen at its maximum
strength in the 'globulin* peak (fig. 14). It
was further from the antibody well (showing that
it was present at a lower concentration) in the
fractions on both sides of the 'globulin' peak.
It was therefore a substance eluted at this point
and not an early eluate of conalbumin. (iii) The
eluate containing the 'globulin* peak did not
show the characteristic pink colour of conalbumin
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when freeze dried. Conalbumin is an iron
binding protein related to the transferrin of
serum. It is normally colourless but turns
pink with iron. This was apparently picked up
from impurities in the commercial grade CM-
cellulose used to reduce the volume of the
eluates before freeze drying and the freeze dried
conalbumin peaks were coloured pink.
It is therefore evident that the straight¬
forward fractionation of egg-white on CM-cellu-
lose by stepwise pH changes is an effective
method of preparing conalburain-free ovalbumin.
Unfortunately the ovalbumin is still associated
with 'globulin'. This might well interfere with
the tanned red cell agglutination test for oval¬
bumin antibodies in the same manner as conalbumin
was said to do (Borduas and Grabar, 1953).
For most other experimental work it Y/ould
also be preferable to use an antigen which was as
pure as possible. It is useful to know that the
main substance and not just some impurity has
been labelled if antigens are to be traced in the
body. Adjuvants may raise unexpectedly high
titres to traces of an impurity, leading to
confusion. Denaturation, polymerization,
adsorption of antigen to an adjuvant or other
material are also more surely followed when the
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substance used is well characterized.
Consideration was therefore given to ways of
reducing or eliminating the 'globulin'.
On immunological analysis only the first
(Al) peak eluted from CM-eellulose seemed to be
relatively free of 'globulin' but the bulk of
the eluted ovalbumin was contained in the second
(A2) peak (fig. 11). The ovalbumin in fresh
egg-white is said to be mainly of type Al
(MacPherson et al., 1944) and it is unlikely
that this was not the case with the egg-white
applied to the column for the present work. It
may be that in the conditions employed some of
the ovalbumin changes to the A2 form by the loss
of a phosphorous atom. It is, however, more
probable that, due to the closeness of the pH of
the buffers used for washing to that of those
used for elution, much of the Al type of oval¬
bumin was lost before elution proper commenced.
The analysis carried out by Rhodes et al. did
show a high ovalbumin Al peak but as they were
interested in a complete analysis of the egg-
white proteins elution was started at a lower pH
than that used here.
For the later investigations, ovalbumin was
required in some quantity. More could have been
obtained if the Al peak was conserved by carrying
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out the preliminary washing with buffer the pH of
which was further from the elution point. This,
however, might have left the ovalbumin contamina¬
ted with ovomucoid and the flavoproteins. The
A2 peak therefore seemed to be a useful choice
for further treatment to obtain a good yield of
very pure ovalbumin.
The method of elution by stepwise buffer
changes was, but for the actual composition of
the impurity, no great improvement on the
crystallization process. When the A1 and A2
peaks were pooled, the electrophoretic pattern
given by them was indistinguishable from that of
twice recrystallized ovalbumin (compare fig. 10
with fig. 15). However, a single refractiona-
tion on CM-cellulose was sufficient to remove
this impurity and gave a final product which
showed only ovalbumin when tested by the methods
and reagents available (figs. 17 and 19).
On the other hand, re-passage of the conal-
bumin containing fractions through the column,
gave materials which were very homogeneous on
electrophoresis (fig. 25) but which were shown
to be mixtures of many antigens by immunological
analysis (fig. 25). This was very disappointing
as Rhodes et al. had reported that their conal-
bumin fractions were very pure. They had, of
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course, only tested them by electrophoretic and
chemical means.
For the preparation of ovalbumin in quantity
a two-stage process appeared to be necessary.
Consideration was therefore given to carrying-
out the primary fractionation of the egg-white
by eluting it from the CM-eellulose with a con¬
tinuously changing gradient buffer arrangement.
With the stepwise method, the pH of each washing
and eluting buffer had to be very accurately
adjusted. The pH meter readings were
occasionally erratic, being particularly
affected by the operation of thermostats in
neighbouring water-baths and incubators.
Frequent checking with the standard buffers was
necessary. A gradient buffer seemed an easy
answer to this as all the wanted pH values would
be passed through in sequence. The method was
also reported to give better separations (Kabat
and Mayer, 1961).
When tried, the separation of the egg-white
proteins by this method was found to be very poor
(fig. 27). The great width of the column used
and hence uneven flow patterns may he one reason
for this. When the stepwise elution technique
was used each eluate had the opportunity to get
well away before the next came off. When a
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gradient buffer was used, different elutions
might take place in nearby parts of the column
at the same time and these might easily become
mixed. Another factor may have been overloading
of the column though the white appearance which
indicated adsorbed protein came only one third
of the way down. Rhodes et al. also reported
that an increase in column length did not improve
the separations obtained with this type of
exchanger.
The method of double fractionation by step¬
wise buffer changes had produced sufficient oval¬
bumin of great purity to use in the tests on the
influence of conalbumin in the tanned cell
agglutination test. Chromatography of whole
egg-white by this technique was too complicated
and time-consuming to be used as a routine
method. Consideration was therefore given to
carrying out the preliminary separation by the
classical method of crystallisation. As pointed
out above, primary separation of ovalbumin on a
column still left as much impurity in the oval¬
bumin as was found in the crystallized product.
The use of chromatography as one stage was,
however, important as this would eliminate
conalbumin.
Two substances cannot be cleanly separated
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by crystallization. Each step increases the
difference between the amount of each substance
present but does not eliminate one of them.
Many times repeated reerystallization of oval¬
bumin might result in a very pure product but by
definition it would still contain traces of most
of the other antigens of egg-white.
An additional difficulty is that the
crystallization process is very dependent on the
physical conditions under which it is carried
out. A stable temperature for each of the steps
is important. This is not at all easy to
achieve day and night in an ordinary laboratory
or during centrifugations, etc.
Chromatography, on the other hand, is very
much a one-step process in which the ionic
strength and pH of the materials can be rigidly
controlled. It can be done over a relatively
short time with everything at one temperature for
the few hours work involved. In addition, it
would be bad luck if the two processes were not
complementary in that each would reduce some
impurity more effectively than the other and so
have an overall additive effect.
The crystallization method described in the
Methods section, though only a rather coarse copy
of the standard technique, did produce ovalbumin
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which was much purer than that bought in from a
commercial source (fig. 29). When followed by
simple chromatography, the remaining impurities
were reduced to undetectable limits with the
minimum of difficulty and complication. It is
not suggested that the ovalbumin was absolutely
pure, hyperimmunization of test animals can show
up faint traces of contaminating antigens in any
material; only the use of artificial poly¬
peptides can be considered to fulfil a need for
absolute purity (Maurer, 1963).
The method described of employing
crystallization followed by chromatography does,
however, appear to be a simple way of producing
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A. INTRODUCTION
The use of tanned red cells coated with
antigen to detect small quantities of antibody by
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their agglutination was first described by Boyden
in 1951. Stavitsky (1994a) developed and
popularized the technique and it is now one of
the most sensitive and convenient of the methods
available for titrating serum antibodies. So
reliable has it become that packaged tests, for
thyroid auto-antibodies and for pregnancy, which
employ the technique, are now marketed.
Difficulties still confront the laboratory
worker using the test under rigorous experimental
conditions. Chief amongst these are: the short
time which the cells can be kept after prepara¬
tion, the great variation in sensitivity found
between different batches, and the problem of
deciding exactly which antigen is reactive when
the cells are coated with mixed materials.
Optimum storage conditions for fresh tanned
and coated red cells would require them to be
sterile but this is difficult to achieve in view
of the repeated treatments and washings required
during their preparation. Most authors prepare
the cells freshly for each set of titrations and
carry these out on one day (i.e. George and
Vaughan, 1962). With some antigens, such as
thyroglobulin, it is possible to preserve the
cells after coating by treating them with
formalin (Fulthorpe et al., 1961). The
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resultant cells show little loss of sensitivity.
Other antigens are damaged by the formalin
and the preserved cells are non-reactive
(Fulthorpe, 1962). To avoid this some authors
have preserved the cells first and then tanned
and coated them (McKenna, 1957; Ingraham, 1958;
Fahey and Humphrey, 1962). McKenna reported
that titrations carried out with his cells showed
good agreement with the results from freshly
prepared material. They could also be frozen or
lyophilized without damage. Fahey and Humphrey
(1962) formalinized their cells by the method of
Csizmas (i960). This is simple and quick to
carry out and the preserved cells are unaggluti-
nated and undistorted, two faults which complicate
other methods.
Preservation of the sensitized cells in
large batches is one way round the great
variation shown by different lots of cells
coated with a single stock of antigen (Button et_
al., I960). A number of investigations into
the reasons for this variation have been carried
out. Boyden (1951), using soluble protein
antigens, and Felton et al. (1961), working with
herpes simplex virus, determined the optimal
concentration of tannic acid, pH at coating, and
the time of exposure to the coating material, by
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empirical experiments. Steffen and Rosak (1965)
investigated the effect of varying the concentra¬
tion of antigen. George and Vaughan (1962)
followed up Dutton et al.'s (I960) observation
that turbid solutions of ovalbumin were better
coating materials than clear ones, by investiga¬
ting the effect on the test's sensitivity of urea
denaturation of the antigen. All these investi¬
gations were done with fresh, unpreserved, cells.
The third problem confronting the user of
tanned cells, is to determine to what antigen
they are reacting when the coating material is at
all impure. Borduas and Grabar (1953) were the
first to report that the contamination of oval¬
bumin coated cells with another egg-white protein
conalbumin, may cause them to give misleading
results. In their view, conalbumin was much
more readily attached to the cells than was
ovalbumin.
Vaughan and Kabat (1953) also pointed out
the dangers of this combination of antigens, but
Stavitsky (1954b) did not think it important as
long as ovalbumin which had been recrystallized
many times was used for coating. In this he was
supported by George and Vaughan (1962).
Linz and Lecocq (1962) and Lecocq and Linz
(1962) investigated the effect of coating tanned
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cells with several antigens, either successively
or mixed together. They found that some
antigens such as horse, bovine;or rabbit whole
serum appeared to be 'strong* in that they
played the predominant role when used with 'weak'
antigens such as bovine or human serum albumin
or egg-white. As the 'strong' antigens were
themselves complex mixtures, the picture is still
in rather a confused state.
In the present investigation experiments
were therefore carried out to determine the
optimum conditions for coating formalinized
tanned cells and the influence of traces of
conalbumin on the specificity of titres of anti-
ovalbumin recorded by the test.
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B. RESULTS
1. Examination of the antigens chosen for use
in the investigation of the influence of
conalbumin on the tanned cell agglutination
'
test.
For use in the experiments on the influence
of conalbumin on the tanned red cell agglutina¬
tion test for anti-ovalbumin antibodies, two
chromatographically prepared antigens were
chosen. The ovalbumin used was preparation C18
(see fig. 16) and the conalbumin was preparation
D28 (see fig. 22).
These materials had already been examined by
electrophoresis and immunodiffusion immediately
after their elution from the chromatography
columns. The ovalbumin appeared to be very pure
indeed, but traces of other antigens were present
in the conalbumin. These two antigens were now
examined further by immunodiffusion and Immuno¬
electrophoresis using different antisera.
For the proposed experiments with tanned
cells it was also necessary to prepare sera
absorbed by each of the antigens. Precipitin
curves were constructed to facilitate this and
these also gave additional information as to the
purity of the antigens used.
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a) Ovalbumin
(i) The material chosen (C18) appeared to
be extremely pure when examined after chromato¬
graphy. A potent serum was raised against it
in the rabbit, as detailed in the Methods
section. This serum gave only one line in
double diffusion against its own antigen and also
against whole egg-white (fig. 31). When the
serum was used to develop immunoelectrophoretic
separations, a faint trace of another antigen
showed up with egg-white but only a line corres¬
ponding to ovalbumin with its own antigen (fig.
32).
When the ovalbumin was examined in double
diffusion with anti-egg-white serum R5E, traces
of another antigen other than ovalbumin were
seen (fig. 33). This antigen was presumably a
remainder of the 'globulin' found in the oval¬
bumin fractions after primary separation of whole
egg-white on CM-cellulose (fig. 14). It showed
no reaction of identity with conalbumin. The
serum used (R5E) did not give so many lines with
whole egg-white or crystalline ovalbumin as did
the anti-egg-white serum BWE (fig. 8) though this
latter serum detected no impurity in the oval¬
bumin 018 (fig. 6).
(ii) The material was further examined by
Fig.51. Immunodiffusion analysis of an
anti-ovalbumin serum.
R4E = antiserum to ovalbumin preparation Cl8.
EV = vhole egg-vhite diluted 1:10.
Cl8 = chromatographically purified ovalbumin.
The plate vas prepared with lon-agar in tris
buffer pH 8.65 (Poulik,1957).
Fig.52. Immunoelectrophoretic analysis of
an anti-ovalbumin serum.
EVJ = vhole egg-vhite.
C?Bl8 = chromatographically prepared ovalbumin
batch Clo.
R4E = antiserum raised against ovalbumin
preparation Cl8.
The arrov points to a faint precipitation arc
indicating that the serum is reacting to another
antigen in egg-vhite as veil as to ovalbumin.
Fig.33• Immunodiffusion analysis of the
ovalbumin and conalbumin preparations chosen
for use in tests with tanned cells.
R5E = anti-egg-vhite serum.
CIS = chromatographically purified ovalbumin,
1 per cent solution.
A faint line can be seen towards the
antigen veil in addition to the chief
ovalbumin line. The split in this
latter is an artifact.
D28 = Chromatographically purified conalbumin,
5 per cent solution. This is seen to
contain a trace of ovalbumin as veil as
conalbumin and other antigens.
EW = whole egg-vhite diluted 1:10.
Coml
OA = twice recrystallized ovalbumin,
commercial source.
This plate was prepared with 1 per cent Ion-agar
in tris buffer (Poulik,1957)•
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constructing curves of its precipitation
characteristics with sera which would themselves
he used in the later experiments. These were an
anti-egg-white serum (R5C) and a serum (R4C)
raised against the antigen C18 itself.
The tests were carried out in capillary
tubes. The heights of precipitate at each
antigen dilution are shown in table 9 and in the
graph, figure 34. Sharp peaks of precipitation
were produced which suggested that the material
was very pure indeed.
Table 9. Height of precipitate produced by the
reaction of dilutions of a 1 per cent















5.5 7.0 10.5 23.0 21.5 14.0 8.5 3.0 2.0 1.0
mm
When another anti-egg-white serum became
available a precipitation curve was constructed
for it also. The results, table 10, are shown
graphically in figure 35. The peak of the
° I 1 1 1 1 1 1 1 1 1
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DILUTION OF ANTIGEN (OVALBUMIN CI0.)
Fig.?4. Precipitation curves (capillary
tube method) given by anti-ovalbumin and by
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DILUTION OF 1% OVALBUMIN SOLUTION.
Fig.55* Precipitation curve(capillary tube
method) given by anti-egg-white serum R5E with
chromatographically purified ovalbumin CIS.
The titres of unused antibody at each point on
the curve were measured with tanned cells
coated with ovalbumin and are shown by the
broken line.
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curve is not as sharp as that in figure 34.
This seruci (!5E) was that which, in a double
diffusion test (fig. 33) > had shown up the faint
line of another antigen-antibody system with the
purified ovalbumin.
Table 10. Height of precipitate produced by
the reaction of dilutions of a 1 per
cent solution of ovalbumin C18 with
equal volumes of neat antiserum.
Serum
Dilutions of Antigen Solution





6.0 7.0 7.5 8.0 8.0 7.0 5.0 3.0 2.0 1.0 mm
(iii) The relationship of the tanned cell
agglutination test to the precipitation curves
^vas also investigated. Portions of the anti-
ovalbumin serum R4C and the anti-egg-white serum
R533 were absorbed with each of the antigen
dilutions used to construct the curve and the
antibody then remaining in them was titrated.
Doubling dilutions of a one per cent
solution of ovalbumin were made in 0.5 ml volumes
of saline in the wells of a W.H.O. plastic plate.
Prom each well 0.2 ml was transferred to a Durham
tube and 0.2 ml of neat serum added. The tubes
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were then corked, inverted several times to mix
the contents, and placed in an incubator at 37°
for two hours. They were then left at 4° over¬
night and in the morning centrifuged at 3000 G
for 30 minutes at 4°. The supernate from each
was then transferred to a clean Durham tube and
titrated with fresh tanned cells coated with
ovalbumin.
The titres found for each serum are given
in table 11. Curves showing the change in titre
at each point have been siiperimposed on the pre¬
cipitation curves in figures 35 and 36. In both
cases there is a sharp rise in titre as soon as
the equivalence point is passed. Removal of
agglutinating antibody is therefore complete at
the point of peak precipitation as shown by the
capillary tube test.
b) Conalbumin
Materials eluted from CM-cellulose in the
conalbumin containing peaks were always found to
contain more than one antigen even after repeated
passages of the column. One of these materials
(D28) was chosen and examined further.
It was made up as a 5 per cent solution (the
conalbumin concentration in normal whole egg-
white is about 0.3 per cent) and set up in double
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Fig.36. Precipitation curve of anti-
ovalbumin serum R4C with chromatographically
purified ovalbumin (cf. fig.35)•
The titres of unused antibody at each point
on the curve ware measured by tanned cells
coated with ovalbumin and are indicated by th
broken line.
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diffusion against anti-egg-white serum R5E. The
result (fig. 33) showed that at least one protein
other than conalbumin was present and that there
also appeared to he a trace of ovalbumin in it.
Immunoelectrophoresis showed faint traces
of two slow moving components in addition to
conalbumin, but no sign of any ovalbumin (fig.
37).
Precipitation curves were prepared for- this
material against anti-egg-white sera and an anti-
ovalbumin serum which were to be used in the
later experiments. The results are given in
table 12, and are plotted in figure 38. Their
flattened shape with anti-egg-white sera is
consistent with there being more than one
antigen-antibody system present. There is a
slight precipitate 'with the anti-ovalbumin serum
in the region of high antigen concentration.
This indicates that the antigen contains some
ovalbumin rather than that the serum contains
any anti-conalbumin antibody.
c) Conclusions
In the characterization of these antigens
and of eluates from CM-celluloee columns,
classical Ouchterlony double diffusion tests
showed themselves to be particularly useful.
Fig.37. Immunoelectrophoretic analysis of
chromatographlcslly prepared conalbumin D28.
R5E « anti-egg-vhi te serum in the centre trough.
EV = vhole egg-vhite.
D1A28 = chromatographically prepared conalburain
D28. Precipitin arcs corresponding to
tvo antigens in addition to conalbumin
can be seen. There is no arc in the
ovalbumin position.
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Table 12. Heights of precipitate produced by the addition of
dilutions of 1 per cent conalbumin D28 to equal
volumes of neat antiserum.
Serum
Dilution of the Antigen Solution








ND 4.0 4.0 ND 3.5 3.5 3.0 2.25 1.25 0.75 0.25 mm




1.0 0.5 0.25 00000000mm
ND = not done.









DILUTIONS OF I °/o ANTIGEN SOLUTION. (D28.)
(R4C.)
Fig.Precipitation curves (capillary
tube method) given by anti-egg-vhite and anti-
ovalbumin sera with chromatographically purified
conalbumin.
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They gave both an analysis of the unknown
mixtures of proteins and an immediate identifica¬
tion of some of the components revealed. The
use of several different sera helped to improve
the resolving power of the method.
Electrophoresis in cellulose acetate paper
was only useful as a rather crude guide to the
materials present. Immunoelectrophoresis was an
advance, but in the author's hands did not reveal
more components than did double diffusion. This
may have been due to the small size of the
samples used.
Hyperimmunization of animals with the
antigens was expected to be a potent method of
detecting impurities. Antigens present in trace
amounts would be expected to stimulate the pro¬
duction of relatively more antibody than their
concentration in the mixture might suggest.
This would be particularly evident as antibodies
to the major antigens reached a plateau after
several injections. Antibody to a trace con¬
taminant in ovalbumin was produced in this manner
(fig. 32). Its very low level was taken to
indicate that the impurity would be of little
importance in simple experimental immunizations.
The precipitin tests were interesting in
that a very high peaked curve was obtained with
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ovalbumin and the earlier rabbit sera (fig. 34).
This was of the type which would be expected with
H (horse) rather than R (rabbit) type antibodies.
A later, more hyperimmune, rabbit serum gave a
much more typical curve (fig. 35). In the case
of conalbumin, known to contain several antigens,
a flattened curve was produced (fig. 38). This
was consistent with several antigen-antibody
systems with different equivalence points being
present at the same time (Cohn et al., 1949).
The peaked curves seen with ovalbumin therefore
appeared to be the reactions of a single antigen-
antibody system.
Titration of supernates from the precipitin
tests showed that absorption of sera just on the
antigen excess side of the equivalence point
would be effective in removing agglutinating
antibodies. Sera so absorbed could therefore
be used as special reagents in later investiga¬
tions.
This was also additional evidence for the
purity of the ovalbumin. George and Vaughan
(1962) found that only when using a chromato-
graphically and electrophoretically purified (but
otherwise uncharacterized) preparation of oval¬
bumin to coat tanned red cells did neutralization
of agglutination occur at the equivalence point
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of the precipitation curve. With less highly
purified ovalbumin there was residual haemagglu-
tination far into the region of antigen excess.
Characterization of the two antigen
preparations ovalbumin 018 and conalbumin D28 by
the above methods showed that both contained
traces of other antigens in addition to the chief
one. In the case of ovalbumin the contaminant
was only present in a. very small quantity. It
was not eonalbuinin and no conalbumin could be
detected. The conalbumin preparation, on the
other hand, contained traces of several antigens
one of which was ovalbumin.
2. To determine whether the addition of conal¬
bumin to the ovalbumin coating of tanned red
cells, alters the specificity of their
reactions
Three batches of fresh tanned red cells were
prepared:
Batch One was coated with chromatographically
prepared ovalbumin (C18, see fig. 16).
Batch Two was coated with chromatographically
prepared conalbumin (D28, see fig. 22).
Batch Three was coated with a mixture of the two
antigens in the ratio, three parts of
ovalbumin to one part of conalbumin.
High titred rabbit sera which had been
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raised against ovalbumin (both crystalline and
chromatographically prepared) and against egg-
white, were titrated with the three batches of
cells. The sera were also titrated after they
had been absorbed with ovalbumin (018) or eonal-
bumin (1)28) and the precipitates removed as
described in Methods section 7 * These absorp¬
tions were carried out on the antigen excess side
of the equivalence points of the sera as deter¬
mined by capillary tube precipitation tests.
In the case of the sera raised against
chromatographically purified ovalbumin, any anti-
eonalbunin antibodies which might possibly be
present were removed by adding an equal volume of
1 per cent conalbumin solution to the serum.
The results of the titrations are presented
in tables 13, 14 and 15- Where possible the
antibody nitrogen content of each serum antibody
was determined and is entered on the tables.
Insufficient serum was available for this to be
done in all cases.
The results obtained can be analysed as
follows:
Table 13. Tests with sera raised against
chromatographically purified
ovalbumin.
a) When an anti-ovalbumin serum was
16 3-
absorbed with ovalbumin it showed no titre to
cells coated with ovalbumin or to cells with
conalbumin in their coating. Therefore, where
cells coated with conalbumin recorded a titre for
a serum after that serum had been absorbed with
ovalbumin the titre recorded must have been a
record of anti-conalbumin antibody.
The very small titres remaining after the
absorption of serum R4C with ovalbumin are
probably slight traces of anti-ovalbumin from
this very potent serum. To completely remove
all traces of precipitating antibody from a serum
it is usually necessary to carry out a second
precipitation after removal of the main
precipitate.
b) The conalbumin coated cells recorded a
good titre of anti-ovalbumin. Absorption of the
serum with conalbumin did not affect this or only
reduced the titre by a single dilution. There¬
fore the cells cannot have been responding to
anti-conalbumin in the serum. The trace of
ovalbumin present in the conalbumin must have
been sufficient to fully sensitise these cells.
The only other possibility would be that the
anti-ovalbumin serum contained antibody to an
impurity ('globulin') with which the conalburain
cells were also coated and that they were
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Titre to cells coated with:
Serum Ovalbumin Conalbumin Ovalbumin 3 parts
Conalbumin 1 part
R4B
Unabsorbed Anti OA 41 40,960 5,120 5,120
R4B
Absorbed with




- - < 10 <20 < 10
R4C
Unabsorbed Anti OA ND 5,242,000 327,000 655,000
R4C
Absorbed with




- ND 40 80 80
ND = not done.
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reacting to this. Traces of another antibody
were seen in hyperimmune anti-ovalbumin sera
(fig. 32) but at an extremely low level. It is
therefore unlikely that they could be responsible
for the pattern of titres shown here.
Table 14. Tests with a serum raised against
twice-reerystallized ovalbumin.
This serum contained about equal amounts of
both anti-ovalbumin and anti-conalbumin anti¬
bodies .
a) When the serum was absorbed with oval¬
bumin, all antibody reacting with the ovalbumin
coated cells was removed (bottom line). There¬
fore the titres recorded by conalbumin coated
cells must be antibody to conalbumin.
b) Conversely, antibody recorded in the
middle line (sera absorbed with conalbumin) must
be antibody to ovalbumin.
c) The antibody nitrogen content of the
serum for each antibody was similar and the
cells, whether coated with conalbumin alone or
mixed with ovalbumin, gave similar titres for
each antibody. For the whole serum, the titres
recorded were slightly higher. This additive
effect would be expected where two different
antibodies were present in similar quantities.
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Table 15. Tests with anti-egg-white sera.
a) Once again, absorption with ovalbumin
left the sera unreactive to ovalbumin coated
cells. The bottom line in the table for each
serum must therefore represent a titre of anti-
conalbumin.
b) With each of the sera, the cells coated
with the mixed antigens recorded a titre for that
serum after one of the antibodies in it had been
removed. These titres were in proportion to the
actual quantity of antibody present. With serum
BWE an additive effect is seen when both anti¬
bodies are present in the unabsorbed serum. As
would be expected this is not seen with serum R5C
which contains a great excess of anti-ovalbumin.
These results show that:
a) Cells which have conalbumin as well as
ovalbumin in their coating are not more sensitive
to anti-conalbumin than they are to anti-oval¬
bumin. They give titres which are in proportion
to the actual antibody content of the serum.
Therefore the titre which they show for an un¬
absorbed serum is that of the antibody present in
the greatest quantity. Then the same amount of
each antibody is present there may be a slight
additive effect.
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b) Very small quantities of ovalbumin
present as an impurity in a conalbumin prepara¬
tion are sufficient to sensitize cells to anti-
ovalbumin antibodies.
c) Conalbumin appears to be a potent
antigen in the rabbit. Antisera to ovalbumin-
prepared-by-cryst&llization may contain an
unexpectedly high level of antibody to conal-
buriin. If unsuspected, these antibodies could
cause confusion in passive haemagglutination
tests carried out with cells coated with the same
crystallized ovalbumin.
3. The preservation of tanned and coated sheep
red cells
Fresh sheep red cells, tanned and then coat¬
ed with antigen constitute a most sensitive test
for antibody. Unfortunately they suffer from
two disadvantages:
(i) They have to be used immediately after
preparation. Only if conditions are favourable
may they sometimes be used for three or four
days, before bacterial contamination and lysis
occurs.
(ii) Each batch of cells prepared may diverge
widely from others in its sensitivity to antibody.
This variation is a great disadvantage for
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measuring antibody levels in experiments lasting
several months unless all the sera are examined
at the same time.
To overcome these difficulties, the known
methods of preserving tanned and coated cells
were examined.
a) Formalinization after preparation
The method used was that of Pulthorpe et al.
(1961). A one per cent suspension of ovalbumin
coated cells was stirred continually whilst
formalin was run in very slowly from a burette
with its tip immersed in the cell suspension.
Cells coated with bovine-serum-albumin were
successfully preserved by the method in this
laboratory under the writer's direction. The
ovalbumin coated cells so treated were completely
inactive.
b) Formalinization before preparation
(i) Formalinization. After some experi¬
mentation with the methods of Fulthorpe (1962)
and of McKenna (1957),both of which were time-
consuming and produced very distorted cells, the
method of Csizmas (I960) was chosen. This was
found to be simple, the conditions were not
critical and the cells produced were undistorted
and unagglutinated. Briefly, the method is to
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place a dialysis sac, partly filled with
formalin, in a suspension of fresh red cells.
The flask is shaken for a few hours during which
time saline is drawn into the sac to dilute the
formalin, whilst formaldehyde gradually escapes
to fix the cells. The sac is then opened to
allow the contents to mix with the cells, and
shaking is continued overnight. The cells are
then washed well with saline (or tap water, for
they are by now almost indestructible) and stored
as a suspension of known concentration in saline
at 4°.
Cells prepared in this way were kept for
periods of a year or more without deterioration.
(ii) Tanning and coating. The formalinized
cells were tanned and coated by published methods
or by those described in the Methods section of
this thesis. They were found to give agglutina¬
tion patterns and titres corresponding to those
given by fresh cells.
It was found, however, that many batches of
fresh tanned cells were much more sensitive and
would therefore detect smaller quantities of
antibody than would the formalinized cells.
Thus, with serum MO, a pool of mouse anti-oval-
bunin sera, fresh cells of batch 219 gave a titre
of 81,920, batch 350 gave a titre of 20,480,
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batch 428 gave a titre of 20,480, and batch 490
gave a titre of 40,960, whilst formalinized cells
of batch B gave a titre of 1280, batch C gave a
titre of 1280, batch D gave a titre of 640, and
batch K gave a titre of 5120.
(iii) The long tern preservation of the
formalinized cells by freezing. It was found
that tanned and coated formalinized cells could
be kept for days or weeks as a 1 per cent suspen¬
sion at 4° in a fully active condition without
preservative. However, some batches lost titre
during this time and others developed obvious
bacterial or fungal contamination.
McKenna (1957) reported that formalinized
cells could be frozen without damage, so this was
tried. Bottles of cells from a batch coated
with ovalbumin were frozen with solid CC^ and
acetone at -70° or by placing them in the deep
freeze for some hours at -20°. On testing with
an anti-ovalbumin serum, cells frozen by either
method or left unfrozen gave exactly the same
end-point.
Later, when large batches of formalinized
cells were prepared, it was found best to quick
freeze the cells in glass, screw cap, Universal
containers with acetone and solid CO^. If they
were frozen slowly at -20°, the sedimentation
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which occurred before freezing was complete
caused them to stick together in lumps. These
could be partly broken up by vigorous shaking,
but a better suspension was produced by ultra-
sonicating the vial for 30 seconds in a bath used
for cleaning electron microscope parts (Ultra¬
sonic Industries Inc., Albertson, N.Y.). This
did not damage the cells and tests showed that it
had no effect on their sensitivity.
Excess suspension left after use was put in
the deep freeze and froze slowly. It therefore
had to be treated in this way with ultrasound if
it was used later. As far as possible, only
quick frozen suspensions were used for titrations.
After having been frozen at -70°, the
bottles of cells were stored at -20°. There was
no indication that the reactivity of ovalbumin
coated cells changed during storage for periods
of up to 18 months.
4. Investigation of the conditions necessary
for tanning and coating forraalinized sheep
red blood cells
The ability to preserve tanned and coated
cells over long periods, as a batch from which
samples could be drawn as required, was a useful
step forward.
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The process of preparing a large volume of
cells was laborious. There were also occasions
when the cells produced only gave very low titres
with standard anti-sera or auto-agglutinated or
were completely inactive. It was also
unfortunate that the preserved cells were less
sensitive than fresh ones.
A series of experiments were therefore
carried out with the object of learning something
of the reasons for these variations. It was
also hoped that it would be possible to devise a
simple method of coating a large number of cells
at one time.
The results which follow were all obtained
by tanning and coating formalinized cells by a
standard method, given in detail below. This
was varied as made necessary by the requirements
of each test.
(i) A volume of formalinized cell suspen¬
sion equivalent to 0.3 ml of packed cells was
placed in a 1 oz screw capped glass vial
(McCartney bottle). More saline was added to
half fill the bottle. It was then centrifuged
at 750 G for 5 minutes at room temperature to
bring down the cells. The supernate was
discarded.
(ii) The cells in the vial were resuspended
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in 5 ml of phosphate buffered saline (P.B.S.)
pH 7.2, made up to the formula given in the
Methods section. Five ml of a 1:10,000 solution
of tannic acid (Mallinkrodt Chemical Corp.) in
P.B.S. was added. The vial was shaken up and
incubated in the 37° water bath for 15 minutes.
At the end of this time, the cells were again
brought down by centrifugation and the supernate
removed. They were then washed once with P.B.S.
and recentrifuged.
(iii) The supernate was discarded and the
cells resuspended in 5 ml of P.B.S. To this was
added the antigen solution, 10 mg of ovalbumin in
5 ml of P.B.S. The vial was gently shaken and
placed in a 37° water bath for 30 minutes.
During this time the vial was shaken once.
(iv) The cells were again spun down at 750 G-
and the supernate removed. They were then
washed three times with P.B.S. After the last
wash they were resuspended to 25 ml in P.B.S. to
which had been added one part in a hundred of
normal rabbit serum (N.R.S.). This serum had
been well absorbed with cells of the batch under
test.
(v) Batches of cells thus prepared were
compared for sensitivity by titration with a
rabbit anti-ovalbumin serum. To make the
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comparisons accurate, the serum dilutions were
first prepared in 1 ml volumes and then 0.1 ml
volumes of each dilution were distributed to the
wells in a plastic plate. One row of wells was
filled for each batch of cells to be tested and
a saline control well added. Cell suspensions
from each batch were added in 0.1 ml volumes to
the serum dilution rows. The plate was shaken
and allowed to stand overnight at room tempera¬
ture without disturbance before the end-points
were read as described in the Methods section of
this thesis. The batches were usually set out
in a random manner on the plate to reduce any
subjective influence on reading the end-points.
In some cases an end-point interpolated between
two dilutions has been recorded.
In the tests which follow it has usually
been possible to mark one vial of cells in each
as representing cells prepared under standard
conditions, i.e. pH 7.2, 1:10,000 tannic acid,
coating with 10 mg ovalbumin, and otherwise as
described above. This vial is marked 'S*.
a) Changes in the conditions under which tanning
and coating was carried out
Test 1. The effect of increasing the number of
cells treated with a standard quantity
of tannic acid and antigen.
Different packed cell volumes of formalinized
176.
cells were treated by the technique described in
the Introduction. This was carried out in vials
of the same size but each batch of cells was
finally diluted to a different volume to make a
1 per cent suspension in each case.
Table 16 shows that there was a very marked
variation in the sensitivity of the cells
produced when they were tested with an anti-
ovalbumin serum. The more cells that were
treated, the less the titre.
Table 16. Titre of anti-ovalbumin serum given
by different volumes of packed cells,
tanned and coated with the same
quantities of materials and under
the same conditions.
Packed cell volume Pinal volume of
1 per cent cells
Titre
0.17 ml 12 ml 1,000,000
S 0.35 ml 25 ml 102,400
0.70 ml 50 ml 25,600
1.4 ml 100 ml 200
2.8 ml 200 ml < 100
S = standard conditions.
Test 2. The effect of changes in the time for
which cells were exposed to tannic acid.
Cells in five vials each containing 0.3 ml
of packed cells were tanned under the standard
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conditions except that the tanning tine was 5,
15, 50, 60, or 120 minutes instead of the
standard 15 minutes. They were then washed
once and each made up to 25 ml of sxispension
with P.B.S. It was found that the same dilution
of normal rabbit serum was required in each case
to stabilize the cells and bring them down to a
perfect negative button in the wells of a plastic
agglutination plate. In the absence of normal
serum, tanned cells, whether coated or not, auto-
agglutinate and give agglutination settling
patterns.
This showed that variation in the time of
exposure of the cells to the tannic acid had no
effect on their agglutinability.
Test 5. Investigation of the relationship
between the strength of the tannic acid
solution used to treat the cells and
the amount of normal rabbit serum
subsequently needed to stabilize them.
Pormalinized cells in three vials were
tanned with either 1:20,000, 1:5,000 or 1:2,500
tannic acid. After washing, each was made up to
a 1 per cent suspension in P.B.S. and tested with
doubling dilutions of absorbed normal rabbit
serum to find out how much was required to bring
them down to a perfect negative button in the
wells of a plastic plate. This was found to be
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1 in 80, 1 in 40 and 1 in 10 respectively.
There is therefore a direct relationship between
the amount of tannic acid used and the amount of
serum needed for stabilization. The cells
agglutinate more strongly as the concentration
of tannic acid is increased.
Test 4. Investigation of the effect of varying
the amount of tannic acid used to treat
the cells whilst subsequently exposing
them to the same amount of antigen.
Five vials of formalinized cells were
treated with tannic acid concentrations from
1:80,000 to 1:5000 as shown in table 17. After
washing, the cells in each vial were coated with
10 mg of ovalbumin and finally resuspended to
25 ml in P.B.S. Tests were then made on the
cells to find out the most suitable concentration
of normal rabbit serum to stabilize each batch.
The appropriate amount of N.R.S. was then
added and the cells in each vial tested with an
anti-ovalbumin serum. The results, table 17,
show that with appropriate stabilization, an
increased amount of tannic acid gives somewhat
greater sensitivity.
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Table 17. The effect of varying the amount of
tannic acid used,on the titre given









1:20,000 1: 50 20,480
S 1:10,000 1: 50 40,960
1: 5,000 1: 50 40,960
S = standard conditions.
Test 5. Could a concentrated suspension of
tanned cells be effectively coated
with antigen?
Pormalinized cells were tanned in bulk by
adding a large volume of them, as a 6 per cent
suspension, to an equal volume of a 1:10,000
solulion of tannic acid. After incubation at
o
37 for 15 minutes the cells were washed once.
This is equivalent to the standard treatment
given to the smaller batches.
After resuspension, these tanned cells v/ere
distributed in different quantities to each of
four vials, so that these contained packed cell
volumes of 0.17, 0.35, 0.70, and 1.40 ml
respectively. The cells in each vial were spun
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down, resuspended to 5 nil and coated with 10 mg
of ovalbumin in 5 ml P.B.S. as in the standard
method. After washing, the contents of each
vial were made up to a 1 per cent suspension as
in Test 1 above.
The suspensions were tested with anti-oval-
bumin serum and found to give the titres shown
in table 18. Prom these results it appears that
many cells can be effectively coated in a small
volume without increasing the amount of antigen
available nor changing the other conditions as
long as the cells have all been effectively
treated with tannic acid.
Table 18. Titres of anti-ovalbumin serum given
by different packed cell volumes of
cells (all equally tanned) coated








0.17 ml 12 ml 10,240
S 0.35 ml 25 ml 30,000
0.70 ml 50 ml 20,480
1.40 ml 100 ml 30,000
S = standard conditions.
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Test 6. The effect of varying the quantity of
antigen used for coating the cells.
Cells in six vials were uniformly tanned
with a 1:10,000 solution of tannic acid. They
were then coated with amounts of ovalbumin
varying from 2.5 to 80 mg per vial before being
washed and resuspended to 25 ml each in the usual
way.
As shown in table 19 there was no
appreciable variation between the batches when
they were tested with an anti-ovalbumin serum.
Table 19. Titre of an anti-ovalbumin serum
given by tanned cells exposed to
different quantities of ovalbumin
during coating.
Amount of ovalbumin used








S = standard conditions.
Test 7. The effect of varying the time during
which coating was carried out.
Seven vials of cells were tanned and coated
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under the standard conditions except that the
time during which each was left in the 37° water-
bath for coating was varied from one to 64
minutes. In the case of the vials of cells
coated for only 1 and 2 minutes both the antigen
solution and the cell suspension were warmed to
37° before being mixed. They were spun down at
a high G force immediately the set time had
expired.
The results, table 20, show that though a
longer period of coating does increase the
sensitivity of the cell3, they were well coated
by exposure to the antigen for only one minute.
Table 20. Titres of anti-ovalbumin given by
cells exposed to the coating antigen
for varying periods of time.








S = standard conditions.
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Test S. The effect of coating cells at
different temperatures.
The normal procedure was followed using
1:10,000 tannic acid and 10 mg of ovalbumin for
each vial. In one set of vials the coating was
done at the normal pH of 7.2 and in the other at
pH 6.2 (see also test 9). The cells were coated
either a) at room temperature with continual
agitation on a Matburn mixer;
or b) in a water bath at 37° with occasional
shaking;
or c) in a water bath at 56° with occasional
shaking.
Coating was carried out for 30 minutes in each
case.
The cells were then washed and resuspended
in the usual way and tested with an anti-oval-
bumin serum to give the results shown in table
21. There was no appreciable difference between
the batches of cells coated at the three
temperatures and two pHs.
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Table 21. Titres of an anti-ovalbumin serum
given by cells coated at different










S = standard conditions.
Test 9. Investigation of the influence of pH
during coating.
Eight vials of cells were uniformly treated
with 1:10,000 tannic acid. After washing they
were resuspended in plain saline. Ten mg of
ovalbumin in 0.15 M phosphate buffer at the
wanted pH was added to each. After coating for
30 minutes at 37° the cells were washed and re-
suspended to 25 ml as usual and tested with an
anti-ovalbumin serum.
The results given in table 22 show that a
slight increase in sensitivity is obtained by
coating the cells at a low pH.
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Table 22. litres of an anti-ovalbumin serum











S = standard conditions.
b) Changes in the materials used
Test 1. A comparison of the amount of normal
rabbit serum needed to stabilize
different batches of formalinized cells
after tanning.
Samples of four batches of cells
forraalinized by Csizmas' method in April 1963,
June 1963, December 1963 and February 1964, were
treated with 1:20,000 tannic acid in February
1964. After a single wash with P.B.S., each
sample was resuspended to 25 ml and tested to
find the dilution of normal rabbit serum needed
to bring it down to a good negative button. In
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each case this occurred at the 1:128 dilution.
There was therefore no difference between
the batches of cells in their ability to be
agglutinated by tannic acid.
Test 2. The sensitivity of tanned and coated
cells prepared from cells forraalinized
at different times and by different
methods.
Cells from four batches formalinized by the
method of Csizmas (I960) and one batch prepared
by the method of McKenna (1957) were tanned and
coated as described above. A sixth batch of
formalinized cells which had kindly been supplied
ready tanned by Miss Marion Wood of Burroughs
Wellcome and Co. Ltd. were also coated with
ovalbumin at the same strength.
After being finally washed, stabilized, and
resuspended to a 1 per cent suspension, the seven
different batches gave the titres shown in table
23 with an anti-ovalbumin serum. Neither
individual batches of cells nor their method of
formalinization appear to have any influence on
the results obtained. There is, however, some
indication that deterioration may occur with age.
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Table 23. Titre of an anti-ovalbumin serum
shown by bc?„tches of cells
formalin!zed at different times and
by different methods but tanned and





Csizmas' method A October 1962 10,240
B April 1963 40,960
C June 1963 40,960
D June 1963 81,920
McKenna's method March 1962 40,960
Burroughs Wellcome Received
October 1962 40,960
(These tests were carried out in June 1963.)
Test 3« The use of different batches of tannic
acid.
Three vials of cells were tanned and coated
in the standard manner. In two cases Mallink-
rodt tannic acid was used. One sample was from
a bottle in constant use in the laboratory and
the other a fresh supply (by courtesy of Dr. G.
Loewi, M.R.C. Rheumatism Unit, Taplow). The
third vial was tanned with tannic acid of unknown
provenance found in the laboratory. It had a
cruder physical appearance and gave a more deeply
coloured solution than did the Mallinkrodt
materials.
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The cells from all three vials were found
to be stabilized by the same concentration of
normal rabbit serum and they gave the same end-
points with an anti-ovalbumin serum.
Test 4. The effect of coating cells with
different batches of ovalbumin.
Six vials of cells were tanned and coated in
the standard manner. A different batch of
chromatographically prepared ovalbumin was used
for each. The results of titration of an anti-
ovalbumin serum with the cells are given in table
24. Most batches gave the same result, although
one of them, JB3, was unsatisfactory for some
unknown reason.
Table 24. Titres of an anti-ovalbumin serum
recorded by formalin!zed tanned




used to coat the cells . Titre
G 25 20,480
J 5+6 (known to contain
conalbumin) 20,480





= the patterns collapsed to form negative
buttons on being allowed to stand overnight.
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Test 5. The effect of denaturing the coating
""
antigen.
George and Vaughan (1962) reported that they
were able to prepare very sensitive batches of
tanned fresh cells by denaturing crystallized
ovalbumin with urea before coating the cells.
This method of denaturation and two others
were therefore tested.
a) Urea. A solution of ovalbumin contain¬
ing 20 mg in 10 ml of saline was prepared.
Solid urea was then added to a final concentration
of 6 M. After 1 hour at 37° and 7 hours at room
temperature the urea was dialysed away overnight
with running tap water.
b) Surface denaturation. The ovalbumin
solution was put in a container of a size such
that ample free space was available (e.g. 10 ml
in a 25 ml bottle). It was then placed on a
Matburn blood cell suspension mixer for 3'h hours
at room temperature. Due to the shaking which
occurred, long strings of denatured ovalbumin
appeared in the solution during this time.
c) Heat. The ovalbumin solution was
placed in a 56° water bath for 3£ hours. During
this time a fine cloudiness appeared.
Three vials of cells were tanned and coated
by the standard method using these preparations
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of denatured ovalbumin. A fourth vial of cells
was coated with normal ovalbumin.
On testing with an anti-ovalburain serum
titres were obtained which are given in table 25.
These do not confirm the results of George and
Vaughan so far as chroraatographieally prepared
ovalbumin and preserved cells are concerned.
The cells coated with the urea denatured material
gave the lowest titres. These relatively small
variations may not, however, have any great
significance.
Table 25. Titres of an anti-ovalbumin serum
given by formalinised cells coated
with ovalbumin which had been





6 M urea 2,560
Shaking at room temperature 10,240
Heating at 56° 40,960
Normal, undenatured ovalbumin 10,240
c) Conclusions
These tests showed that the efficiency with
which the cells were tanned was the chief factor
which affected the sensitivity of the finished
product to antibody. The quantity of antigen,
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the pH, time, temperature, and the "batches of
materials used were of relatively minor
importance.
In designing a simple method for the
preparation of a large volume of cells it was
therefore possible to ignore many factors so long
as the tanning process was efficient. It was
found possible to carry out all the processes on
a very thick suspension (about 25 per cent) of
packed cells in a McCartney bottle. This was
easy to handle in a bench centrifuge and large
volumes of buffer and so forth were not required.
The cells were tanned with an adequately
large amount of tannic acid. It was found to be
important to ensure that this was mixed in very
rapidly to ensure that all the cells were evenly
treated, otherwise some cells were overtanned
and others unaffected.
It was not found necessary to use large
amounts of antigen to coat the cells nor to
increase the times of treatment excessively from
those outlined in the method given above.
Adequate mixing and resuspension at all stages
was important.
After washing had been completed in the
small vial, the cells were resuspended to make
500 ml of a 1 per cent suspension in P.B.S. Up
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to this point no normal rabbit serum was added;
another considerable economy. The suspension
was then tested with dilutions of normal rabbit
serum to find that which was most suitable for
stabilization. After addition of the correct
amount to the bulk suspension, the cells were
bottled in small quantities and quick frozen
with acetone and solid COg before being stored
at -20°. Full details of the process are given
in the Methods section of this thesis.
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C. DISCUSSION
1. The influence of conalbumin on the tanned
red cell agglutination test
An early paper reporting experiments with
Boyden's tarmed red cell agglutination test
(1951) was that of Borduas and Grabar (1953).
Amongst other findings they reported that when
ovalburain-coated red cells were used to titrate
anti-ovalbumin antibodies they actually recorded
antibodies to conalbumin, a minor impurity in the
ovalbumin. If this report was correct, it would
have a most damaging effect on any pretension to
specificity that the tanned cell test might have
with this or other antigen-antibody systems.
Borduas and Grabar based their report on the
following results. Two batches of cells were
prepared, one sensitized with ovalbumin (shown to
contain some conalbumin by immunological examina¬
tion) and the other sensitized with conalbumin
(not characterized). They then measured the
dilution of a 0.1 per cent solution of either
antigen which it was necessary to add to a rabbit
anti-ovalbumin serum to inhibit its ability to
agglutinate these cells. They found that
agglutination of the ovalbumin-coated cells could
be inhibited by a 1:10"^ dilution of conalbumin
-X
or a 1:10 dilution of ovalbumin, i.e. more
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ovalbumin than conalburain was needed. The
agglutination of eonalbumin-coated cells was
inhibited by a 1:10"^ dilution of conalbumin or
a 1:10 dilution of ovalbumin. As before, more
ovalbumin than conalbumin was needed to inhibit
the reaction.
These results suggested that both batches of
cells were reacting to antibodies to some sub¬
stance which was about ten times greater in
quantity in the conalbumin than in the ovalbumin
as so much less conalbumin was required to absorb
it from the serum. Borduas and Grabar inter¬
preted this to mean that the cells were reacting
to anti-conalbumin rather than to anti-ovalbumin
and that the cells were preferentially coated
with conalbumin. Some additional evidence arose
from the fact that the cells had been found to be
optimally coated (to react with this serum) by
much less conalbumin than ovalbumin.
This rather alarming report by Borduas and
Grabar caused two other investigators, who were
working with ovalbumin and tanned red cells, to
make some checks of its validity.
Stavitsky (1954b) examined conalbumin and
ovalbumin preparations which had been re-
crystallized 6 and 8 times respectively. He
found that each was still contaminated with the
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other. These preparations were used in tanned
cell agglutination inhibition tests with an anti-
ovalbumin serum which contained antibodies to
both of them (sic). The results indicated that
the ovalbumin-anti-ovalbumin system was less
sensitive than the conalbumin-anti-conalbumin
system but false results did not seem to be a
danger.
George and Vaughan (1962) also decided that
conalbumin was not a dangerous contaminant of
ovalbumin. An anti-eonalbumin serum prepared by
them and known to contain anti-ovalbumin anti¬
bodies was completely inactivated toward oval-
bumin-coated tanned cells after absorption with
optimal amounts of ovalbumin. This they inter¬
preted as meaning that conalbumin and anti-
conalbumin had no role in the reaction.
The present experiments, the results of
which are analysed in detail on a previous page,
show that cells coated with a mixture of
chromatographically prepared ovalbumin and conal¬
bumin react to the major antibody present in the
serum. They are not more sensitive to anti-
conalbumin than to anti-ovalhumin. It was also
apparent that the cells could be effectively
sensitized by a mere trace of ovalbumin present
as an impurity in conalbumin. It may well be
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that the converse also occurs but no tests were
made.
There was no evidence that any masking of
ovalbumin by conalbumin occxirs such as that
reported by Linz and lecocq (1962). They found
that a 'weak' antigen (bovine serum albumin)
might be well adsorbed by the cells but masked by
a 'strong' antigen (such as human or horse serum)
if this was present at the same time. The cells
could then be only agglutinated by sera against
the 'strong' antigen.
Another finding in the present work was that
rabbit sera raised against twice recrystallized
ovalbumin contained a high level of antibody to
conalbumin. This may help to explain the
findings of Borduas and Grabar.
The Berum tested by Borduas and Grabar had
been prepared with a crystalline ovalbumin
preparation known to contain conalbumin. This
serum was not characterized by immunological
methods and it may have contained a high level of
anti-conalbumin. If so, this would adequately
account for the results obtained. Their
inhibition test was carried out with tenfold
antigen dilution steps and only single dilution
differences were found. It would not therefore
be necessary to have very much more anti-conal-
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bumin than anti-ovalbumin in the serum to reverse
the interpretation of the reported readings if it
is assumed that each batch of cells was
responding to both antibodies.
The lesson of this work appears to be that
well characterized antigens and antibodies should
be used. Often a simple overnight gel diffusion
test will be sufficient to give adequate
information on this point.
2. The optimum conditions for tanning and
coating formalinized sheep red blood cells
Boyden's original development of a passive
agglutination test using tanned red cells (1951)
arose from investigations which he was making
into the agglutination of red cells by tannic
acid. The rationale of the test is that the
tanning process makes a normally non-agglutina¬
ting reaction into an agglutination one by
causing surface changes on the red cells
(Pirofsky et al., 1962), not that it causes
antigens to stick on the cells.
Sindo and Wakakura (1952) found that sheep
red cells would adsorb ovalbumin and so become
susceptible to agglutination or lysis by antisera
even if they were not tanned. In an experiment
not detailed above, the author confirmed that
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formalinized sheep cells could be coated with
ovalbumin even though they were untanned. These
cells only showed very low titres with strong
antisera.
The effect of tanning is therefore to
increase the agglutinability of the red cells and
so make the reaction more sensitive. Adequate
tanning is thus a pre-requisite for the prepara¬
tion of active batches of cells (compare table 16
with table 18). The results reported show that
the more tannic acid that was used the more
agglutinable the cells became (test a.3) and the
more sensitive was the final product (table 17).
However, the use of more tannic acid was not
all gain, for more normal rabbit serum was then
required to stabilize the cells (table 17) and
this would presumably reduce their actual
sensitivity. This is a very important factor in
the tanned cell test. An essential part of the
preparation of cells for the test is their
stabilization with a small quantity of normal
rabbit serum so that they will settle to a non-
agglutination pattern when no antibody is present.
On the other hand, in the test proper more serum,
with stabilizing action, is added in the low
dilutions of the serum being tested. Therefore
in the low dilutions the stabilizing action may
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be greater than the agglutinative action of the
antibody present and artificially low titres will
be recorded. The reality of this effect could
be tested for by adding low dilutions of normal
serum to the tubes in the end-point area of a
test of a high titred serum.
The key to the preparation of tanned cells
as a concentrated suspension rather than the
dilute 1-2 per cent suspension usually used, lay
in the adequate tanning of each cell rather than
the alteration of any other item of treatment.
Finally, no normal rabbit serum was used to
wash the cells after coating. After they had
been made up to the normal 1 per cent suspension
for use they were titrated with normal rabbit
serum. This titration showed the minimum
quantity which would be just sufficient to bring
the cells down to a negative button if no anti¬
body was present and this was added to the batch.
Maximum sensitivity was thus preserved.
Tests were also carried out in which the
conditions used for tanning and coating the cells
were varied. Most of the published work in this
field had been concerned with fresh cells and
formalinized cells may not react in a similar
manner. Comparisons between them nay not,
therefore, be valid.
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"Thus, In the present tests, formalinizsed
cells were found to be almost as well coated by a
solution containing 0.5 rag/al of ovalbumin as
they were by a solution containing 16 mg/ml
(table 19). However, using fresh cells, George
and Yaughan (1962) found that there was a direct
relationship between the quantity of antigen
which was used to coat the cells (0.1 - 1.0 mg/ml)
and their eventual sensitivity. The author
confirmed that this v/as true for fresh cells.
Antigen solutions containing 0.5, 1.0 or
2.0 mg/ml of crystallised ovalbumin were used to
coat three batches of fresh cells. These cells
subsequently recorded titres of 20,480, 40,960,
and 163,840 respectively, for the same serum.
Even with fresh cells different authors have
reported wide variations between the optimum con¬
centration of ovalbumin needed to sensitise the
cells. Boyd en (1951) found that 5 mg/ml v/as
needed for maximum sensitivity whilst Steffen and
Kosak (1963) found maximum sensitivity with 0.3
mg/ml. More or less than this was much less
effective. However, Line et al. (1961) in their
work with several other antigens found that the
concentration of antigen needed to sensitise the
cells could be varied widely without altering the
eventual sensitivity of the resultant cells.
This they considered to be due to the fact that
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only a very small part of the total protein
present was actually adsorbed on to the cells,
though this did seen to be related to the total
amount present.
George and Yaughan (1962) suggested that the
variations between the sensitivity of different
batches of cells coated with ovalbumin might be
explained by assuming that antigen was denatured
to a different extent in each case. They were
able to show that coating fresh cells with urea-
denatured crystallized ovalbumin gave them
greater sensitivity. Denaturation of the anti¬
gen was tried in the present work but only
material heated to 56° for hours seemed to
sensitize the cells more fully (table 25). This
result may be related to the finding of Christian
(1958) that heat aggregated gamma globulin was a
better coating agent for tanned cells than was
non-aggregated material. George and Yaughan
also found that the active coating material from
urea denatured ovalbumin was found in the pellet
after ultracentrifugation.
Urea denaturation was not found to be
effective (table 25). This failure to confirm
the results of George and Vaughan cannot be due
to some physical difference between chromato-
graphically prepared ovalbumin and that prepared
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by the normal method and it is unlikely that any
impurity was present in the material used by
George and Vaughan. A sample of ovalbumin, not
fully characterised, but prepared by them using
two types of chromatography followed by electro¬
phoresis also had its sensitizing ability for red
cells increased by denaturation.
In the present work, the tine of exposure to
tannic acid, the quantity of antigen used, and
the temperature at the time of coating had no
effect on the resultant sensitivity of the cells.
However, by coating the formalinized cells at a
low pH (table 22) or for a long period of time
(table 20) some increase in sensitivity was
obtained though the overall differences were not
very great.
Both Stavitsky (1954a) and Boyden (1951)
coated protein antigens on to the cells at pH 6.4
which Boyden had found to be an optimum.
Tanning was carried out at pH 7.2. Most authors
have followed this procedure without reporting
any tests to find an optimum. However, Felton
et al. (1961) working with herpes simplex virus,
a very different antigen than the purified
proteins usually employed in immunological work,
found that they were unable to sensitize fresh
cells at a pH above 7.0 and that the optimum was
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pH 6.4. There was no sensitization if the cells
were exposed to the antigen for less than 10
minutes though a longer exposure was not
advantageous.
In the present work, the use of different
batches of tannic acid, or of ovalbumin was found
to have no effect on the sensitivity of the cells
(test b.3, and table 24). There did seem to be
some deterioration of the older batches of
formalinized cells which had been stored without
preservative at 4° before treatment (table 23).
The cells were formalinized by the method of
Csizmas (i960). This method was very easy to
carry out with stock reagents from the laboratory
shelves. It was not necessary to neutralize the
formalin (Weinbach, 1958) and formalinization
was completed overnight rather than over a period
of ten days (Ingraham, 1958). The cells
produced were ready for immediate use and did not
have to be dispersed from clumps with a homo-
geniser (Cole and. Parrell, 1955) nor treated with
sodium bisulphite (McKenna, 1957). The cells
produced were normally shaped, un-crenellated,
almost indestructible and it was not necessary to
add any protective glycerol when freezing them
(Pahey and Humphrey, 1962).
The finished suspension was stored in saline
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at 4° without the addition of any Merthiolate
(Weinbach, 1958) or formalin (Ingraham, 1958).
The preserved cells seemed to be very formalin-
free and slow damage by contaminating organisms
may have occurred as no sterile precautions were
taken with them. If a stock of cells is to be
kept for a long period it may therefore be wise
to add some preservative to prevent any
deterioration occurring.
Although a method was evolved for the easy
preparation and storage of formalinized tanned
cells these appeared to be intrinsically less
sensitive than fresh ones. However, their
great convenience as a standard reagent and the
simplicity and reliability of the test carried
out with them, commends them as a first-class
method of antibody titration in any system to
which they can be applied.
Part Five
Experimental
THE MINERAL OIL ADJUVANTS
205.
Preliminary Notes
The results of the experiments carried out
with adjuvants have been arranged in five groups
as follows:
A. Characterization of the normal
antibody response of mice to an
antigen given in a water-in-oil
emulsion
B. The effect of later injections of
antigen, on the normal response to
an antigen given in water-in-oil
emulsion
C. Investigation of the effect of
alterations in the form of the
emulsion
D. Investigations into the raode of
action of the mineral oil adjuvants
E. A comparison in man, of saline and
water-in-oil emulsion influenza
virus vaccines.
A chief aim in all of these experiments was
to find reasons for the action of this type of
adjuvant. There is therefore some overlapping
between the groups.
Titrations were usually carried out with
tanned and coated formalinized red cells, stored
frozen. When very low titres were expected,
fresh cells were used as these were found to be
up to 64-fold more sensitive.








their sensitivity. By checking one hatch
against another their inter-relationships were
established. All the titres quoted have been
adjusted to those which would have been given by
a standard batch of formalinized cells. Thus
some low titres read with fresh cells have had
to be divided by factors up to 64. Hence the
mean titres of less than unity.
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1. The choice of a suitable test dose of
ovalbumin to be used in mice
To avoid immunological paralysis due to the
use of too large a dose of antigen or the lack of
a response diie to too little, it was necessary to
choose the lowest dose of ovalbumin which would
raise an easily measurable level of antibodies.
The route of administration was subcutaneous
and for these preliminary experiments saline was
used as the vehicle for the antigen.
a) Using twice recrystallized ovalbumin
(commercial source)
Mice in four groups of ten were each given
0.5, 1.0, 2.0, or 4.0 mg of ovalbumin dissolved
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in saline and sterilised by Seits filtration.
Another eight mice were left uninoculated.
Serum samples were collected on the days
shown in table 26. These were titrated with
fresh red cells which had been coated with the
same crystalline ovalbumin used for the
inoculations.
On the 39th day after the initial inocula¬
tion the mice in the groups given 0.5, and 2.0 mg
were each given a secondary dose of 1.0 mg of the
same ovalbumin in saline. ' The uninoculated mice
were also given 1.0 mg of ovalbumin at this time.
Three further samples were collected from the
mice in these groups.
The geometric mean titres for each group are
shown in table 26 and figure 39 shows these
results graphically. A dose response curve is
plotted in figure 41 for days 19 and 22 of the
primary response.
Of the mice in the groups given 1.0 and 4.0
mg ovalbumin, only three of ten animals showed
detectable antibodies. In the 2 mg group, seven
out of ten reacted to the primary stimulus and
all reacted to the secondary.
Two milligrams of ovalbumin was therefore
chosen as the standard test dose.
A 16.
Fig.39. The antibody responses of groups of
mice inoculated vith primary doses of 0.5* 1.0,
2.0 or 4.0mg of crystalline ovalbumin in saline.
A secondary stimulation of 1.0 mg of crystalline
ovalbumin in saline vss given on the 39th day.
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b) Chromatographically prepared ovalbumin
later, it was decided that chromatographi¬
cally prepared ovalbumin should be used in the
experiments with adjuvants. This material was
tested as above at the two dose levels of 1.0 and
2.0 mg per mouse. On the 31st day secondary
doses of 1.0 mg were given.
The results of titrations using cells coated
with chromatographieally prepared ovalbumin are
given in table 27 and are shown as a graph in
figure 40. The results of this experiment are
also shown on the dose response curve for
crystalline ovalbumin, figure 41. These graphs
show that the results follow those for crystalline
ovalbumin. No change was therefore made in the
decision to use 2 mg as a standard test dose.
Reference should also be made to table 57.
This gives the results of an experiment in which
doses of ovalbumin from 0.25 yug to 1200 ^ig in
saline were tested in mice.
Table 27. Geometric mean antibody titres of
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0.44 0.31 S 71.4 58.9 58.9
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SECONDARY STIMULATION (l mqm)
Fig.40. The antibody responses of groups
of mice inoculated with 1.0 and 2.0 mg of
chromatographically prepared ovalbumin in saline.
A secondary stimulation with 1.0 mg of the same
ovalbumin in saline was given on the 31st day.
Fig.41. Primary dose response curves for
groups of mice inoculated with various doses of
crystalline or chromatographically prepared
ovalbumin in saline.
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2. The antibody response of mice given ovalbumin
intravenously
A known base-line antibody response record
was required for mice given antigen intra¬
venously. Each mouse in four groups of six were
therefore given 2, 4, 8, or 16 rag of ovalbumin by
the intravenous route. The ovalbumin was
dissolved in saline, Seitz filtered and injected
into the tail veins of un-anaesthetized mice.
•The volume used was 0.2 ml in each case.
Four out of six mice in the 2 rag and 4 rag
groups, and five out of six in the 8 mg and 16 mg
groups showed a measurable response. Table 28
gives the geometric mean titres of serum samples
collected from individual mice in each group. A
dose response curve is plotted in figure 42.
These results showed that for the 2 mg and
4 mg doses, there was no significant difference
(P = 0.9 - 0.8 and 0.7 - 0.6) between the
responses of mice given the antigen by the sub¬
cutaneous or intravenous routes (cf. table 26).
However it must be remembered that these measure¬
ments were made at the limit of sensitivity of
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INTRAVENOUS DOSE OF OVALBUMIN
Fig.42. Dose response curve on the 25th
day after injection for groups of mice given
one dose of 2, 4, 8, or 16 mg of ovalbumin
intravenously in saline.
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Table 28. Geometric mean titres of groups of









15 20 25 36 37
2 mg 6 25.3 g ND ND 0.32 ND ND
4 mg 6 26.9 g ND ND 1.24 ND 0.56
8 mg 6 26.6 g 0.65 2.36 2.41 0.93 ND
16 mg 6 28.6 g 0.50 1.46 4.30 4.82 ND
ND = not done.
3. The antibody response of mice given
ovalbumin in a vvater-in-oil emulsion
Six mice were inoculated subcutaneously with
ovalbumin in a water-in-oil emulsion prepared
with the oil Drakeol 6-YR using Aquaphor as
emulsifier.
The Aquaphor was heated until melted and
0.4 ml of it placed in a sterile mortar. To
this was added 16 mg of ovalbumin which had been
dissolved in 0.43 ml of saline and Seitz
filtered. The two were blended together with a
pestle until all of the water phase had been
absorbed into the Aquaphor to form a smooth
cream. Drakeol 6-YR was then added in two
portions of 0.4 ml each and blended into the
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mixture. The resultant emulsion did not
disperse when a portion was dropped into water
and it was considered to he a good water-in-oil
emulsion.
The mice were each given 0.2 ml of the
emulsion (corresponding to 2 mg ovalbumin) sub-
cutaneously over the back as a primary stimula¬
tion. Thirty-one days later they were each
given a secondary inoculation of 1 mg of oval¬
bumin in saline.
Sera were collected from individual mice at
Intervals and titrated with tanned cells. Geo¬
metric mean titres of the results are given in
table 29» and are shown graphically in figure 43.
The graph shows that the titres were still rising
on the 31st day when the secondary injection was
given.
There was surprisingly little difference in
the height of the secondary responses as shown on
this graph (fig. 43) in comparison with the
primary responses to ovalbumin in the various
vehicles which varied widely. Student's t tests
of the 38th day means showed, however, that the
secondary response after a primary of ovalbumin
in normal saline was significantly lower than
the others.
SECONDARY STIMULATION (l 1119m)
Fig.45. The antibody responses of groups of
mice inoculated -with 2 mg of ovalbumin in saline,
water-in-oil emulsion, oil-in-vater emulsion or
in a multiple emulsion. A secondary stimulation
with 1 mg of ovalbumin was given on the 31st day.
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P = 0.01 - 0.001 for water-in-oil emulsion and
saline.
P = 0.01 - 0.001 for oil-in-water emulsion and
saline.
P = < 0.001 for multiple emulsion and saline.
The primary response curve for ovalbumin in
water-in-oil emulsion shows the steady rise to a
high titre typical of the response of mice given
a soluble antigen in this adjuvant. The curve
in its fully developed form, with a long plateau
following the rise, is better seen in figures 45,
51, and 54.
4. The response of mice to various doses of
ovalbumin in a water-in-oil emulsion
The object of this experiment was to find
out how small a dose of ovalbumin was still
effective as an antigen when given in water-in-
oil emulsion.
Pour water-iri-oil emulsions were prepared
which contained respectively 2, 20, 200 and
1333 of ovalbumin in each 0.2 ml of emulsion.
Mice in four groups of ten were each inoculated
with 0.2 ml of emulsion subcutaneously. Serum
samples were collected from them on the 20th,
31st and 60th days. The results of titrations
of these sera are given in table 30 and a dose














































response curve is plotted in figure 44. A graph
of the results for the 2 jxg and 20 jug groups is
also 3hown in figure 71.
Many individuals in one group of mice, those
given 200 jug, developed abscesses at the
injection site. These and the original emulsion
were found to be contaminated with cocci which
were probably Qaffkya tetragena.
Student's jt tests were carried out on the
results for the 31st day. The probabilities of
the different groups coming from the same popula¬
tion were as follows:
2 jig group and 20 jug group P = 0.05 -0.02
Do. 200 jig group P « 0.001
Do. 1333 jug group P = 0,005-0.0025
20 jig group and 200 jug group P - 0.01
Do. 1333 }ig group P = 0.6 -0.7
200 jxg group and Do. P = 0.005-0.0025
The group given 200 jug each seem to be un¬
related to any of the others. This may indicate
some additional adjuvant effect from the Gafflrya
tetragena infection or from the inflammatory
processes themselves at the site of injection
and infection.
The results for the other groups show that
even a dose as low as 2 jugm of ovalbumin in















Fig.44. Dose response curves for groups of
mice inoculated vith ovalbumin in water-in-oil
emulsion. Plotted on the 20th, 31st and 60th
days after injection.
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response. It is doubtful whether any anti¬
bodies would be detectable, even with the most
sensitive cells, if this dose was given in
saline (cf. table 57).
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B. The effect of later injections of antigen
on the normal response to an antigen given
in water-in-oil emulsion
Page
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1. Investigation of the effect of secondary
injections of ovalbumin in saline, given
after an initial inoculation with ovalbumin
in water-in-oil emulsion
In prophylactic immunization procedures it
is common practice to give more than one
injection of an antigen in order to obtain a
•booster' effect. If a depot forming adjuvant
is actually releasing antigen over a long period
secondary injections would appear to be super¬
fluous. If some more subtle mechanism is
stimulating antibody production a secondary
injection might cause some change to occur which
would he reflected in the shape of the antibody
response curve.
To test these ideas, groups of mice were
given a single secondary injection of ovalbumin
between the 5th and 129th days after a primary
inoculation of ovalbumin in a v/ater-in-oil
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emulsion.
A water-in-oil emulsion containing 2 mg
ovalbumin per 0.2 ml was prepared using a syringe
as described in the Methods section. Seventy
mice were each given 0.2 ml of the emulsion sub-
cutaneously on the same day. The mice were then
divided into seven groups one of which was to be
kept as a control. The mice in the other groups
were each given a single secondary injection of
ovalbumin in saline on the 5th, 10th, 20th, 40th,
80th or 129th days.
Sera were collected at intervals and
titrated with formalinised tanned cells. The
results of these titrations are given in table 31
and are shown graphically in figures 45» 46 and
47. In each graph the curve for one of the
groups given a secondary injection is shown
together with the curve for the control group.
There is some evidence from the curves that the
secondary response occurs as a transitory
incident on the basic pattern of response to
antigen in water-in-oil emulsion. Secondary
injections given on the fifth and tenth days had
no effect on the pattern of response.
As the curves are plotted on semi-
logarithmic graph paper it is possible to compare
the secondary responses directly by tracing the
Fig.43. Antibody response curves of groups
of mice given a secondary injection of 1 mg of
ovalbumin in saline five days after (above) and
ten days after (belov) being inoculated vith
2 mg of ovalbumin in a vater-in-oil emulsion.
The broken line on each graph is the response
of a control group of mice given 2 mg of
ovalbumin in vater-in-oil emulsion only.
Fig.46. Antibody response curves of groups
of mice given a secondary injection of 1 mg of
ovalbumin in saline twenty days after (above)
and forty days after (belov) b^ing inoculated
with 2 mg of ovalbumin in a wster-in-oil emulsion.
The broken line is the response of a control
group of mice given 2 mg of ovalbumin in v&ter-
in-oil emulsion only.
Fig.47. Antibody response curves of groups
of mice given a secondary injection of 1 mg of
ovalbumin in saline eighty days after (above)
end one-hundred-and-tventy-nine days after
(belov) an inoculation of 2 mg of ovalbumin in a
vat°r-in-oil emulsion. The broken line is the
response of a control group of mice given 2 mg
of ovalbumin in a vater-in-oil emulsion only.
220.
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Table 31. Geometric mean titres of groups of mice given a single -secondary injection of ovalbumin in saline at various times after an







































































































































































































































































Days = days from the initial inoculation with water-in-oil emulsion.
S = secondary injection of 1 mg of ovalbumin in saline.
0 « no antibody detected.
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curves one on top of the other with the origins
(the point at which the secondary injection was
given) coincident (Croxton, 1959)• This has
been done in figure 48 which shows that the
secondary response is very similar no matter
when the stimulus was given.
2. Investigation of the influence of the
inoculation of a second antigen in adjuvant
on mice already responding to an antigen in
adjuvant.
The use of a mineral oil adjuvant causes the
antibody response to an antigen to remain at a
high level over a long period of time. In
practical prophylaxis, it may be desirable to
give inoculations of other antigens made up in
the same adjuvant during this period. An experi¬
ment was therefore designed to study the
influence of later Injections of a different
antigen in adjuvant on the existing antibody
response of animals to another antigen which had
also been given in the same adjuvant.
A water-in-oil emulsion containing 2 mg of
ovalbumin per 0.2 ml was prepared by the syringe
method. Mice in three groups of ten were each
given 0.2 ml of the emulsion subcutaneously. A
fourth group was left uninoculated.
On the 16th day, a water-in-oil emulsion
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days after secondary injection.
Fig.48. The secondary antibody response
curves of groups of mice given 1 mg of ovalbumin
in saline on the days shovn above, after a
primary inoculation of 2 mg of ovalbumin in a
vater-in-oil emulsion. These are tracings
(vith the titre at the time of secondary stimulation
as a common origin) from the presentation of the
results on semi-logarithmic axes in figures 46
and 47.
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containing 2 mg of human-garama-globulin in each
0.2 ml was similarly prepared. The uninocula.ted
mice were each given 0.2 ml of this emulsion sub-
cutaneously as also were the mice in one of the
ovalbumin groups. In these latter, the second
inoculation was made on the opposite side of the
back to the site of the first inoculation.
Similarly on the 81st day, the mice in
another of the groups given ovalbumin were each
given 2 rag of human-gamma-globulin in 0.2 ml of
water-in-oil emulsion. This emulsion had been
freshly prepared and no individual control group
was set up for it.
The viscosities of the two human-gamma-
globulin containing emulsions were measured by
the method of Berlin (i960) immediately after
their preparation. The first emulsion gave a
mean flow time of 18 seconds, and the second of
36 seconds, for 0.2 ml (arithmetic means of
seven runs in each case).
Serum samples were collected at intervals
from all of the mice and these were titrated for
anti-ovalbumin and/or anti-human-gamma-globulin
antibodies a3 required. For the anti-human-
gamma-globulin antibodies, forrnalinized cells
coated with human-gamma-globulin were used.
These had been prepared and stored in exactly the
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same way as those coated with ovalbumin. The
results are given in table 32 and figures 49,
50, 51 and 52.
The two inoculations appear to have had no
influence upon each other. There is some
divergence of the antibody response curve for
the second batch of human-gamma-globulin
containing emulsion, from that for the first
batch, perhaps due to their differing viscosities
(fig. 52). Student's t_ tests to compare the
means of the anti-human-gamma-globulin titres of
groups C and I) showed no significant difference.
Group C Group D P
Day 68 with Day 65 0.3-0.2
Day 92 with Day 95 0.4-0.3
At the end of the experiment the depot sites
were examined. In the majority of mice, only
one or two large depots were found, depending on
whether or not the mice had received both
inocula. There was little reaction visible and
only slight encapsulation. This latter was,
however, sufficient to allow depots to be
dissected out whole. Most depots showed
stratification of the emulsion as shown in
figure 72.
Fig.49. The antibody responses of a group
of mice inoculated vith ovalbumin in a vater-in
oil emulsion, folloved by human-gamma-globulin,
also in a vater-ln-oil emulsion, eighteen days
later.
Fig.50. The antibody responses of a group
of mice inoculated vith ovalbumin in a vater-in-
oil emulsion, folloved by human-garnma-globulin,
also in a vater-in-oil emulsion, eighty-one
days later.
?ig.51- The enti-ovalbumin response curves
of three groups of mice each of which ves inoculated
with 2 mg of ovalbumin in s vater-in-oil emulsion.
Group B was subsequently given an inoculation
of human-gamma-globulin in vater-in-oil emulsion
on day l3 (at the arrov marked X). Group C
was inoculated similarly on day 8l (at the
srrov marked Y).
Fig.52. The anti-human-gemma-globulin
response curves of groups of mice inoculated
with 2 nig of humen-gamma-globulin in a vater-in-
oil emulsion whilst already responding to ovalbumin
in a vater-in-oil emulsion. Group D is a
control group which were not given ovalbumin.
pojji 2Z<\.
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Table 32. Geometric mean titres of anti-ovalbumin or of anti-human-gamma-globulin in the sera of groups of mice given injections of these












































Anti-OA: 0 9.0 ND 60 195 480 894 822 1479 1356 1524 1647 1779 1209 1245 870 645
Human-gamma¬
globulin on Days:
- - 0 3 10 17 24 31 38 48 58 68 76 95 116 135 155
day 18 Anti-HGG: H ND 13.5 49.5 121 320 596 556 568 808 1184 1492 1808 1900 3620




Anti-OA: 0 16.5 37.8 180 363 1101 1182 2532 ND 1671 1671 1356 1266 1524 1119 762 1047 603
Human-gamma¬
globulin on Days:
- - - - - - - - 0 1 13 20 31 44 53 68 92 124
































ND = not done. H = Human-gamma-globulin in water-in-oil emulsion— injected.
Days « in each case these are counted from the day on which either—injection was made. They are consistent within the groups but not from
group to group as set out on this table.
HGG = Human-gamma-globulin.
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in the form of the emulsion
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1. The preparation of multiple emulsions
It is probable that small particles of any
water-in-oil emulsion injected subcutaneously
break away from the main mass and become widely
distributed in the body soon after injection
(Preund and Lipton, 1955).
To encourage this process an attempt was
made to supply the water-in-oil emulsion in the




A water-in-oil emulsion containing only
saline was prepared as described in the Methods
section. The viscosity of this emulsion was
increased by cycling it between two syringes
connected by a double hubbed needle (Berlin and
McKinney, 1958).
One millilitre of the resulting emulsion was
added to 9 ml of saline. Vigorous shaking broke
the emulsion into small droplets but they rose to
the top of the mixture very rapidly and
coalesced.
The degree of dispersion was increased by
ultrasonicating the mixture with the M.S.E. probe
but the tiny droplets produced coalesced again
within a few minutes. The addition of a small
quantity of agar to the mixture did not help.
b) First multiple emulsion
Oil-in-water emulsions can readily be made
either by employing a suitable emulsifier of the
detergent type which promotes this type of
emulsion, or in the more classical way with the
vegetable gums. An attempt was made to re-
emulsify the water-in-oil emulsion using one of
these materials.
Two drops of 'Polywog' brand office gum were
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added to the mixture of water-in-oil emulsion
used above and the whole was re-treated with the
ultrasonic probe. An apparently stable emulsion
consisting of tiny drops of water-in-oil emulsion
was formed. The drops did not coalesce or rise
rapidly to the top of the liquid. This type of
emulsion is termed 'multiple' (Sumner, 1954) and
is shown diagramraatically in figure 53. The
nomenclature given is that agreed to in
discussions with the staff of the National
Research Development Corporation.
c) Multiple emulsion prepared with acacia
After obtaining the promising results above,
a second emulsion was prepared by the classical
method of pharmacy.
Two millilitres of a water-in-oil emulsion
containing only saline, were added to 0.25 g of
Acacia B.P. and the mixture ground up in a
mortar. Portions of saline were then added to a
total of 13 ml, grinding and mixing being
continued between each addition.
The dispersion of the water-in-oil phase was
not as great as had been hoped so the whole vras
ultrasonicated with the M.S.E. probe. A cream¬
like mobile fluid was formed. On microscopic
examination this was found to consist of tiny
Fig.53. Diagrammatic representation of
a multiple emulsion.
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droplets of oil containing within themselves
further minute drops. They showed no tendency
to coalesce.
This multiple emulsion was tested by sub¬
cutaneous injection in two groups of five mice.
One group was given the emulsion neat, and the
other group was given it after dilution five
times with saline, the total volume in each case
was the same. Animals from each group were
killed with ether and examined on the 3rd, 7th
and 14th days after inoculation. Table 33 gives
the results of these examinations. There was
little inflammatory or fibrous tissue reaction in
most cases and the depots formed were rather con¬
solidated lumps with a cheese-like consistency.
The emulsion appeared to retain its multiple
form.
d) Multiple emulsion prepared with Tween 80
It was found that a stable multiple emulsion
could be produced more easily by employing Tween
80 as the emulsifier rather than gum. The
primary emulsion was prepared by adding 1 ml of
Incomplete Adjuvant (Difco) to 1 ml of saline and
ultrasonicating the mixture with the M.S.E. probe.
The emulsion formed was checked to ensure that it
was of the correct form and then 4 ml of saline
Table33.Post-mort mappea ancesofthde otsf r dinicbytinjec ion ofamultipleemulsionpreparedwithacacia. Identification numberof mouseDayon which killedSizeof depot (mm)Typeof depot (Macroscopic)Contentsf depot (Microscopic)
Inflammatoryor fibrousreaction
a)Micegivenneatemulsion 18835xx4 193 190 209 2073 7 7 14
5x15
10x4x4 8x5x2 Notn ted
Thickand cheesy Do. Consolidated Do. Do.
b)Micegiventhemulsiondilut d1:5 189 192 191 194 2083 7 7 144x3 1 4x5 1 Manytin dispersed drops 6x30.5 Notn ted
Thickand cheesy Do. Notn ted Consolidated Do.
Multiple Do. Do. Mostlyplain oildrops Multiple Multiple Do. Mostlyplain oildrops Multiple Do.
None Do. Do.
Slight inflammation Marked,fibrous None Do. Slight inflammation None Do.
Notes:Thefirsttwoigur sgiv nnder'sizfdepot'ind ca eta a thesubcutaneoussurfaceoft kin.Thirdfig rindic tets apparentthickness. 'Plaino ldrops'mea sth tecreamyapp aranceftnormalwat r- in-oilemuls onwasabsent.
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and 0.15 ml of Tween 80 were added to it. The
whole was shaken up and ultrasonicated again for
about 10 seconds with ice cooling. An
excellent, stable, milk-like emulsion was formed.
On examination under the l/l2th objective of
a microscope samples of the emulsion were found
to consist chiefly of oil drops of 2-3 ^ diameter.
At least 50 per cent of these contained water
phase drops within them. There were a very few
larger drops and innumerable minute refractive
oil droplets under 1 jx diameter showing Brownian
movement.
A sample of this emulsion was stored at 37°
and found to remain stable up to 119 days after
preparation. It had broken down when examined
on the 271st day. No tests in mice were made
with this emulsion.
2. The antibody response of mice to the
inoculation of ovalbumin in a multiple
emulsion
A water-in-oil emulsion was prepared by
dissolving 25 rag of ovalbumin in 0.5 ml of saline,
adding 0.5 ml of Incomplete Adjuvant (Difco) and
ultrasonicating the mixture with the M.S.E. probe
until a very thick emulsion resulted.
The multiple emulsion was formed from this
231.
by adding 1.5 ml of saline containing 0.02 ml of
Tween 80 and ultrasonicating the mixture. This
was done in several short (5-10 second) bursts
interspersed with shaking. The preparations
were cooled with ice during both ultrasonications.
The final multiple emulsion contained 2 mg
ovalbumin per 0.2 ml. Ten mice were each given
an injection of this volume of emulsion, sub-
cutaneously over the back. Thirty-one days
later they were each given a secondary stimulus
of 1.0 mg of ovalbumin in saline.
Serum samples were collected at intervals
from the individual mice and titrated with tanned
cells. The geometric means of the results of
these titrations are shown in table 34. Figure
43 shows these results as a graph together with a
i
curve for ovalbumin given in water-in-oil
emulsion (Experiment A3). These two curves
fall very closely together.
3. A corai-arison of the antibody responses of
mice to antigens given in water-in-oil and
multiple type emulsions
a) Using ovalbumin as the antigen
A water-in-oil emulsion containing 2 mg of
ovalbumin in each 0.1 ml was prepared as
described in the Methods section. Adequate



























dispersion of the saline phase was obtained by
re-cycling the emulsion through the syringe onlju
Ten mice were each inoculated subcutaneously with
0.1 ml of this material.
A multiple emulsion was formed by adding
2 ml of the above emulsion to 2 ml of saline
containing 0.05 ml of Tween 80. After vigorous
shaking the mixture was ultrasonicated with ice
cooling for 10 seconds until a milky liquid had
formed. A drop dispersed readily in water and
on microscopic examination it was found to be a
good multiple emulsion. Each of ten mice were
inoculated with 0.2 ml of this multiple emulsion,
subcutaneously.
Serum samples were collected from both
groups of mice over a period of one year. The
results of tanned cell titrations for anti-oval-
bumin are given in table 35 and are shown graphi¬
cally in figure 54.
Although for most of the experiment higher
titres were recorded from mice given the multiple
emulsion, this difference was not significant
(P = 0.6 on day 71).
Ten other mice, in two groups, were also
inoculated with both types of emulsion. These
were killed at intervals up to the 21st day and
the inoculation sites examined. Table 36 gives
Fig.54. The antibody response curves of
mice inoculated vith ? rcg of ovalbumin either in
a vater-in-oil emulsion or a multiple emulsion.
paat,
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Days after first inoculation









0 1.2 5.0 40 51 104 194 375 375
0 0.7 20 76 184 375 904 810 1403
468 522 522 308 312 432 388 348 484 602 404 602 (538)
2177 2430 2430 1808 1451 1165 935 750 478 540 620 332 349
Notes: a) At day 266 two mice in the water-in-oil group appeared to— show a natural secondary response (see the individual titres in table 50).
The titres of these mice are included in the means calculated above.
b) The mean for the water-in-oil group on day 538 has been—
with, as detailed in experiment 3)9 , 204 days previously.
put in brackets to indicate that some of these mice had been interfered
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the results of these examinations.
At the end of the experiment the mice in the
main groups were destroyed on the 538th day.
The results of post-mortem examinations of these
mice are given in table 37. At this time eight
mice in each group were surviving, but the
results for only four of the water-in-oil group
are included in the table as the others had been
used in experiment D9.
There was little difference between the type
of depot formed in each case but it must be
pointed out that the mice with the most discrete
water-in-oil depots had been used in experiment
D9 and are not reported in this series.
b) Using influenza virus vaccine as the antigen
Water-in-oil and multiple emulsion vaccines
containing 'Munevan' influenza virus vaccine
(Evans Medical) were prepared in such a way that
the same amount of antigen was delivered in a
0.2 ml dose of either vaccine.
•Munevan' is a saline type vaccine
containing three formalin killed influenza virus
strains. These are 7500 HA units per ml of
A2/Singapore/l/57, 2500 HA units of
A2/England/l/61, and 5000 HA units of
B/England/939/59• Following the work of Berlin
Table37•Resultsofthepost-mortemexaminationfthd potit smicekill d 538thdayafterinooulationwi hater-in-oilmul pleemulsi ndj vant.
Mouse number
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(i960) the vaccines were diluted so that each
mouse received 75 HA units of strain
A2/Singapore/l/57.
The two water-in-oil emulsions, one to be
used as it stood and the other to be made into a
multiple emulsion, were prepared as described in
the Methods section. They were then each sub¬
jected to two short bursts (3-5 seconds) of
ultrasound from the M.S.E. probe to increase the
dispersion of the saline phase. This made them
so thick that they could scarcely be poured.
The multiple emulsion was made by suspending
one part of the appropriate water-in-oil emulsion
(containing 'Munevan* diluted 1 in 3.3) in two
parts of 1 per cent Tween 80 in saline and
dispersing this by ultrasonics as described uncior
M^thod'vi/n. above.
Two groups of six mice were inoculated with
the water-in-oil or the multiple emulsion vaccine.
Individual serum samples were collected on days
0, 21, and 35. These sera were titrated for
haemagglutination inhibiting antibodies by a
modification of the plastic plate method (W.H.O.
1953) using four HA units of virus.
The geometric means of the titres are given
in table 38. The difference between the groups
on the 35th day is just significant, P = 0.05 -
0.02.
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Table 38. Geometric mean titres of haemagglu-
tination inhibiting antibody in the
sera of groups of mice given influenza






Mean Days after inoculation
inoculated weight G 21 35
Water-in-
oil
6 27.6 g 8.3 15.3 31.7
Multiple
emulsion
6 27.2 g 13.6 40.0 100
The remaining portion of the multiple
emulsion was stored at 4°. This was stable for
14 weeks, but when examined after 22 weeks
considerable breakdown and reversion to an oil-
in-water form was found to have occurred.
The mice were destroyed with ether on the
46th day after inoculation. The results of
examination of the inoculation sites are given
in table 39. There was a considerable contrast
between the large single depots of water-in-oil
emulsion and the highly dispersed multiple
emulsion.
4. The response of mice given ovalbumin in a
multiple emulsion diluted with saline
To further investigate the antigenicity of
an antigen contained in a multiple emulsion, mice
240.
Table 39. Post-mortem examination of the sites of inoculation of










526 Large pea-like depot, with
a few smaller drops
Creamy None
529 Do. Creamy None
552 Single large depot Creamy None
536 Numerous large drops
♦
Creamy None
538 Two large drops Creamy None
541 Three large drops Creamy None
b) Mice given multiple emulsion
525 A few tiny dispersed drops Apparently
only oil
None
528 Only one tiny drop located Do. None
531 A few tiny drops only
found with difficulty
Do. None
534 Many small drops in
fibrous tissue
Do. Fibrous scarring
540 A few tiny drops Do. None




as in fig. 72
None
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were inoculated with ovalbumin incorporated into
an emulsion of this type which was then diluted
down with saline. By this means it was hoped to
obtain a greater dispersion of the droplets and
at the same time some indication of the dose
response relationship with this type of emulsion.
A water-in-oil emulsion containing 20 mg
ovalbumin per ml was prepared as described in the
Methods section.
A multiple ermlsion was made from this by
adding it to an equal volume of a solution of
acacia and ultrasonicating the mixture 7/ith the
M.S.K. probe. The mixture was cooled with ice
during this procedure which was carried out in
bursts of 5-10 seconds at a time interspersed
with vigorous shaking.
The acacia solution was made by dissolving
0.2 g of Acacia B.P. in 2 ml saline with the aid
of a 56° water bath.
Five mice were each inoculated subeutaneously
with 0.2 ml of the final emulsion, equivalent to
2 mg of ovalbumin each.
A further ten mice were each inoculated with
0.2 ml of a 1:5 dilution of the emulsion in
saline. This group therefore received 0.4 mg
of ovalbumin each.
A third group of ten mice were each
242.
inoculated with 0.2 ml of the original emulsion
diluted 1:20 with saline, equivalent to a dose
of 0.1 mg of ovalbumin each.
Sera were collected at intervals and
titrated. The geometric means of the results of
these titrations are given in table 40 and are
shown graphically in figure 55. A typical
response curve for mice given ovalbumin in
water-in-oil emulsion (from table 55) is also
plotted on the graph for comparison.
The difference between the water-in-oil and
the neat multiple emulsion is probably signifi¬
cant as a Student's t test gives P « 0.05, or
1 in 20, on the 61st day. This poor response to
a multiple emulsion prepared with acacia may be
accounted for by the inspissated nature of the
depots formed (see below).
All the three groups of mice given multiple
emulsion showed a similar pattern of response.
The multiple emulsion prepared with acacia was
still a very effective adjuvant, hut there is
some indication from the graph that there was a
falling off in titre after the peak, rather than
the maintenance of a plateau as usually seen
with water-in-oil emulsions.
The mice were destroyed with ether on the
156th day and the inoculation sites examined.
Fig.55. The antibody response of groups
of mice inoculated vith 2 mg of ovalbumin in a
vater-in-oil emulsion or in © multiple emulsion
prepared vith acacie. Also shovn are the
responses of groups of mice given the same
multiple emulsion after it had been diluted
1:5 or 1:20 vith saline. The mice in these
latter groups therefore received either 0.4 or
0.1 mg of ovalbumin each.
Table40.Geometricmeantitr sfnti-ovalbura nihsergr upice inoculatedwi hovalbuminm tipleemulsiondiluteditsaline.
Multiple emulsion dilution




































































All had depots; these were in the form of hard,
cream-coloured lumps whose size depended on the
dilution of the emulsion originally injected.
Under the microscope the depots showed many tiny
water-in-oil droplets embedded in a hard gum
matrix which was only broken up with difficulty.
Samples of the emulsions were kept at 37°
and examined at intervals. The neat emulsion
and that diluted 1 in 20 had broken down by the
fifth month after preparation. That diluted
1 in 5 lasted until the eighth month.
5. Intravenous injection of ovalbumin in a
multiple emulsion
The intravenous injection of ovalbumin in a
multiple emulsion was thought to be a possible
way of producing a widespread distribution of
small depots throughout the body.
A water-in-oil emulsion was prepared by
emulsifying 1 ml of saline containing 10 mg of
ovalbumin in 1 ml of oil/Ariacel. This emulsion
was prepared by the syringe method only. To the
2 ml of water-in-oil emulsion thus prepared were
added 0.6 ml of Tween 80 in 8 ml saline. After
shaking, the mixture was ultrasonicated with a
M.S.E. probe for two periods of 20 seconds each
with ice cooling. An excellent milk-like
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multiple emulsion was formed.
A group of five mice were each injected with
0.2 ml of this multiple emulsion into the tail
veins. They showed no discomfort after the
injection. Another group of five mice were each
given 0.2 ml of the emulsion subcutaneously. In
each case, the mice received only 0.2 mg of oval¬
bumin, a tenth of the standard dose.
Sera were collected and titrated at inter¬
vals. Geometric mean titres for the two groups
are shown in table 41 and in the graph figure 56.
The results may also be compared with those for
the intravenous injection of ovalbumin in saline
alone, table 28. The pattern of response is
different and the titres are much higher in the
present exoeriment.
Though the intravenously injected multiple
emulsion does show an adjuvant effect, this is
confined to the 3peed and height of the
immediate response but not its prolongation.
Possibly the tiny drops in the emulsion become
too dispersed in the tissues to form any true
depot.
6. The antibody response of mice to ovalbumin
given with an oil-in-water emulsion
The oil-in-water type of emulsion is said
Fig.56. Hie antibody responses of groups
of mice given 0.2 mg of ovalbumin esch in a
multiple emulsion, either intravenously or
subcutaneously.
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Table 41. Geometric mean titres of groups of mice inoculated with







7 14 21 28 35 47 50 79 82
Intravenous 5 15.3 7.36 4.07 9.50 2.81 ND 0.87 ND 0.19
Subcutaneous 5 ND 8.50 185 317 224 182 ND 139 ND
ND = not done.
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"by several authors (Freund, 1947; Freund et al.,
1948; Salk, 1953) to be ineffective as an
adjuvant. The first emulsion of this type
studied in the present work was formed by
accident and did show an adjuvant effect. The
reality of this effect was confirmed with a
second preparation made under controlled
conditions.
a) This emulsion was formed in error whilst
an early attempt was being made to produce a
water-in-oil emulsion.
Drakeol 6-VK mineral oil, 9 parts, and
Aquaphor 1 part by weight were blended together
in an M.S.E. homogeniser (Aquaphor has the con¬
sistency of lanolin or motor-car grease). The
mixture was then passed through a Seitz filter of
the Hemming type. After centrifugation at
3000 G for 45 minutes, only a small amount of
liquid had passed through and the Aquaphor had
formed a layer over the upper side of the filter
pad (Ford's S.B. grade).
One millilitre of the filtrate was emulsi¬
fied with 1 ml of saline in which 20 mg of oval¬
bumin had been dissolved and Seitz filtered.
The emu'lsifieation method was that of Berlin and
KcKinney (1958) using two syringes coupled by a
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double hubbed needle. The resulting emulsion
was watery and a drop allowed to fall into water
dispersed immediately. The emulsion was there¬
fore assumed to be of the oil-in-water type.
Six mice were each inoculated with 0.2 ml of
this material subcutaneously over the back.
Serum samples were collected at intervals up to
the 31st day and titrated for anti-ovalbumin by
the tanned cell test. On the 31st day all the
mice were given a secondary injection of 1 mg of
ovalbumin in saline. More serum samples were
collected and titrated up to the 83rd day.
Table 42 gives the results of the titrations
and they are shown as a graph in figure 57.
This shows that there was a better response than
that seen with ovalbumin in saline only (figs. 39
and 40). It was, however, not comparable with
that seen when the antigen was given in a water-
in-oil emulsion and the primary response was not
sustained.
The mice were destroyed with ether on the
93rd day after the initial injection. Examina¬
tion of the subcutaneous tissues at the inocula¬
tion site showed that small oil cysts were
present in every mouse. These were found over
areas of the subcutaneous tissues measuring from
20 x 15 mm to 50 x 10 mm. The cysts varied in
A 19
Fig.57. The antibody response curves of
fcvo groups of mice inoculated vith ovalbumin in
oil-in-vater emulsion.
Continuous line = emulsion A, prepared vith
Aquaphor.
Broken line - emulsion B, prepared vith
Tveen 80.
A secondary injection of 1 mg of ovalbumin in
saline was given to each group on the 31st day.
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size from a fine emulsion of tiny specks, to
drops up to 3 mm in diameter. The cysts
appeared to contain clear oil and there was a
minimum of reaction round them.
b) The results of the first trial appeared
to show that there was some stimulation of anti¬
body production over that given by the same dose
of ovalbumin in saline alone. This might, how¬
ever, have been due to some of the correct type
of water-in-oil emulsion having been present in
the mixture. A further test was therefore
devised in an attempt to eliminate this
possibility.
The following materials were mixed and
emulsified with the M.S.E. ultrasonic probe:
Drakeol 6-Vfi 1.2 ml
Tween 80 0.3 ml
Saline 12.0 ml
Ion agar (Oxoid) a few grains
A milk-like stable emulsion was formed. Under
the microscope this was seen to consist mainly of
particles with a diameter of 1 jx or less though
there were a few droplets up to 4-5 jx in diameter.
There was a tendency for the particles to stick
together but not to coalesce.
The emulsion remained stable when left on
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the bench overnight so 24 mg of ovalbumin were
dissolved in 2.4 ml of it. This was carried out
in as gentle a manner as possible to eliminate
any chance of the incorporation of ovalbumin into
the oil drops.
Each of ten mice were inoculated sub-
cutaneously with 0.2 ml of the emulsion. Serum
samples were collected from each mouse at inter¬
vals up to the 31st day. They were then each
given a secondary injection of 1 mg of ovalbumin
in saline. Further samples were collected up to
the 189th day. Table 42 gives the geometric
mean tanned cell titres of these sera and the
results are plotted on the graph figure 57. The
curve closely follows that for the previous test.
The results of this test are also plotted on
the graph in figure 4*3, together with curves for
the response of mice to ovalbumin given either in
saline alone or in water-in-oil emulsion. The
primary response to the ovalbumin with oil-in-
water emulsion lies midway between the two and
the difference is significant in both cases.
(Student's t test gives P = 4. 0.001 with water-
in-oil emulsion and P = ^ 0.001 with saline on
the 22nd day.)
The secondary response titre on the 38th day
is significantly different from that to ovalbumin
251.
in saline only (P = 0.01 - 0.001) but it is not
different to that of mice given ovalbumin in
water-in-oil emulsion as the primary inoculum
(P = 0.2).
The mice were destroyed with ether on the
189th day after the first inoculation. No sign
of any oil could be seen on macroscopic examina¬
tion of the subcutaneous tissues over the back.
All the other organs of the mice were quite
normal.
The unused remainder of the emulsion was
stored at 37°. When examined on the 68th day
after preparation it was still a stable oil-in-
water emulsion.
252.















10 29.8 g 0 ND ND 10.7 17.4
S = secondary inoculation with 1.0 mg ovalbumin in saline.
ND = not done.
ZSZ.
Bays after first injection
22 31 31 38 41 44 54 64 74 80 83 189
12.1 6.0 S 1810 1613 1676 ND NB ND ND 140 ND
7.6 6.1 S 3620 4460 3380 904 522 270 375 ND 76
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1. Do the emulsifiers Arlacel A and Tween 80
have any adjuvant effect themselves?
The unexpected, short term, adjuvant effect
of oil-in-water emulsion reported in experiment
C6 above, could have been due to the presence of
the emulsifier used to obtain a stable oil sus¬
pension. This might also account for the
enhanced response to antigen given in a multiple
emulsion. The emulsifier used in these experi¬
ments (Tween 80) was therefore examined to see
whether it showed any adjuvant effect when used
alone. Arlacel A was tested at the same time.
Three solutions were prepared each of which
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contained 2 rag ovalbumin in 0.2 ml. The
solvents used were:
a) Saline.
b) Five per cent Arlacel A in saline. This
is equivalent to the normal concentration
of Arlacel in a water-in-oil emulsion.
c) 2.5 per cent Tween 80 in saline. This
is about the strength used to form the
oil-in-water emulsion, but is greater
than that used in multiple emulsions.
Arlacel A at this concentration did not form
a true solution but a fairly rapidly separating
oil-in-water type of emulsion. Solution b) was
therefore shaken well to disperse the emulsifier
before each injection was carried out.
Mice in groups of six were each given 0.2 ml
of solutions a), b) and c) and sera were
collected from them at intervals. The geometric
means for titrations of the sera from each of
these groups are shown in table 43 and are
graphed in figure 58.
A Student's t test carried out on the 20th
day means of the saline and Arlacel A groups gave
P between 0.6 and 0.7 indicating that there was
no significant difference.
Thus neither Tween nor Arlacel showed any
adjuvant effect.
Fig.58. The antibody responses of groups
of mice inoculated v?ith 2 mg of ovalbumin in
saline or vith the emulsifiers Arlacel A or
Tween 80.
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Table 43. Geometric mean titres of mice
inoculated with ovalbumin alone or









15 20 24 31 50
OA
alone
6 31 g 0.12 0.38 0.50 0.62 0.40
OA +
Arlacel
6 31 g 0.34 0.42 0.38 0.48 0.50
OA +
Tween
6 31 g 0.10 0.38 0.42 0.56 0.96
2. Investigation of the influence of a saline-
containing water-in-oil emulsion inoculated
into mice at a different time or place to
the antigen
The object of this experiment was to find
out whether the water-in-oil emulsion itself or
its component parts had any stimulating effect on
the antibody forming mechanism when given apart
from the antigen.
A water-in-oil emulsion was prepared by the
syringe method. It contained saline only.
Mice in six groups of five were each given 2 mg
of ovalbumin dissolved in saline, on one day.
Those in two of these groups had been given
0.2 ml of the water-in-oil emulsion subcutaneously
one or two days previously. Another two groups
257.
were given a similar amount of the emulsion one
or two days subsequent to the ovalbumin. Of the
remaining two groups, one was given the emulsion
at the same time as the ovalbumin, but on the
other side of the animal (interval about one
minute). The other group was given the oval¬
bumin solution mixed with the emulsion in the
same syringe. To do this, 1 ml of emulsion was
taken up into the syringe, followed by 1 ml of
ovalbumin solution. The mixture was shaken,
moderately, before each mouse was injected, so
that some of each material was delivered through
the needle.
Serum samples were collected at intervals
from each mouse. The geometric mean titres of
the results of titration of these are given in
table 44. Only group D, those mice given oval¬
bumin mixed in the same syringe with the emulsion,
show any marked enhancement of antibody forma¬
tion. The adjuvant does not therefore appear
to be effective unless the antigen is contained
within it. Some incorporation of antigen into
the emulsion may have occurred in the case of
group D.
The last column in the table gives the
probability of the results for each group being
different from those of mice given 2 mg of oval-






























































































W/0=water-in-oilemulsioncontai ingsali eyOA=2ragovalbuminins line. ND=notdone.
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bumin in saline alone in experiment D1 above.
This was estimated by Student's jt test using the
35th day results of the present experiment and
the 31st day results from experiment Dl. None
of them were significantly different. No
estimate of P was made for group I).
3. The dilution of a water-in-oil emulsion with
more oil
In this experiment an attempt was made to
see whether an excess of the oil phase, together
with a reduced antigen content, would so prevent
the escape of effective quantities of antigen
from the emulsion that only a poor antibody
response would follow its administration.
A water-in-oil emulsion containing 2 mg
ovalbumin per 0.2 ml was prepared as described
in the Methods section.
A control group of five mice were each
inoculated with 0.2 ml of this emulsion sub-
cutaneously, i.e. 2 mg ovalbumin each.
A second group of ten mice were each
inoculated subcutaneously with 0.2 ml of an
emulsion made by diluting the original material
1:5 with more oil/Arlaeel. Each mouse in this
group therefore received 0.4 mg ovalbumin.
A third group of ten mice were given the
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original emulsion diluted 1:20 with oil/Arlacel.
Each mouse received 0.2 ml of the mixture, equi¬
valent to 0.1 mg ovalbumin.
Sera were collected at intervals and the
geometric mean titres of each group are given in
table 45 and are shown graphically in figure 59.
Student's JS tests carried out on the 51st and
61st days means of the control and 1:5 dilution
group gave ? = 0.1-0.2 in both cases. The
differences between the groups are, therefore,
not significant, though the diluted emulsions
gave the better titres.
Post-mortem examination of the sites of
injection were carried out on the 271st day when
the depot contents were collected for use in
experiment D10. Depots were present in all
cases, and were single in form or consisted of a
few large drops. Most of then showed stratifi¬
cation, i.e. there was a clear layer of oil over
creamy material as shown in figure 72.
4- To investigate the effect of incorporating
ovalbumin into adjuvant materials without a
water phase
The objects of these experiments were to
find out whether:
(i) the presence of the water phase was
necessary for adjuvance;
Fig.59. The antibody responses of groups
of mice inoculated vith 2 mg of ovalbumin in a
vater-in-oil emulsion, or vith the same emulsion
diluted 1:5 or 1:20 vith more oil/Arlacel. The
latter groups therefore received 0.4 or 0.1 mg
of ovalbumin each.
261. paye 2(,l.
















15 20 25 30 37 44 51 61 71 80 101 129 178 271
Neat 2 mg 5 29.1 g 5.6 80 88 184 252 313 352 303 632 696 410 410 540 254
1 in 5 0.4 mg 10 26.1 g 27.0 260 470 556 824 1872 2330 2248 2288 1870 1619 1123 1072 2560
1 in 20 0.1 mg 10 26.6 g 25.0 136 372 640 1004 1500 2600 1568 1652 1500 828 528 540 493
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(ii) antigen could be so locked up in the
oil that it was inactive;
or (iii) there was any solution or adsorption
of the antigen by the adjuvant
materials.
Ovalbumin was incorporated into oil or
oil/Arlacel to make four preparations as follows:
a) Ovalbumin in oil
Freeze dried ovalbumin was mixed with the
oil Drakeol 6-VR so that 0.1 ml contained 2 mg
ovalbumin. The mixture was then treated with
the M.S.I, ultrasonic probe until the antigen was
well dispersed. The mixture then showed the
shot-silk appearance seen when ovalbumin is being
crystallized from ammonium sulphate solution.
Ten mice were each given 0.1 ml of this
mixture subcutaneously. Sera were collected at
intervals and titrated with preserved tanned
cells. On the 66th day a secondary injection of
1 mg of ovalbumin in 0.2 ml saline was given to
each mouse. Further sera were then collected
at intervals.
b) Ovalbumin in oil, centrifuged
A similar mixture to the above was prepared
and allowed to stand on the bench for four days
being shaken occasionally. On the fourth day it
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was centrifuged at 3200 G for 30 minutes. The
ovalbumin then presented the appearance of a film
of frosted glass over the bottom of the vial.
The supernate was carefully taken up into a
syringe and three mice v/ere each inoculated sub-
cutaneously with 0.2 ml. Sera were collected at
intervals and titrated with a sensitive batch of
fresh tanned cells.
No secondary injection was given to these
mice.
c) Ovalbumin in oil and Arlacel
(i) Freeze dried ovalbumin was added to the
standard mixture of nine parts of Drakeol 6-VR
and one part of Arlacel A, so that 0.1 ml
contained 2 mg ovalbumin.
The mixture was ultrasonicated and showed
the same silken swirls noted in a) above.
Ten mice were each inoculated with 0.1 ml
subcutaneously and sera were collected at inter¬
vals. These sera were titrated with preserved
cells.
No secondary inoculations were given to
this group.
(ii) A similar batch of material was pre¬
pared and a portion of it used to inoculate five
mice subcutaneously. Sera were collected and
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titrated with fresh cells where the titres were
lo?/.
d) Ovalbumin in oil and Arlacel, centrifuged
The remainder of the preparation of oval¬
bumin suspended in oil/Arlacel from c) (ii) above
was allowed to stand on the bench for four days
with occasional shaking. It was then centri-
fuged at 3200 G for 30 minutes and the supernate
inoculated subcutaneously into three mice in
0.2 ml quantities. Sera were collected at
intervals and titrated with fresh cells.
The results for these experiments are com¬
bined in table 46 and in the graph figure 60.
These show that there is a normal adjuvant type
of response with ovalbumin in the oil/Arlacel
mixture, but only a slight response if the oval¬
bumin is removed by centrifugation. It also
appears that only enough ovalbumin can escape
from plain oil to effect sensitization to a
secondary injection of the antigen.
Post-mortem examination of the depots
a) Ovalbumin in oil (examined on day 219):
The depots showed single or multiple oil
droplets which did not show any visible
inclusions.
Fig.6o. The antibody response curves of
groups of mice inoculated vith ovalbumin
suspended in oil alone or in oll/Arlacel. Also
their response to the latter mixture after
removal of the ovalbumin by centrifugation.
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Ovalbumin in oil, centrifuged (examined on
day 86):
Only large clear oil drops in single or
multiple depots were seen.
Ovalbumin in oil/Arlacel (i. examined on day
219; ii. examined on day 82):
(i) There was markedly more reaction and
fibrotis encapsulation of these depots
than that seen with oil alone in a) and
b). The oil drops themselves were
distinctly cloudy.
(ii) Single or multiple depots were seen.
Where the oil drops were large enough
they appeared to contain a yellowish
deposit in the lower half giving the
same stratified appearance illustrated
in figure 72. This material could
easily be resuspended in the super¬
natant oil.
Ovalbumin in oil/Arlacel, centrifuged
(examined on day 86):
The larger drops in these depots were seen
to contain some fine cloudy white inclusions
as in c) above. Attempts to identify the
included material by microscopic examination
and staining were unsuccessful.
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Mean Days after initial inoculation
Weight 14 21 23 28 31 35 42 50 53 54 66 66 73 80 82 102 123
OA In
Drakeol




3 ND 0 0 - 0 - 0 0 - 0 - - - - - -
OA in
(i) 10 25.9 g - - 27.6 - 91.8 - 242 - 210 - - - 226 - _ - 278
oil/Arlacel




3 ND 0 2.57 - 3.4 - 0.70 0.15 0.27 - - - - -
ND = not done.
- = no serum collected.
0 = no antibodies detected.
S = secondary injection of 1 mg of ovalbumin in saline.
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5. Studies of the dynamics of water-in-oil
emulsions
__
The experiments to be described were
attempts to find out how easily an antigen could
escape from a water-ln-oil emulsion. Could it
escape by merely diffusing through the oily
barrier? Was break-down of the emulsion
necessary for its release? Did other materials
enter the emulsion whilst it was in the animal?
a) Ordinary Ochterlony double diffusion
plates made with 1 per cent New Zealand agar in
saline were poured in small petri dishes.
Various patterns of wells were cut in them using
either a Peinberg cutter (Shandon Scientific Co.,
London) or cork borers and a scalpel. Where a
trough was cut right across the plate great care
was taken to dry the glass surfaces of this with
filter paper fragments before the reagents were
added. Some of the patterns tried are shown in
figure 61 a-d, the troughs across the plate being
about 2 mm wide. Neat egg-white was placed in
the wells on the left-hand side of each plate,
oil/Arlacel mixture in the trough and an anti-
egg-white serum (R5F) in the right-hand wells.
In type A the serum was diluted 1:8 and in the
others 1:2. The plates were then incubated at















Fig.6l. Patterns of veils and troughs cut
in an agar layer in petri dishes. In plate A
some agar has also been removed, from the
surroundings of the left-hand veil.
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In each plate overnight incubation produced
cloudy smoke-like swirls of some material in the
oil/Arlacel. After a few days this settled to
form a deposit over the bottom of the trough.
Precipitation lines appeared in plate D, and in
one of three of type A but not in types B and C.
Great care was taken to eliminate any moisture in
the trough of plates of type A which might allow
the reagents to track across it. In the case of
plate type C a single knife cut seems to have
been a sufficient barrier. It may be, therefore,
that some antigen can escape across the
oil/Arlacel barrier.
b) In an attempt to identify the cloudy
material appearing in the oil/Arlacel, plates of
types B and F were prepared. A fluorescein
labelled (Nairn, 1962) preparation of bovine
serum albumin (Armour) was placed in the well of
each. The plates were incubated at 37° and
examined each day under the light from a Hanovia
Laboratory U.V. lamp fitted with a Corning 5840
filter. In the E type plates, no fluorescent
material was seen to cross the trough over a
period of seven days. When, after this, the
agar on the antigen side was pushed across to
contact the plain agar on the other side,
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transfer of material did occur.
Samples of the oil/Arlacel with its smoke-
like deposit from the plate of type F was
examined under the U.V. microscope. The
contained particles could not he identified nor
were any of them fluorescent.
c) Plates were prepared filled with 1 per
cent Hew Zealand agar in saline to which a
solution of bovine serum albumin (Armour) which
had been fluorescently labelled (by the method
of Nairn, 1962) was added whilst it was cooling.
Wells were cut in this and filled with
oil/Arlacel. After incubation at 37° for four
days samples of the cloudy oil/Arlacel were
collected and examined under the TJ.V. microscope.
Tiny fluorescent fragments of agar were seen and
also fluorescent drops of various sizes.
d) In order to find out whether antibody
could enter the emulsion to combine with the
/
antigen, water-in-oil emulsion depots from mice
used in experiment B1 were examined.
These mice, which had been given a secondary
injection of ovalbumin on the fifth day after
receiving ovalbumin in a water-in-oil emulsion,
were killed with ether on the 233rd day. Six
depots were collected and the emulsion broken by
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adding ether to it. A little distilled water
was then added. The mixture was well shaken and
allowed to stand for an hour before the antigen
layer was pipetted off.
A portion of the antigen layer was examined
by electrophoresis in cellulose acetate paper and
an ovalbumin control was run at the same time.
Figure 62 shows that the only material present
appeared to be ovalbumin.
Another portion was added to an equal volume
of anti-ovalbunin serum R4C and incubated over¬
night at 37°. ?i"hen tested with tanned red cells
the mixture gave a titre four-fold lower than
that of a control. An unexpectedly small
reduction.
e) To investigate further, a water-in-oil
emulsion and its separate components were set up
as Oakley-Fulthorpe type tube diffusion tests
(Crowle, 1961).
The first layer placed in a precipitin tube
was a mixture of equal parts of 2 per cent agar
and serumjor saline as a control. The second
layer was 1 per cent agar alone and the third
layer the material under test. The tubes were
incubated for one day at 37° and then kept for
some months at 4°.
Oh
D£rt.
Fig.62. Electrophoresis on cellulose
cetate paper.
Above: Ovalbumin control.
Belov: The water phase from vater-in-oil
emulsion depots collected from mice
233 days after inoculation.
ectrophoresis carried out for 3 hours.
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Table 47 shows how the components were
arranged in the tubes and the results obtained.
Precipitation lines were only seen in the tube
with anti-egg-white serum in the bottom layer
and ovalbumin in a water-in-oil emulsion at the
top. The supernate from an attempt to dissolve
ovalbumin in oil/Arlacel (experiment D4d) was
inactive in this test though it had shown slight
antigenic activity when inoculated into mice
(fig. 60).
Both Arlacel and the oil/Arlacel mixture
developed a cloudy precipitate when allowed to
stand for some months. This was similar to the
cloudiness in the wells of agar plates reported
in a) and c) above and in the depots of
oil/Arlacel, experiment D4. It presumably
consisted of tiny water droplets drawn into the
mixture.
6. A comparison of the antibody response of mice
to ovalbumin given with aluminium hydroxide
or with water-in-oil adjuvants
If all adjuvants of the depot forming type
have the same mechanism of action, close agree¬
ment might be expected between the antibody
responses to them whatever their chemical
composition.
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Table 47. Results of tube diffusion tests with ovalbumin in water-in-
oil emulsion and its components.
Materials in the layers 2-7 days after preparation Pour months after preparation




State of top layer State of emulsions
Saline Drakeol 6-VR None None Clear -
Saline Arlacel A Yes None Thick white deposit over
the agar surface
-
Saline Oil/Arlacel None None Slight white deposit over
the agar surface
-
Normal serum Oil/Arlacel None None Thick white deposit over
the agar surface
-
Anti-EW Bo. None None Fungus growth -
Saline Water-in-oil emulsion
containing saline only
None None Normal No breakdown but a layer of oil
present over white emulsion
Anti-EW Bo. None None Normal Bo.
Saline Water-in-oil emulsion
containing ovalbumin
None None Breaking down Stratified appearance as shown
in figure 72
Normal serum Bo. None None Complete breakdown Oil over water
Anti-EW Bo. - Yes Bo. Bo.




Anti-EW Bo. None ' None Clear
Normal serum = normal rabbit serum.
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Ovalbumin was adsorbed on to aluminium
hydroxide gel ('Alhydrogel• Dansk Svovlsyre-OG
Superphosphat-Fabrik) as described in the Methods
section of this study.
Ten mice were each incoulated subcutaneously
with 0.2 ml of the suspension so prepared, this
being equivalent to a dose of 2 mg of ovalbumin
each. Another five mice were each given 2 mg
of ovalbumin in 0.2 ml of the standard type of
water-in-oil emulsion. This emulsion had been
prepared with the aid of a 'Bel' cream maker.
At suitable intervals sera were collected
from the mice and titrated with tanned cells.
The geometric mean titres of the results of
titrations for each of the groups are given in
table 48 and are graphed in figure 63.
A statistical comparison of the difference
between the means of each group on the 39th day
gave P = 0.3 - 0.2 which is not significant.
Table 48. Geometric mean antibody titres of
groups of mice inoculated with oval¬
bumin adsorbed on to aluminium


















343 686 640 1374 1194






Fig.65. Antibody response curves of groups
of mice Inoculated vith 2 mg of ovalbumin either
in a water-ln-oil emulsion or adsorbed on to
aluminium hydroxide.
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7. The influence of anti-ovalbumin serum given
at the sane tine as ovalbumin in a water-in-
oil emulsion
The adjuvant effect of a mineral oil
emulsion could be due to an initial stimulating
action of the oil or emulsifier on antibody
forming cells in the presence of antigen. The
administration of an anti-ovalbumin serum at the
same time as an inoculation with ovalbumin in
water-in-oil emulsion might block any action of
this type.
Ten mice were each given a subcutaneous
injection of 0.4 ml of a mouse anti-ovalbumin
serum. This serum was a pool of sera from
previous experiments and gave a titre of 1:2560
with tanned cells.
Fifteen minutes later these mice and also
another control group of four were each given a
subcutaneous injection of 2 mg of ovalbumin in a
water-in-oil emulsion. The injection was made
on the opposite side to the serum.
Serum samples were collected at intervals
and titrated. Geometric means of the titres of
the sera at each bleeding are given in table 49
and are shown graphically in figure 64. The two
curves show little difference. A Student's t_
test carried out on the results for the 31st day,
when the divergence was at maximum, gave P
between 0.2 and 0.3 which is not significant.
Fig.64. Antibody response curves of tvo
groups of mice each inoculated with 2 mg of
ovalbumin in vater-in-oil emulsion. One group
(broken line) was given an inoculation of mouse
antl-ovalbumin serum 15 minutes before the
antigen.
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8. Methylene blue in a water-in-oil emulsion
In an attempt to find out over how long a
period materials given in a water-in-oil emulsion
were able to escape from the depot, a dye which
would be excreted in the urine was incorporated
into an emulsion and inoculated into mice,
Strauch (1929) had carried out a rather similar
experiment using methylene blue emulsified in
olive oil. He found that the dye was excreted
over a period of several weeks.
A water-in-oll emulsion was prepared as
described in the Methods section, using a 4 per
cent solution of methylene blue in normal saline
as the water phase.
Three white mice were each given 0.2 ml of
the emulsion subcutaneously over the back.
Another three white mice were each given 0.1 ml
of 4 per cent methylene blue in saline only.
Each group of mice was kept in a baking tin
type of mouse cage with ample food and water but
no bedding except a sheet of white blotting
paper. To prevent the blotting paper being
chewed by the mice it was covered with a sheet of
perforated zinc. Clean sheets of paper were
placed in the cages every day.
For the first two days after the inocula¬
tions there was very marked staining of the paper
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in each cage by the excreted dye in the urine of
the mice. Thereafter this became much lighter
each day. It was undetectable by the 12th day
in the cage of the mice given the dye in saline,
but did not disappear from the cage of those
given the dye in water-in-oil emulsion until the
19th day.
9. The reinfection of depot contents into the
mice from which it was removed
Late in experiment C3, two of the mice which
had been given ovalbumin in water-in-oil emulsion
showed sudden increases in titre as shown in
table 50. These increases had the
characteristics of a secondary response which may
have been caused by the escape of emulsion from
an encapsulated depot whilst the mice were being
firmly held for bleeding.
An attempt was therefore made to produce
this effect artificially using the four of the
remaining eight mice which did not show high
titres.
Each mouse was anaesthetized with ether.
The adjuvant depot was located by palpation and
the hair over the site clipped. A small slit
was then made with a scalpel and the depot
delivered through this and held with forceps.
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As much of the content as possible was sucked
into a syringe through a 1 mm needle. The depot
was then released and the incision dusted with a
wound dressing powder.
The volume of emulsion collected from each
depot was insufficient for re-injection due to
the dead volumes in syringe and needle. Some
oil/Arlacel was therefore added to make up the
volume to about 0.3 ml. This was then injected
subcutaneously on the other side of the same
mouse. The needles and syringe were flushed out
several times with oil/Arlacel between each
operation.
Serum samples were collected on the 4th, 8th
and 204th days after these manipulations. The
titres of these are given in table 51. The
results show that there was a marked increase in
titre following the treatment. In the case of
mouse number 132, the depot burst on delivery
through the incision and it was only possible to
collect a very tiny amount of the contents for
re-injection. There was no response in this
mouse.
Table 52 gives the titres of the four
remaining animals in the group which neither
showed a natural secondary response, nor were
re-injected.
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Table 50. Antibody titres of mice given ovalbumin in water-in-oil
emulsion in experiment C3a, which showed spontaneous
secondary responses.
Mouse Days from first inoculation
number
114 142 170 198 226 266 296 320 365 383
136 20 20 60 60 60 4860 4860 1620 1620 1620
137 60 60 60 180 180 1620 540 540 180 60
Table 51. Antibody titres of mice reinjected with the contents
of their own water-in-oil emulsion depots.
Mouse
number
Days from first Inoculation
198 226 266 296 320 365 379 383 387 538
130 1620 180 540 540 540 1620 X 540 4860 1280
132 180 60 180 180 180 540 X 540 540 +
135 20 20 20 60 20 180 X 540 4860 640
138 180 540 60 180 180 180 X 1620 4860 320
X = re- injection of depot. + = dead.
Table 52. Antibody titres of individual mice given ovalbumin in
water-in-oil emulsion, experiment C3a.
Mouse Days from first inoculation
number
142 170 198 226 266 296 320 365 383 387 538
131 4,860 14,580 4,860 14,580 4860 4860 1620 4860 4860 4860 640
133 4,860 4,860 4,860 4,860 1620 4860 4860 1620 4860 4860 5120
134 10 10 10 10 10 10 5 10 10 10 10
139 14,580 43,740 14,580 14,580 4860 4860 4860 4860 4860 4860 2560
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It will be seen from the tables that in this
experiment three-fold, instead of doubling,
dilutions were used for most of the serum
titrations.
10. The inoculation of material from water-in-
oil depots into other mice
The groups of mice given ovalbumin in a
water-in-oil emulsion which had been further
diluted with oil (experiment B3) gave an
excellent antibody response. As a check on the
extent to which antigen had survived in the
depots of these mice, the depot contents were
collected and inoculated into fresh mice.
The mice were destroyed with ether on the
271st day after the first injection. The skin
was peeled back and as much material as possible
collected from the depots of each group with a
syringe. This material was then injected sub-
cutaneously into fresh mice.
Serum samples were collected from the
recipient mice on the 52nd day and titrated.
The results are given in table 53. ^t is
apparent that ample antigen remained in the depots
to stimulate a good antibody response in the
second set of mice.
Table53.itresofseracoll ctedfr mmi ein culat dwi hwater-in-oil emulsion,containi govalbumin,recoveredfr mthd potsfth r miceinoculat dearli r.
Typeof inoculum givento original mice
Original dosef ovalbumin permouse
Original number ofmice (Grey)
Number ofmice surviving
G.M.T.ofgroup onthedayt t thedepotsw re collected (271stday)






































11. Investigation of the long terra persistence
of antigen in a mineral oil depot by trans¬
ferring the emulsion to several mice in
sequence
Immediately after chromatographically puri¬
fied ovalbumin became available, three mice were
each given 1 rag emulsified in Freund's complete
adjuvant (Difco). The intention was to raise a
high titred serum in them. Subsequently these
mice were given two secondary injections of oval¬
bumin in normal saline as shown in table 54. The
table also gives the geometric means of three
serum samples collected from the mice.
On the 183rd day after inoculation they were
killed with ether and a post-mortem carried out.
The bodily condition of all three mice was normal
and there was no marked reaction at the injection
sites.
The depots were well encapsulated with
fibrous tissue and it was quite easy to suck up
the contents of each with a syringe. The volume
of material obtained in this way was only 0.2 ml
so another 0.2 ml of Incomplete Adjuvant (Difco)
was mixed with it in the syringe. Two fresh
mice were each inoculated subcutaneously with
0.2 ml of the mixture. Sera were collected at
intervals over a year. The titres of these are
given in table 55.
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One of the two mice died on the 360th day
and the other was killed with ether on the 361st
day. The depot site in the latter was
unremarkable and it was possible to collect some
of the contents. Enough mineral oil (Drakeol
6-VR) was mixed with this to make the colume up
to 0.4 ml and a further two mice were inoculated.
These, the third group of mice to which the
emulsion had been passed, showed an antibody
response (table 56) though it was much more
feeble than that given by the first two groups.
The responses of all the three groups of
mice in which this same emulsion was used are
shown on the graph in figure 65.
Post-mortem examination of the injection
site of one of the third pair of nice which
survived to the 181st day showed that there was
quite a lot of fibrous tissue reaction enclosing
snail oil drops. These drops were clear and
appeared to have no creamy contents.
As a control, another group of four mice
were inoculated with an emulsion prepared from
Freund's Complete Adjuvant (Difco) but not con¬
taining ovalbumin. These mice were observed for
80 days and 3era collected from them. Rone of
these sera showed antibodies against ovalbumin




Fig.65. The antibody responses of three
groups of mice to the same vater-in-oil emulsion
containing ovalbumin. The emulsion vas
recovered from each group of mice when they were
killed and inoculated into fresh mice.
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Table 54. Geometric mean titres of a group of three grey mice
inoculated with ovalbumin in Freund's complete adjuvant.
Days after
first injection:
0 16 44 68 85 183
Dose of ovalbumin: 1 mg - 1 mg - 1 mg
Vehicle: Preund's
complete
- saline - saline -
Titre: 0 28 ND 1280 ND 806
ND = not done.
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Table 55. Geometric mean titres of a second group of mice inoculated— with ovalbumin in Freund's complete adjuvant which had been recovered




Mean Days after injection
weight 0 16 19 22 31 38 45 52 79 110 140 173 201 233 265 293 324 354 361
2 31.0 g 0 20 160 640 640 810 810 810 1403 1620 934 1620 540 312 180 240 160 80 80
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Table 56. Geometric mean titres of the third group of mice
inoculated with ovalbumin in Freund's complete adjuvant,
which had been recovered from another group of mice




28 42 56 117
2 14.1 9.6 14.1 14.1
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12. The response of mice to very small doses
of antigen '
It was just possible that the poor response
of mice to ovalbumin in saline (experiment Al),
in contrast to their response to the antigen in
oil emulsion, was due to the paralysing effect of
an overdose. If this was so then the
superiority of the adjuvant emulsion might be due
to the fact that it had locked up most of the
antigen leaving only an optimum dose free to
stimulate the antibody forming cells. In the
preliminary experiments 500 jig was the lowest
dose used. The ability of very tiny doses of
ovalbumin to raise antibodies in mice was there¬
fore tested.
The nice in seven groups of five were each
inoculated with a single dose of from 0.25 to
1280 jig of ovalbumin in saline. Sera were
collected on the 12th, 16th and 20th days and
titrated with a very sensitive batch of fresh
tanned cells. The results are given in table 57
and are plotted as a dose response curve in
figure 66. They give no evidence that an over¬
dose was being used.
On the 30th day after inoculation all the
mice were given a secondary injection of 0.5 mg
ovalbumin each in saline. A final serum sample
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was collected nine days later and titrated.
These titrations were done with preserved cells
64 fold less sensitive than the fresh ones used
previously. Negative results may not therefore
be fully indicative of there having been no
sensitization by the primary injection.
Once again, these results show that at least
1.0 mg of ovalbumin in saline must be given to
obtain a useful response. The standard dose of
2 mg of ovalbumin per mouse was not excessive.
Table 57. Geometric mean antibody titres of










12 16 20 30 39
0.25 Jig 5 30.7 g 0 0 0 S 0
1.0 jig 5 30.4 g 0 0.02 0 S 0
4.0 jig 5 30.7 g 0.02 0.03 0 S 3.7
16 jig 5 30.5 g 0.05 0.04 0.03 S 0
64 Jig 5 30.1 g 0.02 0.03 0.02 S 0
256 jig 5 30.7 g 0.08 0.40 0.38 S 26.7
1280 jig 5 30.7 g 0.11 0.25 0.56 S 242
0 = no antibodies detected.




Fig.66. Dose response curves for groups of
mice inoculated vith doses of ovalbumin in saline
from 0.25 to 1280 jug. A secondary injection of
0.5 nig of ovalbumin in saline was given to all
groups on the 30th day.
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13. Simulation of the slow release of antigen
from a depot
Experiments BIO and Bll showed that even
after a year, water-in-oil depots still contained
a considerable amount of antigen. Experiment A4
showed that even as little as 2 jig of ovalbumin
was effective in a water-in-oil emulsion. Thus
only tiny quantities of antigen appeared to be
necessary to maintain the high adjuvant response.
An attempt was therefore made to mimic the
slow release from a depot by repeated injections
of antigen, but without giving a high total
weight of antigen.
It was assumed that there was a large
release of antigen from the depot immediately
after injection but that this was followed by a
rapid drop to a minimum release rate. Ten mice
were therefore each given a first dose of 64 ^g
of ovalbumin in saline followed by daily doses,
reduced by a half each time. When 1 p.g per
mouse had been reached the daily dose was kept at
this level for the rest of the experiment.
Inoculations were stopped on the 50th day.
Table 58 gives the inoculation schedule and
table 59 the results of serum titrations carried
out at intervals. This latter table also shows
the geometric mean titres of a typical group of
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mice given 2 mg of ovalbumin each in water-in-oii
emulsion. This was the control group of experi¬
ment Bl.
The results in table 59 are shown as a graph
in figure 67 where it can be seen that the curves
for each group are quite close together until the
50th day. There is then a precipitous fall in
the mean titre of those given the daily
injections which were stopped on that day.
These results show that the adjuvant response can
be mimicked by daily injections of antigen in
saline.
Table 58. Schedule of inoculations of ovalbumin
in saline given daily to mice in an
attempt to mimic the adjuvant
response





64 32 16 8 4 2 1 daily of ovalbumin
injected
= 171 jxg
14. A study of the type of antibody produced by
mice during their response to antigen in
water-in-oil emulsion
The object of this experiment was to find
out to what extent IgM type antibody was being
produced during the adjuvant type of sustained
Fig.67. The antibody response curve of a
group of mice inoculated vith daily doses of
ovalbumin in saline up to the 50th day, compared
vith the response of a group of mice to a single
subcutaneous inoculation of 2 mg of ovalbumin
in a vater-in-oil emulsion.
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Table 59• Geometric mean titres of a group of mice given daily —- inoculations of ovalbumin in saline compared with those of a group of mice






Mean Days after first injection
weight 14 15 20 21 28 30 35 42 43 50 52 62 67 72 82 84 94 100






10 24.2 g 27.6 - - 196 260 - 296 484 689 520 422 508 - 520 -
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response to an antigen in water-in-oil emulsion.
If IgM in addition to IgG type antibody could
have been demonstrated late in the response this
might have been taken to indicate that a
continual release of antigen was taking place
(Bauer, Mathies and Stavitsky, 1963).
Two methods were used: a) the destruction
of IgM antibodies v^ith 2-mereaptoethanol, and
b) the separation of IgM from IgG antibodies by
gel filtration using Sephadex G 200.
a) Treatment with 2-mercaptoethanol
Sera from groups of mice responding to an
inoculation of 2 mg of ovalbumin in water-in-oil
emulsion were collected in pools on the 14th,
21st, 80th, 101st, and 178th days. Two other
pools of sera were from similar mice, but these
had been given secondary inoculations on the 20th
day and the sera had been collected on the 4th,
and 8th days after that.
All the sera were treated with 2-mercapto-
ethanol at the same time and in the same way as
described in the Methods section of this thesis.
A control containing saline in place of the
mercaptoethanol was set up for each serum.
After absorption with sheep cells to remove
any non-specific agglutinins, the treated and
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control sera were titrated with a sensitive batch
of fresh tanned cells. The titrations were
arranged in a random manner on the plates and
were scored without reference to the key.
The results are shown in table 60. Only in
the case of the serum taken on the 14th day was
there any reduction in titre after treatment with
2-mercaptoethanol. The other titres show close
agreement between those treated and the controls.
b) Pel filtration with Sephadex G 200
Three sets of sera were selected from those
of mice responding to ovalbumin in water-in-oil
emulsion.
The first was from mice on the 12th day after
injection of 2 mg of ovalbumin in a water-in-oil
emulsion. The pooled volume available was
0.8 ml.
The second set was from similar mice, but the
sera had been collected on the 27th day. The
pooled volume available was 1.0 ml.
The third set was from similar mice again, but in
this case they had been given a secondary
injection of 1 rag of ovalbumin in saline on the
40th day. The sera were collected on the fourth
day after this. The pooled volume available
was 0.8 ml.
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Table 60. Results of the titration of sera from mice inoculated
































Each pool was passed through a gel filtra¬
tion column of Sephadex G200 as described in
detail in the Methods section. The smaller
protein molecules in serum enter this gel-like
material and their passage through the column is
delayed. The large molecules including the IgM
antibodies cannot enter the gel structure, so
they are swept on by the buffer and appear first
in the eluate.
For the pools of sera numbered one and
three, a column as described under Methods was
used. This was prepared with about 20 g (dry
weight) of Sephadex G200. The height of the
column was 67 cm corresponding to e volume of
about 3370 ml. For the sera reported as the
second pool, the column was re-made, using 28 g
of Sephadex. This gave a height of 90 cm and a
volume of about 4520 ml.
The protein content of each fraction (4.0 or
7.8 ml) was measured with the ultraviolet
spectrophotometer and recorded as optical density
at 280 mu. The graphs, figures 68, 69, and 70,
show the curves drawn from these measurements.
In each case the first peak contains IgM anti¬
bodies, the second peak contains IgG antibodies
and the third peak small molecules such as serum
albumin (Flodin and Killander, 1962). It is
A 33.
Fig.68. Separation of serum proteins on a
Sephadex G200 column. Serum collected from
mice 12 days after an inoculation of 2 mg of
ovalbumin in a vater-in-oil emulsion.
Continuous line = protein content of the fractions.
The square brackets indicate the fractions
pooled for titration.
Bars at the bottom of the graph represent tanned
cell titres of these pools. C = control.











Fig.69. Separation of serum proteins on a
Sephadex G200 column. Serum collected from mice
27 days after inoculation of 2 mg of ovalbumin
in a vater-in-oil emulsion.
Continuous line = protein content of fractions.
Square brackets indicate the fractions pooled
for titration.
Bars at the bottom of the graph represent, the
tanned cell titres of these pools. C control.
M = treated vith 2-mercaptoethanol.
FRACTION NUMBERS/ \
(7-8 ml. each)
Fig.70. Separation of serum proteins on a
Sephadex G200 column. Serum collected from mice
44 days after an inoculation of 2 rng of ovalbumin
in a water-in-oil emulsion, and 4 days after a
secondary stimulation with 1 mg of ovalbumin in
saline.
Continuous line = protein content of the fractions,
Square brackets indicate the fractions pooled for
titration.
Bars at the bottom of the graph represent the
tanned cell titres of these pools. C = control.












seen from these graphs that the separation of the
peaks is not very sharp.
Certain fractions as indicated on the graphs
by the square brackets, were pooled and concentra¬
ted down to the original serum volume by means of
polyethylene glycol. These fractions were then
treated with 2-mercaptoethanol exactly as
described in section a) above. Controls were
also set up. The results of the subsequent
titrations with fresh tanned cells are given in
table 61 and are also shown as bars on each
graph.
No antibodies were detected which could be
destroyed by 2-mercaptoethanol.
15. The antigenicity of 3mall volumes of water-
in-oil emulsion containing ovalbumin
injected directly into lymph nodes
Preund and Lipton (1955) reported that
particles of an injected emulsion reached
regional lymph nodes within an hour of inocula¬
tion. They remained there and were antigeni-
cally effective even if the main depot was
removed. As a check on the antigenicity of tiny
depots of this type, very small quantities of
water-in-oil emulsion containing antigen were
injected directly into a lymph node.
































A water-in-oil emulsion containing 2 mg of
ovalbumin in each 0.2 ml was prepared by the
syringe method. Five mice were each
anaesthetized with ether, their inguinal lymph
nodes (Dunn, 1993) exposed and an injection of
between 0.5 and 1.0 ^il of emulsion made directly
into the substance of the node through a fine
glass tube. This volume was equivalent to a
dose of ovalbumin of between 5 and 10 jig. In
most cases there was no leakage of emulsion and
it could sometimes be seen within the node before
this was replaced. The wounds were dressed and
all healed without complication. Further
details of the technique employed are given in
the Methods section.
The inguinal lymph nodes were chosen as
ovalbumin, fluorescently labelled by the method
of Nairn (1962) and injected subcutaneously over
the back, was seen to drain to these nodes.
Sera were collected at intervals and
titrated. The results are given in table 62.
They are also shown in the graph figure 71
together with the curves for 2 yig and 20 jxg of
ovalbumin in water-in-oil emulsion from experi¬
ment A4 (table 30). The curve for the present
experiment lies between them. A depot within a
lymph node therefore appears to be no more nor no
Fig.71. The antibody response of mice to
the injection of a small quantity of vater-in-
oil emulsion (containing ovalbumin) into an
inguinal lymph node. This is shovn by the
continuous line.
Broken lines shov the antibody responses of mice
given 2 and 20 jag of ovalbumin in 0.2 ml of
vater-in-oil emulsion, subcutaneously.
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less effective than one placed subcutaneously.
When a post-mortem examination of these mice
was carried out on the 55th day, no emulsion was
detected in the injected nodes. They were
examined with a hand lens only.
Table 62. Geometric mean titres of nice given
an injection of 5-10 }ig of ovalbumin
in a small volume of water-in-oil
emulsion directly Into a lymph node.
Number of mice
Days after the injection
24 34 44
5 52 80 140
16. A comparison of the in vivo and in vitro
break-down of water-in-oil emulsions
As has been reported in the results of
experiments B2 and D3, post-mortem examination of
water-in-oil emulsion depots which had remained
in mice for a long period showed that they had a
stratified appearance as shown in figure 72 (left).
It was observed that water-in-oil emulsions
left undisturbed on the bench for some months
after preparation showed a similar stratification.
As they broke down, clear oil rose to the top and
a layer of water, containing antigen, appeared at















Fig. 72. Left. Water-in-oil emulsion depot
removed from a mouse 6-8 months after inoculation.
Right. Vater-in-oil emulsion after
some months storage at room temperature.
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(right). That antigen was present in the lowest
layer was confirmed by observing the break-down
of a water-in-oil emulsion containing ovalbumin
labelled with fluorescein by the method of Nairn
(1962). This ovalbumin was seen in the bottom
layer. A similar stratification was seen in the
water-in-oil emulsions in Oakley-Fulthorpe
immunodiffusion tubes as reported in experiment
D5 (table 47).
It was found that freshly prepared water-in-
oil emulsions of the standard type could be
centrifuged at 750 G for 10 minutes without
breaking. There was no separation of a water
phase, but a layer of clear oil appeared at the
top. This oil was equivalent to about 10 per
cent of the total volume. The relative volume
of oil seen in stratified depots is much greater
than this, suggesting that emulsion break-down
has occurred with slow release of antigen from
the bottom of the depot.
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E. A comparison, in man, of saline and water-
in-oil emulsion influenza virus vaccines
This work was carried out in collaboration
with Dr. J.It. Philp and Dr. S. Helwyn, who
collected the serum samples and carried out the
inoculations, and with the assistance of other
members of the Bacteriology Department, Univer¬
sity of Edinburgh Medical School.
The object of the study was to examine the
local reactions and antibody response of man to a
water-in-oil emulsion influenza virus vaccine
which it was proposed to market in this country.
The tests were controlled with a saline vaccine.
Both vaccines were prepared by Evans Medical
ltd. The saline vaccine 'Munevan' contained
7,500 haemagglutinating (HA) units of formalin
killed virus antigen A2/3ingapore/l/57, 2,500 HA
units of A2/England/l/61, and 5,000 HA units of
B/England/939/59, in each dose of 1 ml. The
water-in-oil adjuvant vaccine 'Admune* contained
one fifth the quantity of each of these antigens
in each 0.25 ml dose.
The adjuvant vaccine had been prepared by
the method of Hiinmelweit (i960) using the mineral
oil Drakeol 6-VR. and the emu^jifier Arlacel A.
The saline vaccine was given by subcutaneous
inoculation, and the adjuvant vaccine by deep
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intramuscular injection to medical students and
volunteers from an industrial laboratory. Forty-
two students and 32 laboratory staff received the
adjuvant vaccine and 46 students and 34 labora¬
tory staff received saline vaccine. The
students were aged between 20 and 26 years and
the laboratory staff between 21 and 59 years, the
mean age of the latter being 31 years. The age
distributions of the groups are set out in table
63.
Blood samples were collected at inoculation
and 1, 4, and 12 months later from the students;
and at inoculation and 1 and 8 months later from
the laboratory staff. The sera were removed
from these and stored at -30°. They were
titrated in pairs or triplets (of sera from each
volunteer) by the standard plastic plate method
(W.H.O. 1953) using four haeaagglutinating units
of the antigens A2/Singapore/l/57 and
B/England/939/59. Both absolute titres and fold
changes in titre between pairs were recorded.
Table 64 gives the geometric means of these
results for each group. Table 65 gives the fold
changes in titre shown by members of the student
groxip whose initial pre-vaccination titres were
higher or lower than the mean. Those with the
low initial titres gave the best response.
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There was no difference between the two vaccine
groups.
Table 66 gives the titres of antibody
against the B strain virus shown by different age
groups of the laboratory staff eight months after
vaccination. There was no evidence that one age
group was responding more strongly than the
others to the B strain virus in the vaccine.
The graphs in figure 73 show the overall
changes in titre for both groups. Figure 74
gives histograms of the fold changes in titre in
the student group between the pre-imraunization
and three subsequent bleeds.
Reactions to the injections were recorded
from the students by individual questioning one
week after the inoculations had been given.
Those for the industrial laboratory staff were
recorded whilst the second blood sample was being
taken at one month. The reactions reported are
given in table 67. None of the volunteers
developed any severe general or local reactions.
The 'general reactions' column in the table
refers to volunteers reporting malaise, slight
fever, etc., which occurred soon after the
injection. Pain at the injection site tended
to persist for a longer period in those given






















1 4 0 12 MONTHS.
Fig.73> Geometric mean haemegglutinetion
inhibiting antibody titres against A2 and B
strains of influenza virus.
Above: Students^ Belov: Industrial laboratory
staff inoculated vith influenza virus vaccine
(mixed strains) in either a saline or oil
adjuvant vehicle.
Fig.74. The numbers of students shoving
the indicated fold changes betveen pre- and
1, 4, or 12 month post inoculation H.I. antibody
fcitres. The students vere divided into two
groups inoculated vith either a saline or oil
adjuvant, mixed strain, influenza virus vaccine.
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This was probably associated with the fact of an
intramuscular injection having been given. The
pain was in no case severe. The minor lesions
were areas of erythema and swelling persisting
for several days. It is notable that these
were much more frequent in the laboratory staff
group. In most of these the lesion was not
noticed by the volunteer himself but was pointed
out to him by his wife.














































Table 64. Geometric mean antibody titres before and after





p f 1 month 4 months 8 months 12 months






31 747 639 - 322
41 1,166 3,080 - 1,324
16 58 64 - 28






34 785 - 507
38 784 - 1,743
22 87 - 76
25 116 - 312
Pinal serum specimens were obtained from 43 students and
26 laboratory staff receiving saline vaccine, and from
40 students and 26 laboratory staff receiving adjuvant
vaccine.
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In the following discussions, the informa¬
tion which has been obtained relating to the mode
of action of the water-in-oil emulsion adjuvants
will be examined first. The practical aspects
of the use of this type of adjuvant will then be
discussed with particular reference to the
influenza virus vaccine trial which was carried
out as part of the study.
The results of the special investigations of
certain of the materials and methods used: oval¬
bumin and the tanned red cell agglutination test,
have been discussed earlier on pages 136 and 193.
A. The mode of action of the mineral-oil
emulsion adjuvants
The many theories developed to account for
the action of the depot-forming adjuvants have
been presented in the -"-ntroduction to this study.
The chief of these suggest that:
a. The adjuvant material has itself some stimu¬
lating action on the antibody forming
apparatus.
b. A special antibody-forning 'organelle' is
formed round the depot.
c. Antigen is held in the depot and released
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slowly so producing a continuous series of
secondary responses,
d. The antigen is presented to the antibody-
forming apparatus in a more acceptable form.
Many investigators believe that a combina¬
tion of these effects is needed to account for
the extraordinary efficiency of this type of
adjuvant in stimulating antibody production.
The most common view of the practical vaccine
maker is summed up in the words of Davenport
(19&1> page 178): "...Thus the emulsified
"inoculum appears to serve not only as a local
"protected depot of antigen, but as a source of
"emulsified antigen which slowly and progressively
"leaves the depot in a shielded state and
"reaches, through the lymphatic system, remote
"foci, where, it is believed, the emulsion breaks
"down and antibody production is stimulated in
"suitable cells. Probably the macrophages which
"accumulate about the antigen depot play an
"important role in the transportation of the
"emulsion droplets.... The suggestion has also
"been made that the mineral oil component of the
"emulsion causes a hypertrophy and hyperplasia of
"the cells capable of forming antibody and there-
"by prepares them to function more effectively
"upon the arrival of antigen."
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The present results suggest that though this
view nay be broadly correct, in fact it gives a
sufficiently false impression of the situation to
hamper the rational use of this type of adjuvant.
In this discussion it will be suggested that the
only function of the mineral oil emulsion is to
form a long term protected depot of antigen.
Tiny quantities of antigen escape from the
emulsion as it slowly breaks down. This antigen
is sufficient to stimulate the antibody forming
apparatus to produce a high level of antibody
over a long period. Oil or emulsion does not
have to leave the depot area and the fibrous
encapsulation which develops is insufficient to
prevent the escape of antigen into the circula¬
tion. There is no evidence that any sort of
organelle is formed nor that any part of the
adjuvant has a specific stimulating effect on
the antibody producing cells.
In short, none of the experiments carried
out gave any reason to doubt that the 'Depot
Theory of Glenny' (Glenny, Buttle and Stevens,
1931) is correct and fully able to account for
the results obtained.
Factors which were found not to be responsible
for the adjuvant effect
The results of a number of experiments
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showed that some apparently promising factors
could be discarded as being responsible for the
adjuvant action of the water-in-oil emulsions.
Materials such as lanolin, which could be
used as emulsifiers, have been shown to stimulate
antibody production to an antigen mixed with thern
in the absence of oil (Ramon, Richou end Staub, 1937)
Dale (1961) found that both Arlacel A and the
mineral oil Bayol P as well as complete water-in-
oil emulsion caused lymphatic proliferation at
the injection site. This she believed might be
related to their adjuvant effect. She did not
test the separate materials for their ability to
stimulate antibody production.
Examination of the adjuvant effect of
complete water-in-oil emulsions by injecting them
at a different site to the antigen have usually
been carried out with water-in-oil adjuvant
containing Mycobacteria. This does cause an
enhanced response (Bishop, 1961; Muramatsu,
1964), presumably due to the known stimulating
effect of the mycobacterial waxes (Pound, 1958;
White et al., 1958). Halbert et al. (1946)
reported that when a plain water-in-oil emulsion
was injected apart from the antigen there was no
enhancement of antibody formation and Bernstein
and Malkiel (1964) found no alterations in
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existing viral, bacterial or pollen antibody
titres after injections of a saline in water-in-
oil emulsion placebo in man.
The results obtained from the present
experiments gave no reason to suppose that the
oil or the emulsifier or the complete emulsion
produced their adjuvant effect by a direct stimu¬
lation of the reticulo-endothelial system or of
any part of the haemopoietic apparatus.
(i) There was no significant difference
between the response of mice inoculated with oval¬
bumin alone or in the presence of the emulsifiers
Arlacel A or Tween 80 (table A3 and fig. 58).
This does not, however, entirely rule out the
possibility that Arlacel A, when held in the oily
depot, may exert some effect on the lymphatic
tissues causing better utilization of the antigen
released. An adjuvant type of response was seen
after the inoculation of ovalbumin incorporated
into an oil/Arlacel mixture without a water phase,
but not after the inoculation of ovalbumin incor¬
porated into the oil alone (table 46 and fig. 60).
However, a physical explanation of this effect is
more probable (see below) than that the Arlacel
had some stimulant action.
(ii) When a y/ater-in-oil emulsion,
containing another antigen, was inoculated 18 or
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81 days after a first injection of ovalbumin in
water-in-oil emulsion no effect was noted on the
response curve to the first antigen (figs. 49 and
50). If there had been some direct stimulating
effect of the adjuvant materials on the antibody
forming cells, some change in the shape of the
response curve to the first antigen would have
been expected. It remained a flat plateau
closely following the response shown by the
controls which had not been given a second
injection (fig. 51).
(iii) A water-in-oil emulsion injected
before, or after, or at the same time as the
antigen had no significant enhancing effect on
antibody production (table 44). When the
antigen was mixed in the same syringe with the
emulsion there was an adjuvant effect (table 44,
group D). A less marked and shorter lived
increase in titre was also seen when ovalbumin
was injected together with an oil-ln-water
emulsion (figs. 43 and 57).
These two results could be taken to indicate
that there was some direct stimulation from the
oil itself. The emulsifiers, as noted above,
did not seem to have any effect (fig. 58).
Other explanations could be that:
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a) Due to the presence of emulsifiers,
there was some automatic incorporation of antigen
into the emulsion. Experiment D5 (page 267)
showed that when oil/Arlacel is placed in the
wells of an agar plate, or over the agar layer in
a precipitation tube, tiny particles, probably of
saline, become included in the mixture and appear
as smoky swirls within it. These later become a
layer at the bottom (table 47). The same
effect is also seen in vivo; plain oil/Arlacel
mixture injected subcutaneously develops a creamy
stratum after some months (experiment D4, page
260).
When ovalbumin and the water-in-oil emulsion
were mixed in the syringe, some ovalbumin may
have entered the emulsion in this way. Only a
little antigen would, need to be incorporated:
20 jig of ovalbumin in a water-in-oil emulsion
would be sufficient to produce an equivalent
level of antibody (see table 30) to that produced
by the mixed ovalbumin and water-in-oil emulsion
(table 44).
b) Another explanation could be that there
is an increased intake of antigen into the
reticuloendothelial system when tiny oil drops
are present at the same time as the antigen.
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Sbarra et al. (1962) showed that substances in
solution and not normally phagocytosed, could be
taken in by macrophages and polymorphs whilst
these were engulfing solid particles. They
called this 'piggy-back phagocytosis'.
c) A third possibility is that the antigens
become adsorbed to the drops of oil and remain
present for some time in the body as a sort of
depot. Boroff and Tripp (1947) devised an
agglutination test using an emulsion of olive oil
droplets which were coated with streptococcal
protein antigens. These aggregated and rose to
the top of the tube if antibody was present.
The author was unable to obtain an effect of this
type with a mineral oil emulsion and ovalbumin.
Other attempts which were made to adsorb or
dissolve ovalbumin in oil did not indicate that
any association occurred (experiment D4» page
260). This explanation cannot therefore be
sustained.
d) Lastly, there may have been a mechanical
cause for the enhanced titres. It was noticed
on microscopical examination that the tiny drop¬
lets in oil-in-water and in multiple emulsions
had a tendency to stick together or agglutinate
without coalescing. Antigen trapped between the
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droplets and subsequently acting as a slow
release depot might be sufficient to account for
the adjuvant effect, particularly the short-terra
one given by the oil-in-water emulsion (fig. 57).
On balance it was concluded that the
components of the emulsion, when not actually
enclosing the antigen, did not stimulate antibody
production.
However, both oil and eraulsifier had to be
present if the antigen included in the mixture
was to be efficiently used. Figure 60 shows
that no detectable antibodies appeared if dry
ovalbumin was incorporated in oil alone, though a
normal type of adjuvant antibody response was
seen if Arlacel was also present. That this was
not merely a gross solution of ovalbumin in the
Arlacel is shown by the fact that the mixture
left after removal of the solid by centrifuga¬
ls
tion, only gave a poor fading response. A bi-
phasic water-in-oil emulsion is therefore not
required for adjuvance, but the emulsifier plays
a vital part in this type of mixture.
A strong argument against the theory that
the only action of a depot is to act as an
1. Of course a slight solubility of ovalbumin in
Arlacel, which seems to be indicated here,
may provide a route out for the main part of
the antigen.
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antigen store, slowly releasing its contents, is
that removal of the depot does not abolish the
adjuvant effect (Westwater, 1940; Holt, 1930;
Freund and Lipton, 1955). However, it seems
probable that secondary depots are rapidly formed
all over the body very soon after a depot forming
adjuvant has been inoculated. These can
function in lieu of the main depot if this is
removed (Freund and Lipton, 1955; Steiner et al.,
I960; Weigle et al., I960).
As a test of the effectiveness of tiny
depots of this type, a very small quantity of a
water-in-oil emulsion containing ovalbumin was
injected into one lymph node. An adjuvant type
of response followed which was appropriate in
extent to the quantity of antigen injected. A
central depot is not therefore necessary for
adjuvance.
The chief observations leading to acceptance of
the present theory _____
The key experiment in this study turned out
to be one which had not been expected to yield any
very useful results. Attempts to mimic the slow
release action of a depot forming adjuvant have
not generally been very successful. Holt (1950)
gave thirty daily doses of plain diphtheria
toxoid to guinea pigs, or an equivalent amount in
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two doses of alum precipitated toxoid. The
multiple dose group showed only about one fifth
as much antitoxin as did the controls.
McKinney and Davenport (1961) found that
there was a sort of threshold level of antigen
(influenza virus) which had to be given daily
before comparable titres to those shown after a
whole dose in water-in-oil emulsion, were
reached. As in Holt'3 experiment the total
amount of antigen given over 42 days added up to
the same dose as that given in adjuvant to the
controls.
The use of fairly large daily doses of
antigen by these investigators was in accord with
the findings of Talmage and Dixon (1933). They
133
reported that * 'I labelled antigens had a half
life of about 14 days in a water-in-oil depot.
This means that 99.9 per cent of the depot
contents would be lost in 154 days. The present
experiments do not confirm a short persistence of
this order.
Mice inoculated with depots removed from
other mice which had been given 2000, 400 or 100
^ig of ovalbumin in emulsion 271 days before,
showed quite good antibody responses (experiment
D10, table 53). A rough check may be made of
the probable antigen content of the material
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injected into the second mice, by referring to
the dose response curves for ovalbumin in a
water-in-oil emulsion, figure 44. Prom this it
can be seen that perhaps 10-200 jig of ovalbumin
was present in the depot material given to each
fresh mouse. This is equivalent to there having
been between 5 and 50 p.g of ovalbumin in each of
the depots removed after 271 days.
A similar calculation for the ovalbumin
content of depots transferred to three sets of
mice (experiment Dll, page 283) shows that perhaps
2 ^ig of ovalbumin was present in each depot at
'the third transfer after 544 days.
These figures correspond to a half life of
ovalbumin in the emulsion of between 80 and 90
days. It is evident that if a short life of
about 14 days was operative, the mice to which
the depot contents were transferred could not
have shown the antibody titres which they did.
Talmage and Dixon calculated that after 301 days
in a depot only 0.025 ^g of antigen (bovine
gamma-globulin) would remain from an initial dose
of 50 mg when the half life was 14 days. There
would have been much less left from the initial
dose of 100-2000 jig used here. It may be that
the emulsions used by Talmage and Dixon were not
very stable, though they do report that the
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rabbits inoculated showed a relatively constant
antibody response for 301 days.
Some other workers have reported a long term
persistence of antigen in water-in-oil emulsions.
Halbert et al. (1946) and Herdegen et al. (1947)
found antigenically active Shigella para-
dysenteriae in water-in-oil emulsions for at
least 22 weeks after injection. Most investiga¬
tors, however, have not followed the animals over
a long enough period for their results to be
relevant here.
A consideration of these results indicated
that the rate of release of antigen from a water-
in-oil depot must be very slow. It was there¬
fore decided that when an attempt was made to
mimic the slow release mechanism, the total dose
of antigen given should not equal the standard
dose of 2 mg usually used for the experimental
work in this study.
McKinney and Davenport (1961) showed that
early release of antigen from a water-in-oil
depot appeared to be important. They found that
irradiation of mice up to 3 days after inocula¬
tion markedly lowered the peak antibody titres
•j 7]
reached. Talmage and Dixon (1953) using I
labelled antigen found that there was a 20-30 per
cent loss from the depot site during the first
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24 hours.
A consideration of the mechanical effect of
injection, the possible presence of large antigen
drops or even of non-incorporated water phase in
the inoculum initially, suggested that a large
loss of antigen from the depot could occur
shortly after injection. One experiment carried
out, in which depots were re-injected into the
mice from which they came and initiated a
secondary response in them, seemed to confirm
this (experiment D9> page 277)*
Another result from the present work also
seemed to show that a fairly large initial dose
might be important. When very small primary
doses of ovalbumin were given to mice, they did
not appear to be sensitized to give a secondary
response (table 57). Therefore a minimum
initial stimulating dose might be required if
detectable antibody levels were eventually to be
raised. This is also in line with the concept
that a minimum sensitizing primary dose of
antigen is required before a secondary response
can be elicited (Svehag and Mandel, 1964).
The initial inoculations were therefore made
fairly large, but they were halved on each
successive day until only 1 ^.g of ovalbumin per
day in saline was being given to each mouse
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(table 58). Over the 50 daily injections a
total of only 171 jig of ovalbumin was given to
each mouse. If this had been given as a single
dose in saline only a very feeble response would
have been observed (cf. table 57).
In fact, the response seen was very similar
to that given by 2 mg of ovalbumin in water-in-
oil emulsion (fig. 67). Furthermore, as a
crucial pointer to the importance of a continual
supply of antigen in maintaining the high level
of antibody response, an immediate fall started
when inoculations were stopped on the 50th day.
Small daily supplies of antigen are there¬
fore sufficient to produce an adjuvant type of
response. There appears to be no need for the
direct intervention of the emulsion forming
materials themselves in this effect. The action
of the oil may be merely to protect the antigen
from destruction and the form of the emulsion is
such that a slow break-down and consequent
release of antigen occurs. There is no need for
the adjuvant itself to leave the depot, a concept
which has bothered other investigators in view of
the fibrous encapsulation of the depot which
occurs after a subcutaneous inoculation.
The release of antigen from a depot of this
type probably occurs in a slow, even and orderly
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fashion. Post-mortem examination of several
groups of mice in which the water-in-oil depots
had been left in situ for long periods showed
them to have a stratified appearance (experiments
B2 and D3, pages 221 and 259)* This appears to
be due to the gradual break-down of the emulsion
allowing more oil to rise to the top (experiment
1)16, page 300 ) • It is exactly matched by the
break-down of a water-in-oil emulsion seen when
it is left in a bottle on the bench (fig. 72).
The antigen leaks out at the bottom and as this
happens the oil layer becomes thicker on top.
This is the same mechanism, but upside down, to
that 3een when a glass of beer is poured out.
The air-in-beer emulsion at the top gradually
breaks down and the level of liquid in the glass
rises.
Confirmatory evidence for the theory from other
experiments
The results discussed above led to the con¬
clusion that the adjuvant effect of a water-in-
oil emulsion was solely due to a slow release of
the protected and enclosed antigen over many
months. Most of the results of the various
experiments which had been carried out could now
be seen to fall into the logical pattern to be
expected from this theory.
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Ovalbumin adsorbed on to aluminium hydroxide
and given to mice by subcutaneous inoculation
elicited similar titres to ovalbumin in water-
in-oil emulsion. Aluminium hydroxide would be
expected to work in rather the same way as an
emulsion, by slowly releasing antigen. Figure
63 shows that the response curves for both were
very similar.
When secondary inoculations of antigen in
saline were given to mice already responding to
the antigen in emulsion^an immediate rise in
titre was produced. This later dropped back to
the plateau level that would have been seen had
no secondary injection been given (figs. 46 and
47). The secondary response was but an incident
on the normal adjuvant response curve. This
would be expected if in fact the plateau level
was due to the continual slow release of antigen
from the depot. It may be objected that this
slow release itself constitutes a secondary
response and that this is incompatible with a
later one. However, D'Antona and Piazzi (1956)
showed that the height of the secondary response
is dependent on the dose given. The sudden
arrival of a large amount of antigen might there¬
fore be expected to cause a rapid increase in
antibody production.
328.
A multiple emulsion containing ovalbumin
when given subcutaneously produced an excellent
response rather higher than that given by a
water-in-oil emulsion (fig. 54). Although the
droplets in the emulsion originally injected were
very tiny, rather larger ones were seen at post¬
mortem (table 37). However, when a multiple
emulsion containing ovalbumin was given intra¬
venously there was a rapid and high immediate
response which was not sustained (fig. 56). In
this case the tiny droplets injected would he
dispersed separately through the various organs
and could not fuse to form depots of a reasonable
size. Each tiny drop would lose its contents
quite quickly so that there would soon be no
protected antigen left.
On the other hand, this rapid response may
explain the higher titres found when antigens
were given in multiple emulsion, compared to
those for similar doses of antigen in water-in-
oil emulsions (figs. 43 and 54 and table 38).
Some of the tiny drops from a subcutaneous
inoculation are bound to find their way into the
blood stream and so cause this type of very rapid
stimulation of the antibody forming cells. The
remainder will coalesce and settle into a depot,
releasing antigen gradually. The high initial
329.
titre would then be expected to fall gradually
to a plateau value as is seen in figure 54.
Antigen presented in multiple emulsions
prepared with Tween gave higher titres than
antigen in water-in-oil emulsion (tables 34, 35
and 38). When a multiple emulsion was made up
with gum, the results were not so good (fig. 55).
At post-mortem examination the depots formed by
this material were found to consist of a hard gum
matrix enclosing the emulsion droplets. These
enclosed droplets might break down to release
antigen as fast as they normally would have done,
but any antigen that was released would reach the
outside of the depot only slowly due to the gum
covering. There would thus be less antigen to
stimulate the antibody forming apparatus than
that coming from a normal depot. This would fit
in well with the lower, falling titres recorded.
The experiment in which methylene blue was
incorporated into an emulsion showed that there
really was a delayed release of material which
had been incorporated into a water-in-oil
emulsion. The method was not sensitive enough
to show the very slow rate of release that it is
necessary to postulate occurs if sufficient
antigen is to remain available for titres to be
kept up over long periods.
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The experiments carried out to see whether
ovalbumin could pass across the oil/Arlacel
barrier were only successful in one case which is
of doubtful significance (experiment D5, page
267). It was also impossible to detect any
narked association, solution in, or adsorption
of the ovalbumin to the adjuvant components.
Even when a standard dose of ovalbumin was
enclosed in oil any antibodies produced to.it
were at an undetectable level (fig. 60).
This suggests that the emulsion formulation
is important for the production of adjuvance.
When the emulsion is prepared with mineral oil
the break-down is slow and there is a gradual
release of very small quantities of antigen.
The disperse phase then settles out to form a
stratified layer from which antigen is liberated
in relatively constant quantities over a long
period of time.
Adjuvance was also seen when ovalbumin was
enclosed in oil/Arlacel without a water phase.
This mixture seems to have the ability of
enclosing within itself droplets of water to make
an emulsion (experiment S5, page 267 )• Smoky
swirls of droplets are seen when it is put in the
wells of an agar plate. It seems very probable
that ovalbumin was able to leak out of such a
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mixture much more easily than it could from
completely inert mineral oil. There may also
have been some slight solution of ovalbumin in
the Arlacel as suggested above.
Diluting a standard water-in-oil emulsion
containing ovalbumin with more oil/Arlacel did
not affect the antibody response to it (fig. 59).
The extra oil might have been expected to hamper
water phase droplets from reaching the outer
surface of the depot where they could release
their contents and so reduce the final titre.
However, if the stratifying process (fig. 72)
took place fairly rapidly these depots would
present the same picture as did those containing
a full dose of antigen, later on in the adjuvant
response. To judge by the antibody titre
plateau seen, a constant antigen release was
taking place. If break-down and consequent
antigen release was only occurring at the bottom
of the drops, the degree of dilution used would
not be expected to have much effect on the rate
of release. Later in the response a difference
might have been seen for where there was less
antigen in the depot this would be exhausted
earlier and the antibody level would then drop.
Unfortunately the experiment was not carried on
for long enough to see whether this did in fact
5J2.
occur.
The more dilute materials give a rather
higher titre though this is not statistically
different. This slight difference may have
occurred in a similar fashion to the higher
titres seen with multiple emulsions. The more
dilute material will have a lower viscosity so
that some of it may have broken away during the
initial inoculation to give a more immediate
stimulation. Prom other results it seems
unlikely that the mere presence of more
oil/Arlacel could account for the increase.
McKinney and Davenport (1961) considered
that an initial release of antigen over the first
few days was of importance in producing the
adjuvant effect. The presence of antibody at
this time might therefore be expected to have
some effect on the shape of the curve. When
this was tried, no difference was seen between
the response of mice given anti-serum at the same
time as ovalbumin in water-ln-oil emulsion, and
the response of mice not given serum (fig. 64).
The experiment itself was of course not entirely
satisfactory as an arbitrary single dose of anti¬
serum was used.
If the antigen initially released was not
important to the adjuvant response its removal or
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neutralization by antibody present at the time of
inoculation would not alter the basic shape of
the response curve. As mouse gamma-globulin
only has a half life of 2 days (Dixon et al.,
1952) the curve would be moved to the right a
little, an effect which would not be readily
seen. Insufficient anti-eerum may also have
been given. The picture is not entirely clear
for antigen-antibody complexes can be good
immunizing agents (Hartley, 1925). Also, if
the adjuvant response curve is due to the slow
release of antigen this antigen must combine with
antibody very soon after it is released from the
depot. But in some way it Btill stimulates a
high titred plateau response.
It v/as unfortunate that it was not possible
to detect any IgM type antibodies during the
adjuvant response. Bauer et al. (1963) found
that in addition to the known rise and fall of
this type of antibody during the primary response,
an additional rise occurred (in rabbits) when a
secondary stimulation was given. Mice are known
to show a similar antibody pattern at the primary
response (Berlin, 1963). The present experi¬
ments only doubtfully detected any sign of this,
probably because the serum collection was not
started until the IgM antibody peak had passed.
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More disappointing was the failure to show any
antibody of this type after a secondary response.
This failure leaves open the question of whether
the production of such an antibody is stimulated
by a continual release of antibody from the depot,
which in effect must constitute a continual
secondary response. On the other hand, the
mouse may not show a similar IgM antibody rise
after secondary stimulation as does the rabbit,
or its extent may be proportional to the dose
given.
A remaining experiment is slightly difficult
to explain. In this the depots were re-injected
into the mice from which they had been removed
(experiment 1)9, page 277)• These mice showed a
secondary response. Holt (1990) carried out a
similar experiment using guinea pigs which had
been inoculated with diphtheria toxoid which had
been adsorbed on to alum. He obtained a similar
result and took this to mean that after 14 days
the depot contents were so walled off as to be
incapable of taking further part in the adjuvant
response. The response curves for a single
injection of the precipitated toxoid were of a
very peaked shape in comparison to the slow rise
followed by a plateau shown by the mice given
ovalbumin in water-in-oil emulsion, so there was
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some reason for this view.
In the present study it is probable that the
mechanical disturbance of the emulsion at
injection was sufficient to cause a certain
amount of break-down. Small dispersed particles
of emulsion may also have been produced. Due to
their greater total surface area the release of
antigen from these would have been quite large
and sufficient to cause a marked secondary
stimulation. D'Antona and Piazzi (1956) showed
that the size of a secondary response is related
to the dose of antigen given. The visible
response seen here thus only indicates that much
more antigen has been released at one time rather
than that continual release from the depot does
not occur. The fact that a secondary response
is seen after re-injection of the emulsion is a
further confirmation of the findings of other
workers that a large amount of antigen is lost
from the depot soon after inoculation.
Some implications of the proposed theory of the
action of water-in-oil emulsion adjuvants
If the sole reason for the adjuvant action
of a water-in-oil emulsion is its ability to
hold, protect, and very slowly release the
antigen, this has important theoretical and
practical implications.
336.
Prom the theoretical point of view it is of
interest that the extremely tiny quantity of
antigen released, which must combine with anti¬
body as soon as it leaves the protection of the
depot, is so efficient in stimulating the anti¬
body forming mechanism. Rapid elimination in an
inactive state might be expected (Weigle, 1961).
It would be instructive to attempt to reproduce
an adjuvant type of response with tiny doses of
an antigen-antibody mixture given daily as in the
key experiment described above.
For the practical use of this type of
adjuvant in immunization procedures, a considera¬
tion of the mechanism proposed to account for the
slow antigen release, is important. The strati¬
fication effect seen in the mouse depots occurs
because mice always remain one way up. This
means that the depot contents settle into a
stable geometry and an even rate of emulsion
break-down and antigen release follows.
It is difficult to foresee whether a depot
which is being shaken about all the time as in a
man's arm or in the neck of a fowl will break
down regularly in this way. The rate of antigen
release may be slower or faster or irregular and
an investigation of this effect is required.
Careful thought should also be given the most
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suitable siting in the body for this type of
adjuvant depot.
The intramuscular inoculation of a water-in-
oil emulsion was found by Salk et al. (1932) to
eliminate the troublesome oil cysts and other
reactions seen in man after subcutaneous
injection. This practice is followed in the
present-day use of these adjuvants with influenza
virus vaccine. Salk and Laurent (1932) reported
that in monkeys there was a dispersion of intra¬
muscularly inoculated emulsion as tiny droplets
along the muscle fibres.
A multiple emulsion is prepared in the form
of tiny drops. When this material is given
intravenously the response is short and quickly
falls (fig. 56). The desired long term response
is not obtained. ^t was postulated above that
this is because the tiny droplets break down fast
due to their large total surface area and no
lasting depot is formed.
Water-in-oil emulsion given intramuscularly
or multiple emulsion given subcutaneously will
not form quite such small isolated droplets, but
the rapid exhaustion of the antibody content of
small drops may explain the fall seen in the
titres of human volunteers given influenza
vaccine intramuscularly in water-in-oil emulsion.
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A more long lasting plateau titre of the type
seen in mice would have been desirable. Ana
movement causing a mixing effect in the tiny
depots may also have played a part in this.
The present study was carried out with a
soluble antigen of small molecular weight. Many
bacterial and viral antigens will be much larger
than ovalbumin. Even after release from the
emulsion these antigens raay not be able to leave
the encapsulating fibrous tissue surrounding the
depot to exert their stimulating effect. This
may be the reason for some of the disappointing
results which are understood to have occurred
with viral antigens in water-in-oil emulsions.
On the other hand, the toxic fractions of
some microbial and viral antigens may give them
a centrally acting adjuvant action which may
overlay the effect of the emulsion. This will
be particularly evident if long-term investiga¬
tions of the antibody response are not carried
out, and the point is not reached at which the
plateau level of antibody produced by the long-
term slow release effect becomes evident.
If antigen size is the only difficulty,
break up of the organism followed by extraction
of the wanted antigen in its purest form may be
useful. This work may also be important to
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stabilize the antigen. If the depot is to be
of long-term value it is essential that the
contained antigen is very stable under these
conditions.
Acting in the way suggested, the water-in-
oil emulsion adjuvants are a most elegant slow
release mechanism ideal for their purpose. By
altering their viscosity, stability, and form by
technical means and by choovsing a suitable site
for the inoculum, it should be possible to
devise practical adjuvants to meet all the
immunization needs of man and the domestic
animals.
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B. The use of mineral oil adjuvants in
practical immunization procedures
Mice inoculated with a single dose of oval¬
bumin enclosed in a water-in-oil emulsion gave a
peak antibody titre which was about one thousand¬
fold higher than that given by mice inoculated
with the same quantity of ovalbumin in saline
(tables 26 and 30). Not only was a very high
titre reached, but, more important, it was sus¬
tained at this level for at least a year (fig.
54). The usefulness of any adjuvant which can
elicit a response curve in this form is self-
evident. Attack by micro-organisms is sporadic
and unexpected; active immunity cannot be
supplied instantly when required, so that
immunizing procedures with a long-term validity
are the most valuable.
Influenza in man is an excellent model of
the patterns of disease against which protection
is needed. Some strains are always present and
are able to attack here and there in a community
without warning. A major mutation has the
characteristics of a new disease; innate
immunity is wanting everywhere and the virus
rapidly spreads over the world documented by
international organizations.
For protection against influenza virus in
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the first form, a long duration of immunity
produced by a simple, single dose means is
required. To defeat its spread in the pandemic
state, a speedy production of vaccine ahead of
its arrival is necessary. The mineral oil
adjuvants appear to be valuable in both roles.
Not only do they give the long lasting protection
required, but the enormous increase in antigenic
efficiency which they engender would enable
smaller quantities of a precious new strain to be
effective as an immunising agent.
The antibody response of men to saline or water-
in-oil emulsion influenza virus vaccines
When, in the present study, an influenza
virus vaccine was tested in man it was not
possible to plot many points on the response
curve. The general shape of a complete curve
may be gauged by examining the two curves in
figure 73. The antibody level against the A2
strain of virus in the laboratory staff group at
8 months, falls exactly on the line drawn between
the 4th and 12th month titres of the student
group. A smoothed curve would show that the
peak titre of each group was reached at about the
second month. At the 4th month the students
given the vaccine in adjuvant show about five
times as much antibody as do those given the
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saline vaccine (table 64).
The adjuvant vaccine only contained one-
fifth as much antigen as did the saline vaccine,
but even when this is allowed for, the adjuvance
shown is very much less impressive than that seen
with ovalbumin in mice. In addition, the
persistence of titres at a high level which is
such a feature of the response of mice given
ovalbumin in adjuvant is not marked. In the
student group, antibodies to both viruses appear
to fall off at the same rate irrespective of
whether the antigens were given in saline or in
adjuvant emulsion. The adjuvant group show an
advantage but this is due to the higher peak
titre reached.
The response of men to influenza virus
vaccine in a water-in-oil emulsion is therefore
dissimilar to that given by mice in the ovalbumin
model. The use of adjuvant was advantageous as
it stimulated the production of much more anti¬
body with less antigen, but the peculiar
persistence of titre which is so desirable was
not seen.
Several reasons for this lack of a high
persistent titre may be suggested. In discussion
of the mode of action of water-in-oil emulsion
adjuvants the belief was expressed that the sole
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reason for the action of these adjuvants is their
ability to hold and protect antigen which is then
gradually released over a very long period of
time. The oil emulsion is otherwise quite
inert. ¥/hen mice were given a water-in-oil
emulsion subcutaneously it formed a circumscribed
pea-like depot which could be easily seen and
palpated (table 39). The human volunteers were
given the emulsified vaccine intramuscularly so
that single depots of this type were not formed.
This latter route causes less reaction and the
oil emulsion becomes dispersed amongst the muscle
fibres (Salk and Laurent, 1952). It seems
probable that these small droplets will each
exhaust their supply of vaccine in a shorter
period than will a single large depot. As the
plateau titre seen in mice is probably maintained
by the slow continual release of antigen, this
titre will fall as exhaustion of the antigen
contained in the droplets approaches. It may be
that this effect is also seen in the falling
curve for the response to ovalbumin in a multiple
emulsion shown in figure 54. When injected sub¬
cutaneously the multiple emulsion tended to form
a dispersed depot of small droplets (table 37).
Another explanation may spring from the fact
that a whole micro-organism rather than a soluble
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antigen of small molecular dimensions is being
used in the vaccine. Though the virus may be
released easily from the oil drops it may not be
able to escape from the encapsulation surrounding
the depot. There is some evidence that encapsu¬
lation of oil drops occurs even when the emulsion
is given intramuscularly (Peck et al., 1964).
It is interesting to speculate on other
possible reasons for the relatively poor results
seen. Any soluble antigen released will at once
be in an environment of gross antibody excess;
all the antigenically active sites on it will
rapidly be occupied by antibody molecules so that
no aggregation of the particles will occur and
the neutralized antigen will remain of small
dimensions. On the other hand, a complex virus
particle liberated whole from the emulsion may
meet many different antibodies which can react
with it. Not only will it be coated with these,
but some of them may be present in such low con¬
centration that an aggregation between several
particles is a possibility.
Quite apart from the difficulty that
particles affected in this way may have in leaving
their environment, the pharmacological activity
of such complexes of many different antigens and
antibodies may lead to destruction of the antigen
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in a way that does not stimulate further antibody
production (Weigle, 1961). Only soluble frag¬
ments of the virus particles may be effective in
the manner desired, but some of these may be
caught up in the reactions occurring round the
complete organisms. It is also possible that
the virus may become attached to the fibrous
capsule or trapped blood cells by its haemagglu-
tinin. As the vaccine has been formalinized,
its ability to subsequently elute from this will
have been destroyed (Rhodes and van Rooyen, 1962).
On the other hand, it may be that few of the
responses of man to influenza virus vaccine were
primary responses as were those of the mice in
the model experiments. Many of the volunteers
must certainly have already been antigenically
stimulated by virus of the strains used in the
vaccine.
It was noted earlier that the results of the
titration of antibody against the A2 strain of
virus are closely comparable in both the student
and laboratory staff groups. There is, however,
a divergence in the levels of antibody against
the B strain of virus. The laboratory staff
show a much higher titre at 8 months than that
which can be estimated from the graph for the
student group at that point. The staff titres
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are in fact higher at 8 months than those of the
students at 4 months. This suggests that many
of the laboratory staff are showing an enhanced
response to the B virus because they have met it
before, whereas few of the students have been
infected with this strain.
The student group consisted of volunteers
aged between 20 and 26 years whereas the labora¬
tory staff group were aged from 21 to 59 years
(table 63). Some older members of the staff
group might therefore have had a different
experience of influenza viruses than the young
students. However, table 66, which shows the
titres of antibody against B virus for the
different age groups in the staff group, does not
indicate that there was any difference in
response between the young and old volunteers.
On the other hand, the difference in
response to the B strain of virus by these two
groups may be geographically determined. The
laboratory staff could have been sensitized by an
Edinburgh epidemic which occurred whilst the
students were dispersed before coming up to the
University.
If all or most of the volunteers are
presenting a secondary response a full curve
might then resemble those in figures 46 and 47.
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In the experiments to which these figures refer,
inoculations of ovalbumin in saline were given to
mice already responding to the antigen in a
water-in-oil emulsion. Secondary responses were
seen but these soon fell back and the titres
stabilized at the normal plateau titre seen after
a single injection of ovalbumin in water-in-oil
emulsion. It may be that a similar stabilisa¬
tion at a low plateau titre would have been seen
here if enough points had been obtained for the
graph and the experiment had been continued for
a longer period.
Another complication may arise from the
nature of the antigen. The influenza virus is
complex with a lipid coat and toxic properties
(Rhodes and van Rooyen, 1962). This may cause
some stimulation of the reticulo-endothelial
system in the manner of the lipopolysaccharide
endotoxins (Farthing, 1961). In effect, the
virus may contain a built-in adjuvant. If a
mechanism of this type is active, the action of
the whole vaccine will be complex and difficult
to interpret.
It seems probable that this slightly
disappointing response to influenza virus vaccine
given in water-in-oil emulsion is due to the
heterogeneity of the experimental conditions of
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this study. The presence of a secondary
response in some of the volunteers, together with
some adjuvant properties of the virus itself may
have enhanced the response to the saline vaccine
more than that to the adjuvant vaccine. The
steady rate of decline of the titres does,
however, suggest that early exhaustion of the
depot due to its intramuscular siting may be of
considerable importance.
Advantages shown by the adjuvant form of the
influenza virus vaccine
The results obtained in this trial of an
adjuvant influenza virus vaccine in man did not
show the dramatic advantage over the saline
vaccine that experiments with ovalbumin in mice
had led one to expect. However, the results do
not indicate that the adjuvant formulation was
valueless; in fact they show that this method
of presenting the antigens has certain advantages.
The adjuvant form of the vaccine contained
one-fifth as much antigen as did the saline
vaccine but the response to it was very much
higher. This in itself may not be very
important as there is some evidence that very low
titres of haemagglutination inhibiting antibody
(1:16 or below) are sufficient to protect against
natural infection (Meiklejohn et al., 1932).
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There also seems to be no doubt that influenza
vaccines containing antigens prepared in the same
way as those used here are protective (Hawkins
et al.. 1956; Meiklejohn, 1962). This being
so, the volunteers given the adjuvant vaccine
will be protected for a longer period. They had
the higher titres and the graphs show that the
titres are falling at the same rate in the case
of each vaccine.
The advantage of the adjuvant vaccine is
well illustrated in figure 74. This shows
histograms of the fold changes in titre between
the initial, pre-vaccination, antibody level and
that measured 1, 4, and 12 months later. A line
has been drawn between the 2- and 4-fold levels
on each histogram; to allow for experimental
error it is assumed that at least a four-fold
rise in titre must be recorded before a subject
can be said to have responded to the vaccine.
Consider the results for the A2 strain of
virus. The diagrams show that a year after
vaccination nearly all (95 per cent) of those
given adjuvant vaccine are still showing titres
well in advance of their resting levels before
vaccination. Though 84 per cent of the group
given the saline vaccine are still over the line
at this time, it is apparent that many of these
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will soon fall back to their pre-vaccination
level of protection within a few months.
Kesult3 for the B strain of virus are not as
striking, though it is evident that the advantage
lies with the adjuvant formulation.
When considering any results from trials
with influenza vaccines the question of who the
protection should be aimed at must be considered.
The virus strains used in this particular vaccine
are those to which the population may have
already been exposed. Many of the subjects
inoculated will have already been sensitized and
be showing a secondary rather than a primary
response. The titres of these volunteers make
the best showing on the graphs and charts but
they are probably already protected.
A minority of the population will not have
met the antigens, will give a poor, primary type
response but may end up with protection where
they had none before. A saline vaccine would be
expected to provoke a primary and probably poor
response in these subjects whereas the adjuvant
formulation, with its built-in secondary stimula¬
tion mechanism, might enable them to show much
better final titres.
A count of the fold changes in titre for
students whose initial antibody titres were high
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or low shows that those with low initial anti¬
body levels responded better than did those
with initial high antibody levels (table 65).
However, the pattern is the same for both
vaccines so the adjuvant vaccine does not show
any superiority. The reason for this may be
that the virus itself is slightly adjuvant and
the response is always better than that seen
with 3imple antigens.
The reactions of man to the inoculation of a
water-in-oil emulsion vaccine
Except when an epidemic threatens due to a
new mutation of the virus, influenza vaccine will
not be readily accepted by the general population
unless it is very easily administered and causes
no noticeable reactions. This is especially
important in the case of children who are probably
an important factor in the spread of influenza
virus during an epidemic (Hennessy et al., 1964).
The first oil emulsion influenza vaccines to
be U3ed caused most unpleasant oil cysts and
abscesses (Henle and Henle, 1945; M.R.C. Report,
1957). The work of Balk and his colleagues
showed that these side effects could be eliminated
by choosing tested materials and by giving the
vaccine intramuscularly. McLean et al. (1964)
found that Berlin's mouse test (1962) was an
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excellent screening method to check completed
emulsions for safety. Only those which were
shown to be unsatisfactory by this test caused
nodules or abscesses in man.
In the present study, records were kept of
the reactions encountered with both of the
vaccines (table 67). Though these appear to be
numerous it should be made clear at once that no
oil cysts or any reaction of great moment was
reported. The Information was collected by
specifically questioning each subject. This has
undoubtedly emphasised the occurrence of
reactions, but the fact that they were remembered
indicates that they were not negligible.
The few general reactions were reports of
slight malaise following inoculation and these
might or might not have been actually associated
with it. The toxic properties of the virus and
remaining egg-derived materials present in the
inoculum would be expected to show their effects
most markedly in the saline group. Incorpora¬
tion into a water-in-oil emulsion would
undoubtedly reduce their toxic effect (Ramon et
al., 1937; Halbert et al., 1945). The distri¬
bution in the table shows no such bias, so it is
probable that most of the reports are of chance
indisposition not related to the vaccination
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itself.
Reports of pain show a distribution which
may be related to the route of injection used.
In all cases it was very slight. Minor lesions
consisted of erythema, induration and swelling
persisting for several days and were almost
entirely confined to the saline group. These
lesions were not usually noticed until the area
of redness was brought to the volunteer's notice
by someone else.
Despite the frequency of mild reactions
almost all the subjects found both vaccines quite
acceptable. On the whole, the adjuvant vaccine
was rather better received, sone subjects having
found the swelling and erythema produced by the
saline vaccine slightly alarming. This latter
effect would, of course, be reduced if a non¬
toxic vaccine prepared from purified viral
haemagglutinins was used (Davenport et al., 1964).
The most detailed recent account of a trial
of a water-in-oil emulsion vaccine is that of
Cutler et al. (1962). They used a poliomyelitis
vaccine (which, of course, had none of the known
toxic attributes of influenza virus) incorporated
into an emulsion prepared from the same materials
as those used in the present trial. Only 1.1 per
cent of 23,000 recipients showed any side effects.
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These consisted almost entirely of slight local
pain and tenderness. Bell et al. (1961) also
found only 0.03 per cent (in Caucasians) to
1.47 per cent (in Negroes) of cysts or abscesses
in 11,000 people given an oil adjuvant influenza
vaccine. The safety of this type of adjuvant
thxis seems to be well established.
The effect of 'booster' inoculations and the use
of the same adjuvant with other vaccines given
later
With many vaccines it has become almost a
tradition to follow an initial dose with a
'booster* some weeks later. When saline
vaccines are used this is undoubtedly valuable
especially where no immunity is present initially.
The oil adjuvant vaccines, on the other hand,
should produce a high and long-lasting antibody
level sufficient to prime the defence mechanism
for a long period. The value of increasing this
titre at all is debatable and the efficiency with
which it can be done, unknown.
Using the model system of mice given oval¬
bumin in a water-in-oil emulsion, some tests were
carried out to elucidate this point. Mice
already responding to the antigen, which had been
inoculated in a water-in-oil emulsion, were given
a single 'booster' secondary injection of oval-
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bumin in saline. Injections given on the 5th
and 10th days, whilst the climb of the titre to
plateau level was occurring, had no effect on the
shape of the curve (fig. 45). Inoculations
given later, on the 20th, 40th, 80th or 129th
days, produced typical secondary responses (figs,
46 and 47). These appeared to be very similar
to one another (fig. 48). In each case the
post-secondary fall in titre continued fairly
rapidly until a level was reached which was equi¬
valent to the plateau of response which would
have been seen had no secondary inoculation been
given.
Though a short-terra advantage was obtained
the long-term picture was not altered. If
lasting protective antibody levels are required,
•booster' inoculations appear to be unnecessary.
Whether this would be so with the rather
different curve seen with influenza virus vaccine
in man is not known. To obtain a higher peak
titre might mean that it would fall faster so
that there would be no advantage. If it fell at
the same rate, the time during which protective
antibody titres were available would be extended.
It was also evident from the experiment that
the antibody forming mechanism was still as
capable of responding to extra antigen later in
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the response as it was at the beginning.
'Tiredness' did not occur due to the continual
high level of antibody being produced.
If water-in-oil emulsion vaccines come into
general use, man and animals may be given a
number of different vaccines formulated in this
way during their lives. The oil component of
these emulsions is not metabolised and will
probably persist for many years. It is there¬
fore important to know whether there is any
mutual interaction between two vaccines of this
type which is due to the emulsion forming
materials employed.
Mice responding to an antigen which had been
given in water-in-oil emulsion were therefore
inoculated later with another, unrelated, antigen
in the same type of adjuvant. The results,
illustrated in figures 49-52, showed that neither
vaccine had any effect at all on the response to
the other. It is therefore assumed that it
would be perfectly satisfactory to formulate many
vaccines in this manner and inoculate them as
required.
A new method of improving the convenience of
water-in-oil emulsions for practical use
The adjuvant influenza vaccine used in the
tests with human volunteers ('Admune') was packed
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in cartridge inserts which were used in a dental
syringe. This inoculum was given through a
needle with an outside diameter of 0.75 mm. The
trauma caused by the use of a needle of this size
undoubtedly contributed to the reports that pain
at the site of injection lasted longer in this
group.
Water-in-oil emulsions are thick, creamy
materials difficult to pour or inject through
anything but a wide bore needle. Even with the
powerful syringes used, small quantities of
emulsion were left in the cartridge on a few
occasions. For human use, single dose syringes
or cartridges are to be recommended but for many
veterinary applications this is completely un¬
economic. Unfortunately, water-in-oil emulsions
are unsuited for use in multi-dose containers.
To fill any syringe with these materials,
especially without entrapping air, is tedious and
difficult.
By preparing a multiple emulsion from the
water-in-oil emulsion many of these difficiilties
nay be overcome. The thiok unpourable vaccine
is converted into a mobile water-like fluid which
can easily be drawn up into a syringe and
injected through a fine needle. A vaccine
formulated in this way will be at least as
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effective as one in a water-in-oil emulsion
(figs. 43 and 54 and table 38). There is also
some evidence (reviewed in the discussion on the
mode of action of adjuvants) that the response
to an antigen contained in a multiple emulsion
may occur more quickly and earlier due to a rapid
entry into the general circulation of tiny drops
containing portions of the antigen.
Other advantages are, that large single
depots of unmetabolisable oil are not produced,
and that it may be possible to enclose an antigen
in less oil whilst still retaining a. total dose
volume which can be simply injected with an
ordinary syringe.
This new formulation may therefore
considerably extend the range of employment of
water-in-oil emulsion vaccines.
Parts Seven and Eight
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SUMMARY
A review has been made of the literature
relating to:
(a) Adjuvants in general, the oil emulsion
adjuvants in particular, and the mode of action
of the depot-forming adjuvants.
(b) The preparation and purity of the antigen,
ovalbumin, which was used in the chief investi¬
gations .
(c) The tanned red cell agglutination test, the
antibody measuring method employed in this study.
Special reference was made to the effect of
conalbumin on the specificity of the test when
used to measure antibodies raised against impure
preparations of ovalbumin.
It was found that commercially obtained
twice recrystallized ovalbumin, when examined by
immunological methods, contained at least four
other antigens in addition to ovalbumin. Conal¬
bumin was one of these antigens. Egg-white
proteins eluted from CM-cellulose were
characterized immunologically. It was found
that very pure, conalbumin-free ovalbumin could
be prepared by this technique.
Erom this a method was developed for the
preparation of highly purified ovalbumin in
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quantity for use as an antigen. Ovalbumin \*?as
first extracted from egg-white by an abridged
method of crystallisation with ammonium sulphate.
The remaining impurities were then removed by a
simple chromatographic process on a GM-cellulose
column.
A suggestion that tanned cells coated with
impure ovalbumin would respond chiefly to traces
of anti-conalbumin in an anti-ovalburain serum was
not confirmed. Cells coated with a mixture of
ovalbumin and conalbumin responded to whichever
antibody was present in the greatest quantity in
the serum. Conalbumin appeared to be a very
good antigen in the rabbit and it was concluded
that this may account for the anomalous results
reported by other workers.
The conditions under which formalinised
sheep red cells are tanned and coated were
examined in detail. Wide variations in antigen
concentration, pH» temperature, time, materials,
etc., had little effect on the resulting
sensitivity of the cells. Variations in the
strength of the tannic acid used to treat the
cells had a marked effect. A method was devised
for tanning and coating formalinized sheep cells
in bulk. The cells were then stored frozen in
small portions for use as required over many
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months.
Ovalbumin inoculated into mice sub-
cutaneously in a water-in-oil emulsion was found
to stimulate a characteristically high and
sustained response. A high 'plateau' antibody
titre was seen which lasted for at least a year.
Secondary inoculations of ovalbumin in
saline given to mice on the 5th and 10th days
after their inoculation with ovalbumin in a
water-in-oil emulsion had no effect on the
response curve. Secondary inoculations given
between the 20th and 129th days stimulated
secondary responses which appeared as transitory
incidents on the general pattern of the adjuvant
response. These secondary response curves were
almost identical in shape. It was concluded
that 'booster* inoculations may not be found
useful when an adjuvant vaccine of this type is
used.
Two unrelated antigens, ovalbumin and
human-gamma-globulin, given separately in water-
in-oil emulsions to the same animals at different
times showed no mutual interactions. From this
it was concluded that several vaccines to be
given at different times could be satisfactorily
formulated as water-in-oil emulsions.
The emulsifiers Arlacel A and Tween 80
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showed no adjuvant activity when used alone.
Complete water-in-oil emulsion when inoculated
into mice apart from the antigen in time or
place, had no adjuvant effect. Ovalbumin
inoculated in an oil-in-water emulsion stimulated
slightly enhanced titres but no sustained
response. It is suggested that this response is
due to mechanical reasons or 'piggy-back* phago¬
cytosis. ¥o association between, or adsorption
of antigen on to the components of the emulsion
could be demonstrated. IgM type antibody
production was not detected during the adjuvant
response,
A tiny volume of water-in-oil emulsion
containing ovalbumin and injected directly into
a lymph node, stimulated an adjuvant response.
This is held to confirm the view of other workers
that small dispersed depots can be important as
sources of antigen. Removal of the main antigen
depot at the injection site is not therefore a
good test of the ability of a depot-forming
adjuvant to act by slowly releasing antigen over
a long period of time.
Ovalbumin was shown to persist in a fully
active form within an emulsion in vivo in the
mouse for at least 544 days. The break-down of
water-in-oil emulsions in vitro and in vivo
363.
appeared to follow a similar course. In both
cases there was a slow release of the water
phase and hence of the antigen.
The adjuvant type of response curve in mice
could be mimicked by very small daily doses of
antigen in saline. It was therefore postulated
that the only action of a water-in-oil emulsion
adjuvant is to hold, protect, and then very
slowly release the antigen into the circulation
over a long period of time. The implications
of this theory are discussed.
A new type of oil emulsion, a multiple
emulsion in which the antigen is contained within
a secondary dispersed phase in oil droplets is
described. This is a mobile liquid, easily
withdrawn from containers and used with a normal
syringe. Its adjuvant properties were found to
be at least as great as those of a normal water-
in-oil emulsion.
The responses of men to commercial saline
and water-in-oil emulsion influenza virus
vaccines were compared. The adjuvant vaccine,
though containing only one-fifth as much anti¬
genic material as the saline vaccine, stimulated
much higher titres. The titres in both groups
were found to fall at the same rate and no
persistent plateau titre was detected such as
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that seen in mice given ovalbumin in water-in-oil
emulsion. The reason for this is discussed and
explanations suggested.
The reactions to the use of saline and
adjuvant influenza virus vaccines in man were
recorded. Reactions to the saline vaccine were
more marked than those to the adjuvant vaccine
but no serious reactions were reported. Pain
and tenderness lasted slightly longer in the
volunteers inoculated with the adjuvant vaccine,
which was given intramuscularly, than in those
given the saline vaccine subcutaneously. This
was probably related to the routes of inoculation
used. The volunteers found the adjuvant vaccine
quite acceptable and it was concluded that the
water-in-oil emulsion adjuvants are useful
adjuncts to immunization procedures.
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